<SEC-DOCUMENT>0001104659-24-049160.txt : 20240419
<SEC-HEADER>0001104659-24-049160.hdr.sgml : 20240419
<ACCEPTANCE-DATETIME>20240419084517
ACCESSION NUMBER:		0001104659-24-049160
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20240419
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240419
DATE AS OF CHANGE:		20240419

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ClearSign Technologies Corp
		CENTRAL INDEX KEY:			0001434524
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35521
		FILM NUMBER:		24855760

	BUSINESS ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133
		BUSINESS PHONE:		(918) 236-6461

	MAIL ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLEARSIGN COMBUSTION CORP
		DATE OF NAME CHANGE:	20080507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2412212d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:clir="http://clearsign.com/20240419">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_clir_clearsign.com_20240419 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20240419_20240419 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001434524 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001434524</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clir-20240419.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001434524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-19</xbrli:startDate>
        <xbrli:endDate>2024-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b>&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20240419__20240419_zLNlzIIS3Dik"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
<span id="xdx_908_edei--DocumentPeriodEndDate_c20240419__20240419_zgHqV9saytw6"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April 19, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20240419__20240419_zzNOVpQoY8al"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000011" name="dei:EntityRegistrantName">CLEARSIGN TECHNOLOGIES CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in  Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20240419__20240419_zSAzZ57DXRI"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityFileNumber_c20240419__20240419_zHH7PYywh7qc"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000013" name="dei:EntityFileNumber">001-35521</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20240419__20240419_zAOzY99c6xhl" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000014" name="dei:EntityTaxIdentificationNumber">26-2056298</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>incorporation)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font-weight: bold; vertical-align: top; text-align: center"><b>(Commission File No.)</b></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(IRS Employee
    <br/>
Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20240419__20240419_z07vGdDfosjf"><b><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000015" name="dei:EntityAddressAddressLine1">8023 E. 63rd Place, Suite 101</ix:nonNumeric></b></span>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20240419__20240419_z5hWyerbj8ce"><b><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000016" name="dei:EntityAddressCityOrTown">Tulsa</ix:nonNumeric></b></span><b>,
<span id="xdx_904_edei--EntityAddressStateOrProvince_c20240419__20240419_z5I1oZ61y06k"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Oklahoma</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20240419__20240419_zoexQ6koxQj9"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000018" name="dei:EntityAddressPostalZipCode">74133</ix:nonNumeric></span></b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90D_edei--CityAreaCode_c20240419__20240419_zvltictUqei4"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000019" name="dei:CityAreaCode">918</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20240419__20240419_zUtY24I7ytD4"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000020" name="dei:LocalPhoneNumber">236-6461</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Issuer Telephone number)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20240419__20240419_zFHq95lEYwgj"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_904_edei--SolicitingMaterial_c20240419__20240419_zFA0I9ukdei"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20240419__20240419_zxr3eIt5j3kg"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20240419__20240419_zP7bM0cT0THf"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13(e)-4(c))</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 34%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which <br/>
registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--Security12bTitle_c20240419__20240419_zr5yWHkYanfh"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000025" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--TradingSymbol_c20240419__20240419_zIHz2vQgVQE2"><ix:nonNumeric contextRef="AsOf2024-04-19" id="Fact000026" name="dei:TradingSymbol">CLIR</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--SecurityExchangeName_c20240419__20240419_zQkEIE3dQa4g"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top"><td style="width: 100%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth
    company </span><span style="font: 10pt Wingdings"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20240419__20240419_zIlL6ienOrE9"><ix:nonNumeric contextRef="AsOf2024-04-19" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Underwritten Public Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
April&#160;19, 2024, ClearSign Technologies Corporation, a Delaware corporation (the &#8220;Company&#8221;), entered into an underwriting
agreement (the &#8220;Underwriting Agreement&#8221;) with Public Ventures, LLC (&#8220;Public Ventures&#8221;), as underwriter, relating
to the offering, issuance and sale of an aggregate of (i)&#160;4,620,760 shares of the Company&#8217;s common stock, par value $0.0001
per share (&#8220;Common Stock&#8221;), and (ii)&#160;redeemable warrants to purchase 4,620,760 shares of Common Stock (the &#8220;Common
Warrants&#8221;), for aggregate gross proceeds of $4,251,099 (the &#8220;Public Offering&#8221;). The Common Warrants will have an exercise
price of $1.05 per share, subject to adjustment as provided for therein, will be exercisable immediately and be exercisable for a period
of 5 years from the date of issuance. Additionally, the Company may redeem the Common Warrants once they become exercisable upon 30 days&#8217;
advance notice if the closing price of the Common Stock reported equals to or exceeds $2.275 for any 20 business days within a 30 consecutive
business-day period. The Common Warrants will be offered and sold at the rate of one (1)&#160;Common Warrant for every one (1)&#160;share
of Common Stock purchased in the Public Offering. The public offering price for each set of one (1)&#160;share of Common Stock and accompanying
Common Warrant will be $0.92, yielding an effective price of $0.91 per share and $0.01 per Common Warrant. The net proceeds to the Company
from the Public Offering are expected to be approximately $3,630,091, assuming no exercise of the underwriter&#8217;s over-allotment option
(described below) and after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Public Offering is being made pursuant to the Company&#8217;s effective shelf registration statement on Form&#160;S-3 (File No.&#160;333-265967)
that was declared effective on August&#160;12, 2022 (as amended, the &#8220;Registration Statement&#8221;) by the Securities and Exchange
Commission (the &#8220;SEC&#8221;), the base prospectus included therein, the preliminary prospectus supplements filed with the SEC and
a final prospectus supplement to be filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Underwriting Agreement, the Company granted to Public Ventures, as underwriter in the Public Offering, an option, exercisable not
later than 45 days after the execution of the Underwriting Agreement, to purchase from the Company (i)&#160;up to an additional 693,114
shares of Common Stock and accompanying Common Warrants to purchase up to 693,114 shares of Common Stock; or (ii)&#160;up to an additional
693,114 shares of Common Stock only, representing up to fifteen percent (15%) of the shares of Common Stock and Common Warrants, or Common
Stock only, as the case may be, sold in the Public Offering for the purpose of covering over-allotments of such securities, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the terms of the Underwriting Agreement, the Company has agreed to&#160;certain restrictions on the issuance and sale of its Common
Stock and securities convertible into shares of Common Stock until December&#160;31, 2024, subject to certain exceptions set forth therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Underwriting Agreement contains customary representations, warranties and agreements by the Company, conditions to closing, indemnification
obligations of the Company and the underwriters, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the
Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties
to such agreement, and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Underwriting Agreement, the Company agreed to issue to Public Ventures, or its designees, upon the closing of the Public Offering,
warrants (the &#8220;Underwriter&#8217;s Warrants&#8221;) to purchase Common Stock equal to eight percent (8%) of the total number of
shares of Common Stock sold in the Public Offering, or up to 369,660 shares of Common Stock assuming no exercise of the underwriter&#8217;s
over-allotment option (the &#8220;Underwriter&#8217;s Warrant Shares&#8221;). The Underwriter&#8217;s Warrants will be exercisable at
an exercise price of $1.1375 per share. The Underwriter&#8217;s Warrants will become exercisable 180 days after the execution of the Underwriting
Agreement, expire 5 years after the execution of the Underwriting Agreement and may be exercised on a cashless basis based on a formula
set forth therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Underwriting Agreement, the Company&#8217;s directors, officers and five percent (5%) or greater beneficial stockholder entered
into lock-up agreements with Public Ventures, pursuant to which the Company&#8217;s directors and officers have agreed, for a period of
180 days after the closing of the Public Offering, or, with respect to the five percent (5%) or greater stockholder, until December&#160;31,
2024, not to dispose their shares of Common Stock or Common Stock equivalents, subject to certain exceptions (collectively, the &#8220;Lock-Up
Agreements&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company will also enter into a warrant agent agreement with the Company&#8217;s transfer agent, VStock Transfer, LLC (&#8220;VStock&#8221;),
which will act as warrant agent for the Company, setting forth certain terms and conditions with respect to VStock&#8217;s service as
warrant agent for the Common Warrants (the &#8220;Warrant Agent Agreement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Public Offering is expected to close on or about April&#160;23, 2024, subject to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing description of the Underwriting Agreement, the Common Warrants, the Underwriter&#8217;s Warrants, Lock-Up Agreements and the
Warrant Agent Agreement is not complete and is subject to, and qualified in its entirety by, reference to the full text of such documents,
forms of which are filed as Exhibit&#160;1.1, 4.1, 4.2, 10.2, 10.3 and 10.1, respectively, to this Current Report on Form&#160;8-K (this
&#8220;Form&#160;8-K&#8221;) and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Concurrent Private Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
April&#160;19, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with
an accredited investor (&#8220;Private Purchaser&#8221;) whereby the Company will issue, in&#160;a&#160;private placement (the &#8220;Concurrent
Private Offering&#8221;) to be completed concurrently with the completion of the Public Offering, an aggregate of (i)&#160;5,405,405
shares of Common Stock (the &#8220;Private Shares&#8221;), and (ii)&#160;redeemable warrants (the &#8220;Private Warrants&#8221;) to
purchase up to an aggregate of 8,108,108 shares of the Company&#8217;s common stock (&#8220;Private Warrant Shares&#8221;), in a ratio
of one and a half (1 &#189;) Private Warrants for every one (1)&#160;Private Share sold in the Concurrent Private Offering, for aggregate
gross proceeds of $5,000,000.<span style="background-color: white">&#160;</span>The Private Warrants will be exercisable at an exercise
price of $1.05 per share, will be exercisable 6 months after issuance and will expire 5 years from the date of issuance. Additionally,
the Private Warrants may be redeemed by the Company on the same terms as the Common Warrants once they become exercisable, provided that
the Private Warrants may only be redeemed if there is an effective registration statement covering the resale of the Private Warrant
Shares. The offering price for each Private Share and accompanying one and a half (1 <sup>1</sup>/<sub>2</sub>) Private Warrants
will be $0.925. The net proceeds from the Concurrent Private Offering are expected to be approximately $4,481,000, after deducting placement
agent fees and other estimated offering expenses payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
connection with the Concurrent Private Offering, the Company has agreed to file a registration statement covering the resale of the Private
Shares and the Private Warrant Shares within 45 days of the date of the Securities Purchase Agreement, subject to the terms and conditions
of the Securities Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Securities Purchase Agreement contains customary representations, warranties&#160;and agreements of the Company and the Private Purchaser
and customary indemnification rights and obligations of the parties. The representations, warranties and covenants contained in the Securities
Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties
to such agreement, and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to a letter agreement dated as of April&#160;17, 2024, the Company engaged Public Ventures to act as its exclusive placement agent in
connection with the Concurrent Private Offering (the &#8220;Engagement Letter&#8221;). Pursuant to the Engagement Letter, the Company
has agreed to pay Public Ventures a cash fee equal to eight percent (8.0%) of the aggregate gross proceeds of the Concurrent Private Offering,
excluding the proceeds, if any, from the exercise of the Private Warrants. In addition, the Company agreed to issue to Public Ventures
or its designees, upon the closing of the Concurrent Private Offering, warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase
up to 432,432 shares of Common Stock (the &#8220;Placement Agent Warrant Shares&#8221;). The Placement Agent Warrants will be exercisable
180 days after the execution of the Securities Purchase Agreement, expire 5 years after the date of the Securities Purchase Agreement
and may be exercised on a cashless basis based on a formula set forth therein. The Placement Agent Warrants will have substantially the
same terms as the Underwriter&#8217;s Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Concurrent Private Offering is expected to close on or about April&#160;23, 2024, subject to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing description of the Securities Purchase Agreement, the Private Warrants and the Placement Agent Warrants is not complete and
is qualified in its entirety by reference to the full text of such documents, forms of which are filed herewith as Exhibits&#160;10.4,
4.3 and 4.4, respectively, to this Form&#160;8-K and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 3.02 Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. The offer and sale of the Underwriter&#8217;s
Warrants, Underwriter&#8217;s Warrant Shares, Private Shares, Private Warrants, Private Warrant Shares, Placement Agent Warrants and Placement
Agent Warrant Shares have not been registered under the Securities Act and are instead being offered pursuant to the exemption provided
in Section&#160;4(a)(2)&#160;under the Securities Act and Rule&#160;506(b)&#160;promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 7.01. Regulation
FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
April&#160;19, 2024, the Company issued a press release announcing that it had priced the Public Offering and the Concurrent Private Offering.
A copy of the press release is furnished hereto as Exhibit&#160;99.1 to this Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
information in this Form&#160;8-K under Item 7.01, including the information contained in Exhibit&#160;99.1, is being furnished to the
SEC and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended
(the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated
by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by a specific reference
in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Cautionary Statement Regarding Forward-Looking
Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Statements
contained in this Form&#160;8-K regarding matters that are not historical facts are &#8220;forward-looking statements&#8221; within the
meaning of the Private Securities Litigation Reform Act of 1995. Such statements may involve risks and uncertainties, such as statements
related to the anticipated closing of the Public Offering and the Concurrent Private Offering and the amount of proceeds expected from
the Public Offering and the Concurrent Private Offering. The risks and uncertainties involved include the Company&#8217;s ability to satisfy
certain conditions to closing on a timely basis or at all, as well as other risks detailed from time to time in the Company&#8217;s SEC
filings, including in its annual filing on Form&#160;10-K filed with the SEC on April&#160;1, 2024, the preliminary prospectus supplements
filed with the SEC on March&#160;18, 2024 and April&#160;19, 2024, and the final prospectus supplement to be filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>(d)&#160;Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 3%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2412212d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated April&#160;19, 2024, by and between ClearSign Technologies Corporation and Public Ventures, LLC, as Representative of the Underwriters.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Common Warrant.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Underwriter&#8217;s Warrant.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Private Warrant.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex4-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4*</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2412212d1_ex4-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Placement Agent Warrant.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Warrant Agent Agreement by and between ClearSign Technologies Corporation and VStock Transfer, LLC.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Lock-Up Agreement (directors and officers).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Lock-Up Agreement (5% or greater stockholder).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated April 19, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2412212d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1**</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2412212d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated April&#160;19, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">* Filed herewith.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">** Furnished herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span>&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dated: April&#160;19, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CLEARSIGN TECHNOLOGIES CORPORATION</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Colin James
    Deller</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colin James Deller</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</span></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>





<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WlI3g/AyKYksQiK6XXKKJd2R2e3vkXrLViUaBobhnO8cIUJR0Eo3yHBaVCUcsO0a5RAqvCCjOaN35OtNBv5WeNXWsTJueH9gTp5Bz8wmUiovDNaHtlhnEKdRMo9kCvE0S2ew34qg13MyF12jcVo1oEwNe6aONTrF7zHhoF5kqH0PVUdkq8lkkEziUf6AjBMJO3qoJ/HNQlnmIgiHCUTBdO+8a/lyaHoSlg22vs6O9H+DLwk1SpE= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2412212d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4,620,760 SHARES <FONT STYLE="text-transform: uppercase">of
Common Stock</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>and
4,620,760 warrants to purchase Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARSIGN
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">April&nbsp;19, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Ventures, LLC&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">14135 Midway Road, Suite&nbsp;G-150&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Addison, TX 75001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, ClearSign
Technologies Corporation, a company incorporated under the laws of Delaware (the &ldquo;<U>Company</U>&rdquo;), hereby confirms its agreement
(this &ldquo;<U>Agreement</U>&rdquo;) with Public Ventures, LLC, as the underwriter (including others acting as an underwriter, then together,
the &ldquo;<U>Underwriters</U>&rdquo; and each, an &ldquo;<U>Underwriter</U>&rdquo; that are named in <U>Schedule I</U> hereto and in
which case Public Ventures, LLC is acting as representative and therefore referred to herein as the &ldquo;<U>Representative,</U>&rdquo;
and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term
Representative as used herein shall have the same meaning as the Underwriter) on the terms and conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is understood that the
Underwriters are to make a public offering of the Public Securities (as defined below) as soon as the Representative deems it advisable
to do so. The Public Securities are to be initially offered to the public at the public offering prices set forth in the Prospectus Supplement
(as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is further understood that
you will act as the Representative for the Underwriters in the Offering (as defined below) and sale of the Closing Securities (as defined
below) and, if any, the Option Securities (as defined below) in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section&nbsp;1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with such Person as such terms are used in and construed under Rule&nbsp;405 promulgated by the Commission
pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>CERCLA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Closing Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the hour and the date on the Trading Day on which all conditions precedent to (i)&nbsp;the Underwriters&rsquo; obligations
to pay the Closing Purchase Price and (ii)&nbsp;the Company&rsquo;s obligations to deliver the Closing Securities, in each case, have
been satisfied or waived, but in no event later than 10:00 a.m.&nbsp;(New York City time) on the second (2<SUP>nd</SUP>) Trading Day following
the date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(b), which aggregate purchase price shall be
net of the underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Auditor</U>&rdquo; means BPM CPA LLP, with offices located at 1723 Cloverfield Blvd #4017 Santa Monica, California 90404.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Mitchell Silberberg&nbsp;&amp; Knupp LLP, with offices located at 437 Madison Avenue, New York, New York 10022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Controlled
Person</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;6.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Engagement
Agreement</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;7.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Environmental
Law</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>ERISA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(z).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Execution
Date</U>&rdquo; shall mean the date on which the parties execute and enter into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a)&nbsp;shares of Common Stock, equity awards or other securities of the Company under any
equity compensation plan or stock or option plan of the Company or pursuant to another type of arrangement for services rendered or to
be rendered to the Company, duly adopted for such purpose by a majority of the Board of Directors (including, in the case of plans or
arrangements relating to employee compensation, the consent of the majority of the non-employee members of the Board of Directors) or
a majority of the members (who are the non-employee members) of a committee established for such purpose for services rendered or to be
rendered to the Company, (b)&nbsp;securities upon the exercise or exchange of or conversion of or vesting of any securities exercisable
or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such
securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities or to extend the term of such securities, (c)&nbsp;securities issued pursuant
to clirSPV LLC&rsquo;s participation right granted in connection with that certain Stock Purchase Agreement dated July&nbsp;12, 2018,
between the Company and clirSVP LLC (the &ldquo;<U>clirSPV Shares</U>&rdquo;) and (d)&nbsp;securities issued pursuant to acquisitions
or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued
as &ldquo;restricted securities&rdquo; (as defined in Rule&nbsp;144) and carry no registration rights that require or permit the filing
of any registration statement in connection therewith within 120 days following the Closing Date, and provided that any such issuance
shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or
an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in
addition to the investment of funds, but, unless approved by the Representative, which approval shall not be unreasonably withheld, conditioned
or delayed, shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or
to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>General
Disclosure Package</U>&rdquo; means each Permitted Free Writing Prospectus, the Prospectus and the Preliminary Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Golenbock</U>&rdquo;
means Golenbock Eiseman Assor Bell&nbsp;&amp; Peskoe LLP, with offices located at 711 Third Avenue, New York, New York 10017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
means (a)&nbsp;any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in
the ordinary course of business), (b)&nbsp;all guaranties, endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;
and (c)&nbsp;the present value of any lease payments in excess of $100,000 due under leases required to be capitalized in accordance with
GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(o).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Iran Sanctions</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(pp).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>IT Systems
and Data</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(nn).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements that are delivered on the date hereof (i)&nbsp;by each of the Company&rsquo;s officers
and directors, in the form of <U>Exhibit&nbsp;A</U> attached hereto and (ii)&nbsp;by each of the Company&rsquo;s shareholders actually
and beneficially holding 5% or more shares of Common Stock, in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; means (i)&nbsp;a material adverse effect on the legality, validity or enforceability of any Transaction Document,
(ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of
the Company and the Subsidiaries, taken as a whole or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(ff).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Offering</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;2.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Closing Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Closing Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.2(b), which aggregate purchase price
shall be net of the underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Securities</U>&rdquo; shall mean the Option Shares and the Option Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Over-Allotment
Option</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Permitted
Free Writing Prospectus</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means any preliminary prospectus supplement relating to the Public Securities included in the Registration Statement
or filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;promulgated by the Commission pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final base prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the final supplement to the Prospectus complying with Rule&nbsp;424(b)&nbsp;promulgated by the Commission
pursuant to the Securities Act that is filed with the Commission relating to the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Securities</U>&rdquo; means, collectively, the Closing Securities and, if any, the Option Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Warrants</U>&rdquo; means, collectively, the Closing Warrants and, if any, the Option Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means, collectively, the various parts of the registration statement prepared by the Company on Form&nbsp;S-3 (File
No.&nbsp;333-265967) with respect to the Public Securities, each as amended as of the date hereof, including the Prospectus, the Preliminary
Prospectus, the Prospectus Supplement and all exhibits filed with or incorporated by reference into such registration statement, and includes
any Rule&nbsp;462(b)&nbsp;Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;405</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;462(b)&nbsp;Registration
Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Public Securities, which was filed
with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule&nbsp;462(b)&nbsp;promulgated by
the Commission pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Sarbanes-Oxley
Act</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(r).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selected
Dealer</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;6.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Share
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any significant subsidiary of the Company as defined in Article&nbsp;1, Rule&nbsp;1-02 of Regulation S-X promulgated by the Commission
pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or NYSE
American (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreements, the Warrant Agency Agreement, the Warrants, the Underwriter Warrant,
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, 18 Lafayette Place, Woodmere, New York 11598, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriter
Warrant</U>&rdquo; means that certain Underwriter Warrant, dated as of the Closing Date and the Option Closing Date, if any, issued by
the Company to the Representative, in the form of <U>Exhibit&nbsp;C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain Warrant Agency Agreement, dated on or about the date hereof, by and between the Company
and VStock Transfer, LLC, and includes the Warrants to be issued to the public which forms an exhibit thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
shall mean the redeemable warrants to purchase one share of Common Stock, exercisable for a period of five years from the date of this
Agreement, at a price equal to the per share public offering price of the Closing Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(b)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Upon
the terms and subject to the conditions set forth herein, the Company agrees to sell in the aggregate (i)&nbsp;4,620,760 shares of Common
Stock, and each Underwriter agrees to purchase, severally and not jointly, at the Closing, the number of shares of Common Stock (the &ldquo;<U>Closing
Shares</U>&rdquo;) set forth opposite the name of such Underwriter on <U>Schedule I</U> hereof and (ii)&nbsp;4,620,760 Warrants, and each
Underwriter agrees to purchase, severally and not jointly, at the Closing, the number of Warrants (the &ldquo;<U>Closing Warrants</U>&rdquo;)
set forth opposite the name of such Underwriter on <U>Schedule I</U> hereof (together the Closing Shares and the Closing Warrants are
referred to herein as the &ldquo;<U>Closing Securities</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
aggregate purchase price for the Closing Securities shall equal the amount set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereto (the &ldquo;<U>Closing Purchase Price</U>&rdquo;). The purchase price to the Underwriters for one share of Common Stock shall
be $0.8372 per share (the &ldquo;<U>Share Purchase Price</U>&rdquo;) and the purchase price to the Underwriters for one Warrant shall
be $0.0092 per Warrant (the &ldquo;<U>Warrant Purchase Price</U>&rdquo;) (which represents an underwriting discount of 8.0% of the purchase
price per share of Common Stock and per Warrant offered to investors); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">On
the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available funds
equal to such Underwriter&rsquo;s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter its respective
Closing Securities and the Company shall deliver the other items required pursuant to Section&nbsp;2.3 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of counsel to the
Underwriters or such other location as the Company and Representative shall mutually agree. The Public Securities are to be offered initially
to the public at the public offering price set forth on the cover page&nbsp;of the Prospectus Supplement (the &ldquo;<U>Offering</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Over-Allotment
Option</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">For
the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Shares and Closing Warrants,
the Representative is hereby granted an option (the &ldquo;<U>Over-Allotment Option</U>&rdquo;) to purchase, in the aggregate, up to 693,114
shares of Common Stock (the &ldquo;<U>Option Shares</U>&rdquo;) at the Share Purchase Price and up to 693,114 Warrants (the &ldquo;<U>Option
Warrants</U>&rdquo;) at the Warrant Purchase Price; provided that this option may be exercised by the Representative as to any number
of Option Shares only or Option Shares and Option Warrants, as determined by the Representative, in up to the same ratio of Option Warrants
to Option Shares (i.e., no more than one Option Warrant for each Option Share purchased) as offered by the Company to the public in the
Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">In
connection with an exercise of the Over-Allotment Option, the purchase price to be paid for the Option Securities is equal to the product
(i)&nbsp;of the Share Purchase Price multiplied by the number of Option Shares to be purchased, and (ii)&nbsp;of the Warrant Purchase
Price multiplied by the number of Option Warrants to be purchased (the aggregate purchase price to be paid on an Option Closing Date,
the &ldquo;<U>Option Closing Purchase Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Over-Allotment Option granted pursuant to this Section&nbsp;2.2 may be exercised by the Representative as to all (at any time) or a lesser
amount (from time to time) of the Option Securities within forty-five (45) days after the Execution Date. An Underwriter will not be under
any obligation to purchase any Option Securities prior to the exercise of the Over-Allotment Option by the Representative. The Over-Allotment
Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in
writing by overnight mail or other electronic transmission setting forth the number of the Option Securities to be purchased and the date
and time for delivery of and payment for the Option Securities (each, an &ldquo;<U>Option Closing Date</U>&rdquo;), which will not be
later than two (2)&nbsp;full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and
the Representative, at the offices of Golenbock or at such other place (including remotely by other electronic transmission) as shall
be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities does not occur on the Closing
Date, each Option Closing Date will be as set forth in the notice. Upon exercise of the Over-Allotment Option, the Company will become
obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will become obligated
to purchase, the number of Option Securities specified in such notice. The Representative may cancel the Over-Allotment Option at any
time prior to the expiration of the Over-Allotment option by written notice to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Deliveries</U>.
The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">At
the Closing Date, the Closing Securities and, as to each Option Closing Date, if any, the applicable Option Securities, which securities
shall be delivered via The Depository Trust Company facilities for the accounts of the several Underwriters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">At
the Closing Date, a legal opinion of Company Counsel addressed to the Underwriters, including, without limitation, a negative assurance
letter, in customary form reasonably acceptable to the Representative, and as to each Option Closing Date, if any, a bring-down opinion
and negative assurance letter from Company Counsel in form and substance reasonably satisfactory to the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Contemporaneously
herewith, a cold comfort letter addressed to the Underwriters and in form and substance satisfactory in all respects to the Representative
from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as of the Closing Date and
each Option Closing Date, if any;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">On
the Closing Date and on each Option Closing Date, the duly executed and delivered Officer&rsquo;s Certificate, substantially in the form
required by <U>Exhibit&nbsp;D</U> attached hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">On
the Closing Date and on each Option Closing Date, the duly executed and delivered Secretary&rsquo;s Certificate, substantially in the
form required by <U>Exhibit&nbsp;E</U> attached hereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(vi)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Contemporaneously
herewith, the duly executed and delivered Lock-Up Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing
Conditions</U>. The respective obligations of the Underwriters hereunder in connection with the Closing and each Option Closing Date are
subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
accuracy in all material respects when made and on the Closing Date and the Option Closing Date, as the case may be, (other than representations
and warranties of the Company already qualified by materiality, which shall be true and correct in all respects) of the representations
and warranties of the Company contained herein (unless as of a specific date therein, in which case they shall be accurate in all material
respects as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">all
obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
delivery by the Company of the items set forth in Section&nbsp;2.3 of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Registration Statement has become effective and at the Closing Date and each Option Closing Date, if any, no stop order suspending the
effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending before or threatened
by the Commission, and any requests for additional information on the part of the Commission (to be included in the Registration Statement
or the Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission and the Underwriter. A prospectus
supplement containing Rule&nbsp;430B Information shall have been filed with the Commission in the manner and within the period required
by Rule&nbsp;424(b)&nbsp;promulgated by the Commission pursuant to the Securities Act (without reliance on Rule&nbsp;424(b)(8)) or a post-effective
amendment providing such information shall have been promptly filed and declared effective in accordance with the requirements of Rule&nbsp;430B
promulgated by the Commission pursuant to the Securities Act. Any material required to be filed by the Company pursuant to Rule&nbsp;433(d)&nbsp;promulgated
by the Commission pursuant to the Securities Act shall have been timely filed with the Commission in accordance with such rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">by
the Execution Date, if required by FINRA, the Underwriters shall have received clearance from FINRA as to the amount of compensation allowable
or payable to the Underwriters as described in the Registration Statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(vi)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
Company shall have submitted a Notification: Listing of Additional Shares with Nasdaq with respect to the Closing Shares and the Option
Shares to be sold at the Closing Date and the shares of Common Stock underlying the Closing Warrants shall have received no objection
thereto from the Nasdaq Capital Market; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(vii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">prior
to and on each of the Closing Date and each Option Closing Date, if any: (i)&nbsp;there shall have been no material adverse change or
development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition, prospect or business activity is set forth in the Registration Statement,
the General Disclosure Package or the Prospectus Supplement; (ii)&nbsp;no action, suit or proceeding, at law or in equity, shall have
been pending or threatened against the Company or any Affiliate of the Company before or by any court or federal or state commission,
board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business,
operations, prospects or financial condition or income of the Company, except as set forth in the Registration Statement, the General
Disclosure Package or the Prospectus Supplement; (iii)&nbsp;no stop order shall have been issued under the Securities Act and no proceedings
therefor shall have been initiated or threatened by the Commission; and (iv)&nbsp;the Registration Statement and the Prospectus and any
amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the
Securities Act and the rules&nbsp;and regulations thereunder and shall conform in all material respects to the requirements of the Securities
Act and the rules&nbsp;and regulations thereunder, and neither the Registration Statement nor the Prospectus nor any amendment or supplement
thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Execution Date, as of the Closing
Date and as of each Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsidiaries</U>.
Each Subsidiary of the Company has been duly organized and is validly existing in good standing under the laws of the jurisdiction of
its incorporation or organization, has corporate or similar power and authority to own, lease and operate its properties and to conduct
its business as described in the Registration Statement, the General Disclosure Package and the Prospectus Supplement and is duly qualified
to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership
or leasing of property or the conduct of business, except where the failure to so qualify would not have a Material Adverse Effect. Except
as otherwise disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, all of the issued and
outstanding capital stock or equity interests of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable
and is owned by the Company, directly or through Subsidiaries, free and clear of any material security interest, mortgage, pledge, lien,
encumbrance, claim or equity. None of the outstanding shares of capital stock or equity interests of any Subsidiary was issued in violation
of any preemptive or similar rights of any securityholder of such Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Organization;
Qualification; Authorization</U>. The Company has been duly organized and is validly existing as a corporation in good standing under
the laws of the State of Delaware and has corporate power and authority to own, lease, and operate its properties and to conduct its business
as described in the Registration Statement, the General Disclosure Package and the Prospectus Supplement and to enter into and perform
its obligations under this Agreement, the other Transaction Documents, and the various other agreements required hereunder and thereunder
to which it is a party; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each
other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of
business, except for such jurisdictions where the failure to so qualify individually or in the aggregate would not have a Material Adverse
Effect. All necessary corporate action has been duly and validly taken by the Company to authorize the execution, delivery and performance
of each of this Agreement and the other Transaction Documents and the issuance and sale of the Common Stock. Each of this Agreement and
the other Transaction Documents have been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Violations</U>. Neither the Company nor any of its Subsidiaries (i)&nbsp;is in violation of its certificate or articles of incorporation,
by-laws, certificate of limited partnership, agreement of limited partnership, certificate of formation, operating agreement or other
organizational documents, (ii)&nbsp;is in default under, and no event has occurred which, with notice or lapse of time, or both, would
constitute a default under any bond, debenture, note, indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
evidencing an obligation for borrowed money or any other material agreement or instrument to which it is a party or by which it is bound
or to which any of its properties or assets is subject, or (iii)&nbsp;is in violation of any statute, law, rule, regulation, ordinance,
directive, judgment, decree or order of any judicial, regulatory or other legal or governmental agency or body, foreign or domestic, except
(in the case of clause (ii)&nbsp;or (iii)&nbsp;above) for violations or defaults that would not (individually or in the aggregate) reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Conflicts</U>. Neither the execution, delivery and performance of this Agreement or the other Transaction Documents by the Company nor
the consummation of any of the transactions contemplated hereby (including, without limitation, the issuance and sale by the Company of
the Public Securities) will give rise to a right to terminate or accelerate the due date of any payment due under, or conflict with or
result in the breach of any term or provision of, or constitute a default (or an event which with notice or lapse of time or both would
constitute a default) under, or require any consent or waiver under, or result in the execution or imposition of any lien, charge or encumbrance
upon any properties or assets of the Company or any of its Subsidiaries pursuant to the terms of: (i)&nbsp;any indenture, mortgage, deed
of trust or other agreement or instrument evidencing an obligation for borrowed money or any other material agreement or instrument to
which either of the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their properties
or businesses is bound, or any franchise, license, permit, judgment, decree, order, statute, rule&nbsp;or regulation applicable to either
of the Company or any of its Subsidiaries, or (ii)&nbsp;violate any provision of certificate or articles of incorporation, by-laws, certificate
of limited partnership, agreement of limited partnership, certificate of formation, operating agreement or other organizational documents
of either of the Company or any of its Subsidiaries, except (A)&nbsp;in the case of clause (i)&nbsp;above, for violations or defaults
that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and (B)&nbsp;for such consents
or waivers which have already been obtained and are in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filing with the Commission
of the Prospectus Supplement and (ii)&nbsp;such filings as are required to be made under applicable state securities laws, the rules&nbsp;and
regulations of FINRA and the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Registration
Statement</U>. The Company has filed with the Commission a &ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3 under the Securities
Act, which became effective on August&nbsp;12, 2022 (the &ldquo;<U>Effective Date</U>&rdquo;), for the registration under the Securities
Act of the Public Securities. At the time of such filing, the Company met the requirements of Form&nbsp;S-3 under the Securities Act.
The Registration Statement meets the requirements set forth in Rule&nbsp;415(a)(1)(x)&nbsp;under the Securities Act and complies with
said Rule&nbsp;and the Prospectus Supplement will meet the requirements set forth in Rule&nbsp;424(b)&nbsp;promulgated by the Commission
pursuant to the Securities Act. The Company is eligible to use Form&nbsp;S-3 under the Securities Act and it meets the transaction requirements
with respect to the aggregate market value of securities being sold pursuant to this Offering and during the twelve (12) months prior
to the Offering, as set forth in General Instruction I.B.6 of Form&nbsp;S-3. Any reference in this Agreement to the Registration Statement,
the Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein pursuant
to Item 12 of Form&nbsp;S-3 which were filed under the Exchange Act, on or before the date of this Agreement, or the issue date of the
Prospectus or the Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Prospectus or the Prospectus Supplement shall be deemed to
refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Prospectus
or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement to
financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
 &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Prospectus or the Prospectus
Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and
other information which is or is deemed to be incorporated by reference in the Registration Statement, the Prospectus or the Prospectus
Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus
or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s
knowledge, is threatened by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Issuance
of Securities</U>. The Public Securities have been duly authorized for issuance and sale to the Underwriter or its nominees pursuant to
this Agreement, and when the Public Securities have been issued and delivered by the Company pursuant to this Agreement against payment
of the consideration set forth herein, the Public Shares will be validly issued, fully paid and non-assessable and the Public Warrants
will be duly authorized and validly issued, and the Common Stock underlying the Public Warrants, when issued in accordance with the terms
of the Warrants, will be validly issued, fully paid and non-assessable; and the issuance of the Public Securities is not subject to any
preemptive or other similar rights of any securityholder of the Company. The Common Stock and Warrants conform in all material respects
to all statements relating thereto contained in the Registration Statement, the General Disclosure Package and the Prospectus Supplement
and such description conforms in all material respects to the rights set forth in the instruments defining the same; and no holder of
the Public Securities will be subject to personal liability by reason of being such a holder. The Underwriter Warrants have been duly
authorized for issuance and sale to the Underwriter or its nominees and the Common Stock underlying the Underwriter Warrants, when issued
in accordance with the terms of the Underwriter Warrants, will be validly issued, fully paid and non-assessable, and the issuance of the
Underwriter Warrants is not be subject to any preemptive or similar rights of any securityholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Capitalization</U>.
The capitalization of the Company is as set forth in the Registration Statement, the General Disclosure Package and the Prospectus Supplement.
Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Company has not issued
any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of stock options
under the Company&rsquo;s equity incentive plans or stock or option plans, the issuance of shares of Common Stock pursuant to the Company&rsquo;s
employee stock purchase plans or other stock plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding
as of the date of the most recently filed periodic report under the Exchange Act. Except as disclosed in the Registration Statement, the
General Disclosure Package or the Prospectus Supplement, no Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as disclosed in the Registration
Statement, the General Disclosure Package or the Prospectus Supplement, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, Common Stock Equivalents,
or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or the capital stock of any Subsidiary.
The issuance and sale of the Public Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock, Common
Stock Equivalents or other securities to any Person (other than the Underwriters and the holders of the Warrants). Except as disclosed
in or contemplated by the Registration Statement or the General Disclosure Package, there are no outstanding securities or instruments
of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or
instrument upon an issuance of securities by the Company or any Subsidiary. Except as disclosed in or contemplated by the Registration
Statement, the General Disclosure Package or the Prospectus Supplement, there are no outstanding securities or instruments of the Company
or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. Except as disclosed
in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. The authorized shares of the Company conform in all material respects to all statements relating thereto contained
in the Registration Statement and the Prospectus. The offers and sales of the Company&rsquo;s securities were at all relevant times either
registered under the Securities Act and the applicable state securities or Blue Sky laws or, based in part on the representations and
warranties of the purchasers, exempt from such registration requirements. No further approval or authorization of any stockholder, the
Board of Directors or others is required for the issuance and sale of the Public Securities, other than the Commission or FINRA. There
are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which
the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof, for the twelve months
preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
 &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
Registration Statement, the General Disclosure Package and the Prospectus Supplement comply in all material respects with applicable accounting
requirements and the rules&nbsp;and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;), applied on a consistent
basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that
unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements
and documents described in the Registration Statement, the General Disclosure Package or the Prospectus Supplement conform in all material
respects to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities Act and
the rules&nbsp;and regulations thereunder to be described in the Registration Statement, the General Disclosure Package or the Prospectus
Supplement or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each
agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or
affected and (i)&nbsp;that is specifically referred to in the Registration Statement, the General Disclosure Package or the Prospectus
Supplement, or (ii)&nbsp;is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is
in full force and effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other
parties thereto, in accordance with its terms, except (x)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability of any indemnification or contribution provision
may be limited under the federal and state securities laws, and (z)&nbsp;that the remedy of specific performance and injunctive and other
forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore
may be brought. None of the agreements or instruments set forth in clause (i)&nbsp;of the previous sentence has been assigned by the Company,
and neither the Company nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge,
no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the Company&rsquo;s
knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any
existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having
jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws
and regulations, except for such violations that would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof or the Registration Statement,
the General Disclosure Package or the Prospectus Supplement, (i)&nbsp;there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent
or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past
practice and (B)&nbsp;liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared
or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock, (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company equity compensation plans or other stock plans and (vi)&nbsp;no officer or director of the Company
has resigned from any position with the Company. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Public Securities contemplated by this Agreement, no event, liability, fact,
circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least one (1)&nbsp;Trading Day prior to the date that this representation is made. Unless otherwise disclosed in
an SEC Report filed prior to the date hereof, the Registration Statement, the Disclosure Package or the Prospectus Supplement, the Company
has not: (x)&nbsp;issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (y)&nbsp;declared
or paid any dividend or made any other distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Rule&nbsp;405</U>.
At (i)&nbsp;the Effective Date, (ii)&nbsp;the earliest time after the Effective Date that the Company or another offering participant
made a bona fide offer (within the meaning of Rule&nbsp;164(h)(2)&nbsp;promulgated by the Commission pursuant to the Securities Act) of
the Public Securities and (iii)&nbsp;the execution of this Agreement, the Company was not and is not an &ldquo;ineligible issuer,&rdquo;
as defined in Rule&nbsp;405 promulgated by the Commission pursuant to the Securities Act (&ldquo;<U>Rule&nbsp;405</U>&rdquo;), without
taking account of any determination by the Commission pursuant to Rule&nbsp;405 that it is not necessary that the Company be considered
an ineligible issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Litigation</U>.
Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, there is no judicial,
regulatory, arbitral or other legal or governmental proceeding or other litigation or arbitration, domestic or foreign, pending to which
the Company or any of its Subsidiaries is a party or of which any property, operations or assets of the Company or any of its Subsidiaries
is the subject. To the Company&rsquo;s knowledge, no such proceeding, litigation or arbitration is threatened or contemplated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(m)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Labor
Relations</U>. Neither the Company nor any of its Subsidiaries is involved in any labor dispute or, to the knowledge of the Company, is
any such dispute threatened, which dispute would reasonably be expected to result in a Material Adverse Effect. The Company is not aware
of any existing or imminent labor disturbance by the employees of any of its or its Subsidiaries, principal suppliers or contractors which
would reasonably be expected to result in a Material Adverse Effect. The Company is not aware of any threatened or pending litigation
between either of the Company or any of its Subsidiaries and any of its executive officers and has no reason to believe that such officers
will not remain in the employment of the Company or its Subsidiaries, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(n)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Title
to Assets</U>. The Company and its Subsidiaries own or lease all such properties as are necessary and material to the conduct of its business
as presently operated as described in the Registration Statement, the General Disclosure Package or the Prospectus Supplement. The Company
and its Subsidiaries have good and marketable title to all personal property owned by them, free and clear of all Liens except such as
are described in the Registration Statement , the General Disclosure Package or the Prospectus Supplement or such as would not (individually
or in the aggregate) have a Material Adverse Effect. Except as disclosed in the Registration Statement, the General Disclosure Package
or the Prospectus Supplement, any real property and buildings held under lease or sublease by the Company and its Subsidiaries are held
by them under valid, subsisting and enforceable leases with such exceptions as are not material to, and do not interfere with, the use
made and proposed to be made of such property and buildings by the Company and its Subsidiaries. Neither the Company nor any of its Subsidiaries
has received any notice of any claim adverse to its ownership of any real or personal property or of any claim against the continued possession
of any real property, whether owned or held under lease or sublease by the Company or its Subsidiaries, that would have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(o)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Intellectual
Property</U>. The Company and each of its Subsidiaries owns or possesses, and will continue to own or possess immediately following the
Closing in all material respects, legally enforceable rights to use all patents, patent rights, inventions, trademarks, trademark applications,
trade names, service marks, copyrights, copyright applications, licenses, software, know-how and other similar rights and proprietary
knowledge as presently conducted (collectively, &ldquo;<U>Intellectual Property</U>&rdquo;) necessary for the conduct of their respective
businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">There are no inventorship
challenges, opposition or nullity proceedings or interferences declared, commenced, provoked, or, to the Company&rsquo;s knowledge, threatened
with respect to any patents or patent applications owned or licensed by the Company (excluding for the avoidance of doubt, normal processing
of any patent or patent application before applicable patent authorities). To the Company&rsquo;s knowledge, no person or entity (including
any current or former employee or consultant of the Company) is infringing, violating or misappropriating any of the Intellectual Property
owned or licensed by the Company. To the Company&rsquo;s knowledge, neither the conduct nor sales nor use of any products or services
offered by the Company infringes, violates, or constitutes a misappropriation of any Intellectual Property of a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company and
its Subsidiaries have complied with their duty of candor and disclosure to the United States Patent and Trademark Office and any relevant
foreign patent office with respect to all Intellectual Property registrations filed by or on behalf of the Company or any of its Subsidiaries
and have made no material misrepresentation in such applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">All assignments
of Intellectual Property owned by the Company and its Subsidiaries have been properly executed and recorded, except for such deficiencies
as would not materially affect the enforceability thereof. To the Company&rsquo;s knowledge, all Intellectual Property owned and licensed
by the Company is valid and enforceable. All issuance, renewal, maintenance and other payments that are or have become due with respect
to Intellectual Property owned by the Company and used by the Company in the conduct of its business as presently conducted have been
timely paid by or on behalf of the Company. Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus
Supplement, there are no third party joint owners of any Intellectual Property owned by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company has
not used open source materials, in a manner that grants, to any third party, any rights or immunities under Intellectual Property owned
by the Company (including using any open source materials that require, as a condition of exploitation of such open source materials,
that other software incorporated into, derived from or distributed with such open source materials be (i)&nbsp;disclosed or distributed
in source code form, (ii)&nbsp;licensed for the purpose of making derivative works, or (iii)&nbsp;redistribute at no charge or minimal
charge).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Each employee of
the Company or any of its Subsidiaries who is engaged in the creation and development of inventions, discoveries or improvements to the
Company&rsquo;s product portfolio has executed a written agreement expressly assigning to the Company or its relevant Subsidiary all of
such employee&rsquo;s right, title and interest in any inventions, discoveries, or improvements, whether or not patentable, invented,
created, developed, conceived or reduced to practice during the term of such employee&rsquo;s employment and related to the work performed
by such person for the Company or its relevant Subsidiary, and all Intellectual Property rights therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(p)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Insurance</U>.
The Company and its Subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in
such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business,
and all such insurance is in full force and effect. The Company does not have any reason to believe that it or any of its Subsidiaries
will not be able (A)&nbsp;to renew, if desired, its existing insurance coverage as and when such policies expire or (B)&nbsp;to obtain
comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and not at a
cost that is materially more significant. Since January&nbsp;1, 2022, The Company has not been denied any insurance coverage that it has
sought or for which it has applied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(q)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transactions
With Affiliates and Employees</U>. No transaction has occurred between or among either of the Company, its Subsidiaries and any of their
officers or directors, or five percent stockholders or any affiliate or affiliates of any such officer or director or five percent stockholders
that is required to be described in and is not described in the Registration Statement, the General Disclosure Package or the Prospectus
Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(r)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Sarbanes-Oxley</U>.
The Company has taken all commercially reasonable actions to ensure that it is in compliance in all material respects with all provisions
of the Sarbanes-Oxley Act of 2002 and all rules&nbsp;and regulations promulgated thereunder or implementing the provisions thereof (the
 &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;) that are then in effect and with which the Company is required to comply. The Company has not,
directly or indirectly, including through any Subsidiary, extended credit, arranged to extend credit, or renewed any extension of credit,
in the form of a personal loan, to or for any executive officer of the Company or any of its Subsidiaries, or to or for any family member
or affiliate of any director or executive officer of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(s)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Internal
Accounting Controls</U>. The books, records and accounts of the Company and its Subsidiaries accurately and fairly reflect, in all material
respects, the transactions in, and dispositions of, the assets of, and the results of operations of, the Company and its Subsidiaries.
Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Company and such Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i)&nbsp;transactions are executed
in accordance with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation
of financial statements in accordance with GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in
accordance with management&rsquo;s general or specific authorization and (iv)&nbsp;the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware
of (x)&nbsp;any material weakness or significant deficiency in the design or operation of internal controls which could adversely affect
the Company&rsquo;s ability to record, process, summarize and report financial data or any material weaknesses in internal controls, except
as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement; or (y)&nbsp;any fraud, whether
or not material, that involves management or other employees who have a role in the Company&rsquo;s internal controls.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(t)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Certain
Fees</U>. There are no claims, payments, issuances, arrangements or understandings for services in the nature of a finder&rsquo;s, consulting
or origination fee with respect to the introduction of the Company to the Underwriters or the sale of the Public Securities hereunder
or any other arrangements, agreements, understandings, payments or issuances with respect to the Company that may affect the Underwriters&rsquo;
compensation, as determined by the FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(u)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Investment
Company</U>. The Company is not and, after giving effect to the Offering, the sale of the Public Securities and the application of proceeds
thereof as described in the General Disclosure Package, will not be required to register as an &ldquo;investment company&rdquo; within
the meaning of the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section&nbsp;12(b)&nbsp;of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act. The Company has not received any notification that the Commission is contemplating terminating such Exchange
Act registration. Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the
Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has
been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading
Market. Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Company is,
and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company
or another established clearing corporation and the Company is current in payment of the fees of the Depository Trust Company (or such
other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(w)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Disclosure;
10b-5</U>. The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules
as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any, at the time it
became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable rules&nbsp;and regulations
under the Securities Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Preliminary
Prospectus, Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities
Act and the Exchange Act and the applicable rules&nbsp;and regulations. Each of the Preliminary Prospectus, Prospectus and the Prospectus
Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading; provided that this representation and warranty shall not apply to statements made or statements omitted upon and in conformity
with written information furnished to the Company with respect to the applicable Underwriters by or on behalf of the Representative expressly
for use in the Registration Statement, Prospectus, Preliminary Prospectus or Prospectus Supplement, or any amendment or supplement thereto,
with the understanding that the Representative has provided only the statements in the Underwriting section of the Registration Statement,
the General Disclosure Package and Prospectus Supplement in the subheadings &ldquo;Discretionary Accounts&rdquo; and &ldquo;Price Stabilization,
Short Positions and Penalty Bids&rdquo; and the second sentence of &ldquo;Electronic Offer, Sale and Distribution of Securities.&rdquo;
(the &ldquo;<B>Underwriter Information</B>&rdquo;) The SEC Reports, when they were filed with the Commission, conformed in all material
respects to the requirements of the Exchange Act and the applicable rules&nbsp;and regulations, and none of such documents, when they
were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make
the statements therein (with respect to the SEC Reports incorporated by reference in the Preliminary Prospectus, Prospectus or Prospectus
Supplement), in light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated
by reference in the Preliminary Prospectus, Prospectus or Prospectus Supplement, when such documents are filed with the Commission, will
conform in all material respects to the requirements of the Exchange Act and the applicable rules&nbsp;and regulations, as applicable,
and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein,
in light of the circumstances under which they were made not misleading. There are no documents required to be filed with the Commission
in connection with the transaction contemplated hereby that (x)&nbsp;have not been filed as required pursuant to the Securities Act or
(y)&nbsp;will not be filed within the requisite time period. There are no contracts or other documents required to be described in the
Preliminary Prospectus, Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(x)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Integrated Offering</U>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this Offering of the Public Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder
approval provisions of any Trading Market on which any of the securities of the Company are listed or designated. Except as described
in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Company has not sold or issued any shares
of Common Stock during the six-month period preceding the date of the Prospectus, including any sales pursuant to Rule&nbsp;144A under,
or Regulations D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, qualified stock options plans
or other employee compensation plans or other stock plans or pursuant to outstanding options, rights or warrants. Neither the Company
nor any of its affiliates (as such term is defined under Rule&nbsp;144 of the Securities Act) has, prior to the date hereof, made any
offer or sales of any securities which are required to be &ldquo;integrated&rdquo; pursuant to the Securities Act or the Rules&nbsp;with
the offer and sale of the Public Securities pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(y)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Public Securities hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute unreasonably small capital to carry on
its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)&nbsp;the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking
into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or
circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws
of any jurisdiction within one year from the Closing Date. The Registration Statement, the General Disclosure Package or the Prospectus
Supplement sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for
which the Company or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness,
which would have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(z)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>ERISA</U>.
The Company fulfilled its obligations, if any, under the minimum funding standards of Section&nbsp;302 of the U.S. Employee Retirement
Income Security Act of 1974 (&ldquo;<U>ERISA</U>&rdquo;) and the regulations and published interpretations thereunder with respect to
each &ldquo;plan&rdquo; as defined in Section&nbsp;3(3)&nbsp;of ERISA and such regulations and published interpretations in which its
employees are eligible to participate and each such plan is in compliance in all material respects with the presently applicable provisions
of ERISA and such regulations and published interpretations. No &ldquo;Reportable Event&rdquo; (as defined in 12 ERISA) has occurred with
respect to any &ldquo;Pension Plan&rdquo; (as defined in ERISA) for which the Company could have any liability. The execution of the Transaction
Documents and consummation of the Offering does not constitute a triggering event under any plan or any other employment contract, whether
or not legally enforceable, which (either alone or upon the occurrence of any additional or subsequent event) will or may result in any
payment (of severance pay or otherwise), acceleration, increase in vesting, or increase in benefits to any current or former participant,
employee or director of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(aa)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Tax
Status</U>. The Company and its Subsidiaries have filed all material federal, state, local and foreign tax returns which are required
to be filed through the date hereof, which returns are true and correct in all material respects, or has received timely extensions thereof,
and has paid all taxes shown on such returns and all assessments received by the Company to the extent that the same are material and
have become due. There are no material tax audits or investigations pending; nor are there any material proposed additional tax assessments
against either the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(bb)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Foreign
Corrupt Practices</U>. Neither the Company nor any other person associated with it or acting on its behalf including, without limitation,
any director, officer, agent or employee of the Company or its Subsidiaries, has, directly or indirectly, while acting on behalf of the
Company or its Subsidiaries: (i)&nbsp;used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses
relating to political activity; (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or to foreign
or domestic political parties or campaigns from corporate funds; (iii)&nbsp;violated any provision of the FCPA; or (iv)&nbsp;made any
other unlawful payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(cc)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Accountants</U>.
To the knowledge and belief of the Company, the Company Auditor (i)&nbsp;is an independent registered public accounting firm as required
by the Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the fiscal year ending December&nbsp;31, 2024. The Company Auditor has not, during the periods covered by the financial
statements included in the Prospectus, provided to the Company any non-audit services, as such term is used in Section&nbsp;10A(g)&nbsp;of
the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(dd)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>[Intentionally
omitted].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ee)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>[Intentionally
omitted].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ff)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>OFAC</U>.
Neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate
of the Company or its Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of
the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;); and the Company will not directly or indirectly use the proceeds of the Offering,
or lend, contribute or otherwise make available such proceeds to its Subsidiaries or any joint venture partner or other person or entity,
for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(gg)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(hh)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a
bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all jurisdictions, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines,
issued, administered or enforced by any governmental agency (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;) and no action,
suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company and its Subsidiaries
with respect to the Money Laundering Laws is pending, or to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(jj)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>D&amp;O
Questionnaires</U>. All information contained in the questionnaires completed by each of the Company&rsquo;s officers and directors and
provided to the Underwriter as well as the biographies of such individuals in the Registration Statement is true and correct in all material
respects and the Company has not become aware of any information that would cause the information disclosed in the questionnaires completed
by the directors and officers to become inaccurate and incorrect in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(kk)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>FINRA
Affiliation</U>. To the knowledge of the Company, no: (i)&nbsp;officer or director of the Company or its Subsidiaries, (ii)&nbsp;owner
of 5% or more of the Company&rsquo;s unregistered securities or (iii)&nbsp;owner of any amount of the Company&rsquo;s unregistered securities
acquired within the 180-day period prior to the date of the Preliminary Prospectus has any direct or indirect affiliation or association
with any FINRA member. The Company will advise the Underwriter and its counsel if it becomes aware that any officer, director or stockholder
of the Company or its Subsidiaries is or becomes an affiliate or associated person of a FINRA member participating in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ll)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Officer&rsquo;s
Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative or Golenbock
shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(mm)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Board
of Directors</U>. The Board of Directors is comprised of the persons set forth in the SEC Reports. The qualifications of the persons serving
as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act and the rules&nbsp;promulgated
thereunder applicable to the Company and the rules&nbsp;of the Trading Market. At least one member of the Board of Directors qualifies
as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act and the rules&nbsp;promulgated thereunder and
the rules&nbsp;of the Trading Market. In addition, except as disclosed in the Registration Statement, the General Disclosure Package or
the Prospectus Supplement, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as
defined under the rules&nbsp;of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Except as disclosed
in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, the Board of Directors has validly established
an audit committee whose composition satisfies, and upon completion of the Offering will satisfy, the requirements of Section&nbsp;303A
of the Nasdaq Listing Rules&nbsp;and the Board of Directors and/or the audit committee of the Board of Directors has adopted a charter
that satisfies the requirements of Section&nbsp;303A of the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Board of Directors
has validly established a compensation committee whose composition satisfies, and upon completion of the Offering will satisfy, the requirements
of Section&nbsp;303A of the Nasdaq Listing Rules&nbsp;and the Board of Directors and/or the compensation committee of the Board of Directors
has adopted a charter that satisfies the requirements of Section&nbsp;303A of the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Board of Directors
have adopted a claw back policy which meets the requirements of Nasdaq and filed the same with its SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(nn)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Cybersecurity</U>.
Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, and except as would not,
individually or in the aggregate would have a Material Adverse Effect, (i)(x)&nbsp;there has been no security breach or other compromise
of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware,
software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or
on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y)&nbsp;the Company and the Subsidiaries
have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security
breach or other compromise to its IT Systems and Data; (ii)&nbsp;the Company and the Subsidiaries are presently in compliance with all
applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the
aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially reasonable
safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security
of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent
with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(oo)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Environmental
Laws</U>.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except as disclosed in the Registration Statement, the
General Disclosure Package or the Prospectus Supplement: (i)&nbsp;the Company and each of its Subsidiaries is in compliance in all material
respects with all rules, laws and regulation relating to the use, treatment, storage and disposal of toxic substances and protection of
health or the environment (&ldquo;<U>Environmental Law</U>&rdquo;) which are applicable to its business; (ii)&nbsp;neither the Company
nor any of its Subsidiaries has received any notice from any governmental authority or third party of an asserted claim under Environmental
Laws; (iii)&nbsp;the Company and each of its Subsidiaries has received all permits, licenses or other approvals required of it under applicable
Environmental Laws to conduct its business and is in compliance in all material respects with all terms and conditions of any such permit,
license or approval; (iv)&nbsp;to the knowledge of the Company, no facts currently exist that will require either Company or its Subsidiaries
to make future material capital expenditures to comply with Environmental Laws; and (v)&nbsp;no property which is or has been owned, leased
or occupied by either of the Company or its Subsidiaries has been designated as a &ldquo;Superfund site&rdquo; pursuant to the Comprehensive
Environmental Response, Compensation of Liability Act of 1980, as amended (42 U.S.C. Section&nbsp;9601, et. seq.) (&ldquo;<U>CERCLA</U>&rdquo;),
or otherwise designated as a contaminated site under applicable state or local law. Neither the Company nor its Subsidiaries has been
named as a &ldquo;potentially responsible party&rdquo; under CERCLA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(pp)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Iran
Sanctions</U>. Neither the Company nor any of its directors or officers or, to the knowledge of the Company, any agent, employee, affiliate
or other person acting on behalf of the Company has engaged in any activities sanctionable under the Comprehensive Iran Sanctions, Accountability,
and Divestment Act of 2010, the Iran Sanctions Act of 1996, the National Defense Authorization Act for Fiscal Year 2012, the Iran Threat
Reduction and Syria Human Rights Act of 2012 or any Executive Order relating to any of the foregoing (collectively, and as each may be
amended from time to time, the &ldquo;<U>Iran Sanctions</U>&rdquo;); and the Company will not knowingly, directly or indirectly use the
proceeds of the Offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other
person or entity, for the purpose of engaging in any activities sanctionable under the Iran Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(qq)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Statistical
and Market Related Data</U>. The statistical and market related data included in the Registration Statement , the General Disclosure Package
and the Prospectus Supplement are based on or derived from sources that the Company believes to be reliable and accurate. The Company
had a reasonable basis for, and made in good faith, each &ldquo;forward-looking statement&rdquo; (within the meaning of Section&nbsp;27A
of the Act or Section&nbsp;21E of the Exchange Act) contained or incorporated by reference in the Registration Statement, the General
Disclosure Package or the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(rr)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stabilization
or Manipulation</U>. Neither the Company nor any of its Subsidiaries has taken, nor will it take, directly or indirectly, any action designed
to or which might reasonably be expected to cause or result in, or which has constituted or which might reasonably be expected to constitute,
the stabilization or manipulation of the price of the Common Stock or any other security of the Company to facilitate the sale or resale
of any of Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ss)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Prohibited
Activities</U>. Except as disclosed in the Registration Statement, the General Disclosure Package or the Prospectus Supplement, and as
preapproved in accordance with the requirements set forth in Section&nbsp;10A of the Exchange Act, the Auditors have not been engaged
by the Company to perform any &ldquo;prohibited activities&rdquo; (as defined in Section&nbsp;10A of the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(tt)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Off-Balance
Sheet Arrangements</U>. Except as disclosed in the Registration Statement or in the General Disclosure Package, there are no material
off-balance sheet arrangements (as defined in Item 303 of Regulation S-K) that have or are reasonably likely to have a material current
or future effect on the Company&rsquo;s financial condition, revenues or expenses, changes in financial condition, results of operations,
liquidity, capital expenditures or capital resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(uu)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Payment of Net Proceeds to FINRA Members</U>. None of the net proceeds of the Offering will be paid by the Company to any participating
FINRA member or any affiliate or associate of any participating FINRA member, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendments
to Registration Statement</U>. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed
copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed
copies of the Registration Statement (without exhibits), the Prospectus and the Prospectus Supplement, as amended or supplemented, in
such quantities and at such places as an Underwriter reasonably requests. Neither the Company nor any of its directors and officers has
distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale
of the Public Securities other than the Prospectus, the Prospectus Supplement, the Registration Statement, and copies of the documents
incorporated by reference therein. The Company shall not file any such amendment or supplement to which the Representative shall reasonably
object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Federal
Securities Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Compliance</U>.
During the time when a Preliminary Prospectus, Prospectus and Prospectus Supplement is required to be delivered under the Securities Act,
the Company will use its commercially reasonable efforts to comply with all requirements imposed upon it by the Securities Act and the
rules&nbsp;and regulations thereunder and the Exchange Act and the rules&nbsp;and regulations thereunder, as from time to time in force,
so far as necessary to permit the continuance of sales of or dealings in the Public Securities in accordance with the provisions hereof
and the Preliminary Prospectus, Prospectus and Prospectus Supplement. If at any time when a Preliminary Prospectus, Prospectus and Prospectus
Supplement relating to the Public Securities is required to be delivered under the Securities Act, any event shall have occurred as a
result of which, in the opinion of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented,
includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time to
amend the Preliminary Prospectus, Prospectus and Prospectus Supplement to comply with the Securities Act, the Company will notify the
Underwriters promptly and prepare and file with the Commission, subject to Section&nbsp;4.1 hereof, an appropriate amendment or supplement
in accordance with Section&nbsp;10 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Filing
of Final Prospectus Supplement</U>. The Company will file the Prospectus Supplement (in form and substance satisfactory to the Representative)
with the Commission pursuant to the requirements of Rule&nbsp;424.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exchange
Act Registration</U>. For a period of two (2)&nbsp;years from the Execution Date, the Company will use its commercially reasonable efforts
to maintain the registration of the Common Stock under the Exchange Act. The Company will not deregister the Common Stock under the Exchange
Act without the prior written consent of the Representative, which consent shall not be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Free
Writing Prospectuses</U>. The Company represents and agrees that it has not made and will not make any offer relating to the Public Securities
that would constitute an issuer free writing prospectus, as defined in Rule&nbsp;433 of the rules&nbsp;and regulations under the Securities
Act, without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is herein
referred to as a &ldquo;<U>Permitted Free Writing Prospectus</U>&rdquo;. The Company represents that it will treat each Permitted Free
Writing Prospectus as an &ldquo;issuer free writing prospectus&rdquo; as defined in Rule&nbsp;405 under the Securities Act, and has complied
and will comply with the applicable requirements of Rule&nbsp;433 of the Securities Act, including timely Commission filing where required,
legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
to the Underwriters of Prospectuses</U>. The Company will deliver to the Underwriters, without charge, from time to time during the period
when the Preliminary Prospectus, Prospectus and Prospectus Supplement is required to be delivered under the Securities Act or the Exchange
Act such number of copies of each Preliminary Prospectus, Prospectus and Prospectus Supplement as the Underwriters may reasonably request,
including exhibits, and all post-effective amendments thereto and copies of all exhibits filed therewith or incorporated therein by reference
and all original executed consents of certified experts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Effectiveness
and Events Requiring Notice to the Underwriters</U>. The Company will use its commercially reasonable efforts to cause the Registration
Statement to remain effective with a current prospectus until nine (9)&nbsp;months from the Execution Date, and will notify the Underwriters
immediately and confirm the notice in writing: (i)&nbsp;of the effectiveness of the Registration Statement and any amendment thereto;
(ii)&nbsp;of the issuance by the Commission of any stop order or of the initiation, or to its knowledge the threatening, of any proceeding
for that purpose; (iii)&nbsp;of the issuance by any state securities commission of any proceedings for the suspension of the qualification
of the Public Securities for offering or sale in any jurisdiction or of the initiation, or to its knowledge the threatening, of any proceeding
for that purpose; (iv)&nbsp;of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
Statement or Prospectus or Prospectus Supplement; (v)&nbsp;of the receipt of any comments or request for any additional information from
the Commission; and (vi)&nbsp;of the happening of any event during the period described in this Section&nbsp;4.4 that, in the judgment
of the Company, makes any statement of a material fact made in the Registration Statement or Preliminary Prospectus, Prospectus and Prospectus
Supplement untrue or that requires the making of any changes in the Registration Statement or the Preliminary Prospectus, Prospectus and
Prospectus Supplement in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
If the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company will
use commercially reasonable efforts to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.5</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Review
of Financial Statements</U>. For a period of five (5)&nbsp;years from the Execution Date, so long as the Common Stock is registered pursuant
to the Exchange Act, the Company, at its expense, shall cause its regularly engaged independent registered public accountants to review
(but not audit) the Company&rsquo;s financial statements for each of the first three (3)&nbsp;fiscal quarters prior to the announcement
of quarterly financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.6</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Expenses
of the Offering</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>General
Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and each Option Closing Date, if any,
to the extent not paid at the Closing Date, all reasonable, necessary and accountable out-of-pocket expenses incident to the performance
of the obligations of the Company under this Agreement (except for those that FINRA regulation requires to be borne by a selling agent,
placement agent or underwriter), including, but not limited to: (a)&nbsp;all filing fees and communication expenses relating to the registration
of the Public Securities to be sold in the Offering (including the Option Securities) with the Commission; (b)&nbsp;all FINRA Public Offering
Filing System fees associated with the review of the Offering by FINRA; all fees and expenses relating to the listing of such Closing
Securities and Option Securities on the Trading Market and such other stock exchanges as the Company and the Representative together determine;
(c)&nbsp;all fees, expenses and disbursements relating to the registration or qualification of such Public Securities under the &ldquo;blue
sky&rdquo; securities laws of such states and other foreign jurisdictions as the Representative may reasonably designate (including, without
limitation, all filing and registration fees, and the fees and expenses of Blue Sky counsel); (d)&nbsp;the costs of all mailing and printing
of the underwriting documents (including, without limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any
Agreement Among Underwriters, Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration
Statements, prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses and Prospectus
Supplements as the Representative may reasonably deem necessary; (e)&nbsp;the costs and expenses of the Company&rsquo;s public relations
firm; (f)&nbsp;the costs of preparing, printing and delivering the Public Securities; (g)&nbsp;fees and expenses of the Transfer Agent
for the Public Securities (including, without limitation, any fees required for same-day processing of any instruction letter delivered
by the Company); (h)&nbsp;stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters;
(i)&nbsp;the fees and expenses of the Company&rsquo;s accountants; (j)&nbsp;the fees and expenses of the Company&rsquo;s legal counsel
and other agents and representatives; and (k)&nbsp;the Underwriters&rsquo; costs of mailing prospectuses to prospective investors. The
Underwriters may deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or each Option Closing Date,
if any, the expenses set forth herein to be paid by the Company to the Underwriters, subject to the maximum amount permitted under Section&nbsp;4.6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Expenses
of the Representative</U>. The Company further agrees that, in addition to the expenses directly incurred by the Company pursuant to Section&nbsp;4.6(a),
on the Closing Date, the Company will reimburse the Representative up to an aggregate of $125,000.00 of fees and expenses, comprised of
the reasonable fees, costs and disbursements of its legal counsel up to $100,000.00, and other all documented, accountable and reasonable
out-of-pocket expenses of the Representative up to $25,000, by deduction from the proceeds of the Offering contemplated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.7</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Application
of Net Proceeds</U>. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application
described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.8</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
of Earnings Statements to Security Holders</U>. The Company will make generally available to its security holders as soon as practicable,
but not later than the first day of the fifteenth full calendar month following the Execution Date, an earnings statement (which need
not be certified by independent public or independent certified public accountants unless required by the Securities Act or the Rules&nbsp;and
Regulations under the Securities Act, but which shall satisfy the provisions of Rule&nbsp;158(a)&nbsp;under Section&nbsp;11(a)&nbsp;of
the Securities Act) covering a period of at least twelve consecutive months beginning after the Execution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.9</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stabilization</U>.
Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Representative)
has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to
cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.10</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Internal
Controls</U>. The Company shall use commercially reasonable efforts to maintain a system of internal accounting controls sufficient to
provide reasonable assurances that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorization;
(ii)&nbsp;transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to
maintain accountability for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization; and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.11</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Accountants</U>.
The Company shall continue to retain a nationally recognized independent certified public accounting firm for a period of at least five
(5)&nbsp;years after the Execution Date. The Underwriters acknowledge that the Company Auditor is acceptable to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.12</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>FINRA</U>.
The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any 10% or greater shareholder
of the Company becomes an affiliate or associated person of an Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.13</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely contractual
and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer
shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in
connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to
the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering that are not
limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the shares
and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company
hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with
respect to any breach or alleged breach of fiduciary duty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.14</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Board
Composition and Board Designations</U>. While the Common Stock is listed on the Trading Market, the Company shall ensure that: (i)&nbsp;the
qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley
Act and the rules&nbsp;promulgated thereunder and with the listing requirements of the Trading Market and (ii)&nbsp;if applicable, at
least one member of the Board of Directors qualifies as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley
Act and the rules&nbsp;promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.15</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Securities
Laws Disclosure; Publicity</U>. At the request of the Representative, by 8:30 a.m.&nbsp;(New York City time) on the date hereof, the Company shall issue a press release disclosing the material terms of the Offering. The Company and the
Representative shall consult with each other in issuing any other press releases with respect to the Offering, and neither the Company
nor any Underwriter shall issue any such press release nor otherwise make any such public statement without the prior written consent
of the Company, with respect to any press release of such Underwriter, or without the prior written consent of such Underwriter, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law in the reasonable judgment of the disclosing party&rsquo;s counsel, in which case the disclosing party shall promptly
provide the other party with prior notice of such public statement or communication. The Company will not issue press releases or engage
in any other publicity, without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m.&nbsp;(New York City
time) on the first Business Day following the 45th day following the Closing Date, other than normal and customary releases issued in
the ordinary course of the Company&rsquo;s business or as otherwise permitted under the terms of this Section&nbsp;4.15.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.16</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Underwriter
of the Public Securities is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Underwriter of Public Securities could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.17</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Option
Securities pursuant to the Over-Allotment Option, including for the avoidance of doubt, the Common Stock underlying the Warrants pursuant
to the terms of the Warrant for the reservation of shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.18</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common
Stock (including the Closing Shares, the Option Shares, and the Common Stock underlying the Closing Warrants and Option Warrants) on the
Trading Market on which it is currently listed. The Company further agrees, if the Company applies to have the Common Stock traded on
any other Trading Market, it will then include in such application all of the Closing Shares, Option Shares and the Common Stock underlying
the Closing Warrants and Option Warrants, and will take such other action as is necessary to cause all of such shares of Common Stock
to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take commercially reasonable efforts
to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules&nbsp;of the Trading Market. The Company agrees use commercially reasonable efforts
to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing
corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.19</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.20</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsequent
Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">From
the date hereof until December&nbsp;31, 2024, neither the Company nor any Subsidiary (other than to the Company) shall issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or file
any registration statement or amendment or supplement thereto, other than (i)&nbsp;the Prospectus Supplement or any other amendments and
supplements to the Registration Statement in connection with the Offering, (ii)&nbsp;a registration statement on Form&nbsp;S-8, (iii)&nbsp;a
registration statement covering the Common Stock underlying the Underwriter Warrants or (iv)&nbsp;a registration statement covering the
clirSPV Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">From
the date hereof until December&nbsp;31, 2024, the Company shall be prohibited from effecting or entering into an agreement to effect any
issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving
a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i)&nbsp;issues or
sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional
shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate or other price that is based upon, and/or
varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or
equity securities or (B)&nbsp;with a conversion, exercise or exchange price that is subject to being reset at some future date after the
initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price regardless
of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled.
Any Underwriter shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be
in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, this Section&nbsp;4.20 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.21</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Research
Independence</U>. The Company acknowledges that each Underwriter&rsquo;s research analysts and research departments, if any, are required
to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and
that such Underwriter&rsquo;s research analysts may hold and make statements or investment recommendations and/or publish research reports
with respect to the Company and/or the Offering that differ from the views of its investment bankers. The Company hereby waives and releases,
to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of
interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be
different from or inconsistent with the views or advice communicated to the Company by such Underwriter&rsquo;s investment banking divisions.
The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable
securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or
equity securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFAULT BY UNDERWRITERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the Closing Date or
any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing Securities or Option Securities,
as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise than by reason of any default on
the part of the Company), the Representative, or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters,
shall use their reasonable efforts to procure within 36 hours thereafter one or more of the other Underwriters, or any others, to purchase
from the Company such amounts as may be agreed upon and upon the terms set forth herein, the Closing Securities or Option Securities,
as the case may be, which the defaulting Underwriter or Underwriters failed to purchase. If during such 36 hours the Representative shall
not have procured such other Underwriters, or any others, to purchase the Closing Securities or Option Securities, as the case may be,
agreed to be purchased by the defaulting Underwriter or Underwriters, then (a)&nbsp;if the aggregate number of Closing Securities or Option
Securities, as the case may be, with respect to which such default shall occur does not exceed 10% of the Closing Securities or Option
Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in proportion to the respective
numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder, to purchase the
Closing Securities or Option Securities, as the case may be, which such defaulting Underwriter or Underwriters failed to purchase, or
(b)&nbsp;if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall
occur exceeds 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the Company or the Representative
will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the Company except
to the extent provided in Article&nbsp;VI hereof; provided that if the default occurs with respect to the Option Securities only, this
Agreement may not be terminated by the Representative as to the Closing Securities. In the event of a default by any Underwriter or Underwriters,
as set forth in this Article&nbsp;V, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative,
or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes
in the Prospectus or in any other documents or arrangements may be effected. The term &ldquo;Underwriter&rdquo; includes any Person substituted
for a defaulting Underwriter. Any action taken under this Section&nbsp;shall not relieve any defaulting Underwriter from liability in
respect of any default of such Underwriter under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Indemnification
of the Underwriters</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless the Underwriters,
and each dealer selected by each Underwriter that participates in the offer and sale of the Public Securities (each a &ldquo;<U>Selected
Dealer</U>&rdquo;) and each of their respective directors, officers and employees and each Person, if any, who controls such Underwriter
or any Selected Dealer (&ldquo;<U>Controlling Person</U>&rdquo;) within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act, against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all
legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened,
or any claim whatsoever, whether arising out of any action between such Underwriter and the Company or between such Underwriter and any
third party or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute
or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue
statement of a material fact contained in (i)&nbsp;any Preliminary Prospectus, if any, the Registration Statement or the Prospectus (as
from time to time each may be amended and supplemented); (ii)&nbsp;any materials or information provided to investors by, or with the
approval of, the Company in connection with the marketing of the offering of the Public Securities, including any &ldquo;road show&rdquo;
or investor presentations made to investors by the Company (whether in person or electronically); or (iii)&nbsp;any application or other
document or written communication (in this Article&nbsp;VI, collectively called &ldquo;<U>application</U>&rdquo;) executed by the Company
or based upon written information furnished by the Company in any jurisdiction in order to qualify the Public Securities under the securities
laws thereof or filed with the Commission, any state securities commission or agency, Trading Market or any securities exchange; or the
omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance upon and
in conformity with written information furnished to the Company with respect to the applicable Underwriter by or on behalf of such Underwriter
expressly for use in any Preliminary Prospectus, if any, the Registration Statement, Prospectus, Preliminary Prospectus or Prospectus
Supplement, or any amendment or supplement thereto, or in any application, as the case may be. With respect to any untrue statement or
omission or alleged untrue statement or omission made in the Preliminary Prospectus, if any, the indemnity agreement contained in this
Section&nbsp;6.1 shall not inure to the benefit of an Underwriter to the extent that any loss, liability, claim, damage or expense of
such Underwriter results from the fact that a copy of the Prospectus was not given or sent to the Person asserting any such loss, liability,
claim or damage at or prior to the written confirmation of sale of the Public Securities to such Person as required by the Securities
Act and the rules&nbsp;and regulations thereunder, and if the untrue statement or omission has been corrected in the Prospectus, unless
such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations under this Agreement. The Company
agrees promptly to notify each Underwriter of the commencement of any litigation or proceedings against the Company or any of its officers,
directors or Controlling Persons in connection with the issue and sale of the Public Securities or in connection with the Registration
Statement or Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Procedure</U>.
If any action is brought against an Underwriter, a Selected Dealer or a Controlling Person in respect of which indemnity may be sought
against the Company pursuant to Section&nbsp;6.1, such Underwriter, Selected Dealer or Controlling Person, as the case may be, shall promptly
notify the Company in writing of the institution of such action and the Company shall assume the defense of and may settle such action,
including the employment and fees of counsel (subject to the reasonable approval of such Underwriter or Selected Dealer, or Controlling
Person as the case may be) and payment of actual expenses. Such Underwriter, Selected Dealer or Controlling Person shall have the right
to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter,
Selected Dealer or Controlling Person unless (a)&nbsp;the employment of such counsel at the expense of the Company shall have been authorized
in writing by the Company in connection with the defense of such action, or (b)&nbsp;the Company shall not have employed counsel to have
charge of the defense of such action within a reasonable time after receiving written notification of the applicable action by the Underwriter,
Selected Dealer or Controlling Person, as the case may be, or (c)&nbsp;<FONT STYLE="background-color: white">the named parties to any
such proceeding (including any impleaded parties) include both the Company, on the one hand, and an Underwriter, Selected Dealer or Controlling
Person, on the other hand, and representation of both parties by the same counsel would be inappropriate due to actual or potential differing
interests between them</FONT>, in any of which events set forth in clauses (a), (b)&nbsp;and (c)&nbsp;the reasonable fees and expenses
of not more than one additional firm of attorneys (subject to the reasonable approval of the Company) selected by such Underwriter (in
addition to local counsel), Selected Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary
contained herein, if any Underwriter, Selected Dealer or Controlling Person shall assume the defense of such action as provided above,
the Company shall have the right to approve the terms of any settlement of such action which approval shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Indemnification
of the Company</U>. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, its directors, officers
and employees and agents who control the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the
Exchange Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company to such
Underwriter, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions made in any
Preliminary Prospectus, if any, the Registration Statement, Prospectus, Preliminary Prospectus or Prospectus Supplement or any amendment
or supplement thereto or in any application, in reliance upon, and in strict conformity with, written information furnished to the Company
with respect to such Underwriter by or on behalf of such Underwriter expressly for use in such Preliminary Prospectus, if any, the Registration
Statement, Prospectus, Preliminary Prospectus or Prospectus Supplement or any amendment or supplement thereto or in any such application.
For purposes of this Section&nbsp;6.3, it is acknowledged that the information provided by the Underwriter or on behalf of the Underwriter
is only the Underwriter Information. In case any action shall be brought against the Company or any other Person so indemnified based
on any Preliminary Prospectus, if any, the Registration Statement, Prospectus, Preliminary Prospectus or Prospectus Supplement or any
amendment or supplement thereto or any application, and in respect of which indemnity may be sought against such Underwriter, such Underwriter
shall have the rights and duties given to the Company, and the Company and each other Person so indemnified shall have the rights and
duties given to such Underwriter by the provisions of this Article&nbsp;VI. The Underwriters' obligations in this Section&nbsp;6.3 to
indemnify the Company are several in proportion to their respective underwriting obligations and not joint. Notwithstanding the provisions
of this Section&nbsp;6.3, no Underwriter shall be required to indemnify the Company or its directors, officers and employees and agents
who control the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act for any amount
in excess of the underwriting discounts and commissions applicable to the Public Securities purchased by such Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Contribution
Rights</U>. In order to provide for just and equitable contribution under the Securities Act in any case in which (i)&nbsp;any Person
entitled to indemnification under this Article&nbsp;VI makes a claim for indemnification pursuant hereto but it is judicially determined
(by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of
the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article&nbsp;VI
provides for indemnification in such case, or (ii)&nbsp;contribution under the Securities Act, the Exchange Act or otherwise may be required
on the part of any such Person in circumstances for which indemnification is provided under this Article&nbsp;VI, then, and in each such
case, the Company and each Underwriter, severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages
and expenses of the nature contemplated by said indemnity agreement incurred by the Company and such Underwriter, as incurred, in such
proportions that such Underwriter is responsible for that portion represented by the percentage that the underwriting discount appearing
on the cover page&nbsp;of the Prospectus bears to the initial offering price appearing thereon and the Company is responsible for the
balance; provided, that, no Person guilty of a fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities
Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section,
each director, officer and employee of such Underwriter or the Company, as applicable, and each Person, if any, who controls such Underwriter
or the Company, as applicable, within the meaning of Section&nbsp;15 of the Securities Act shall have the same rights to contribution
as such Underwriter or the Company, as applicable. Notwithstanding the provisions of this Section&nbsp;6.4, no Underwriter shall be required
to contribute any amount in excess of the underwriting discounts and commissions applicable to the Public Securities purchased by such
Underwriter. The Underwriters' obligations in this Section&nbsp;6.4 to contribute are several in proportion to their respective underwriting
obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Contribution
Procedure</U>. Within fifteen days after receipt by any party to this Agreement (or its representative) of notice of the commencement
of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party
(&ldquo;<U>contributing party</U>&rdquo;), notify the contributing party of the commencement thereof, but the failure to so notify the
contributing party will not relieve it from any liability which it may have to any other party other than for contribution hereunder.
In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or its representative
of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate therein with the
notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any party seeking
contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written
consent of such contributing party. The contribution provisions contained in this Section&nbsp;6.4 are intended to supersede, to the extent
permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VII.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Termination
Right</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i)&nbsp;if any
domestic or international event or act or occurrence has materially disrupted, or in its opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii)&nbsp;if trading on any Trading Market shall have been suspended or materially
limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required
by FINRA or by order of the Commission or any other government authority having jurisdiction, or (iii)&nbsp;if the United States shall
have become involved in a new war or an increase in major hostilities, or (iv)&nbsp;if a banking moratorium has been declared by a New
York State or federal authority, or (v)&nbsp;if a moratorium on foreign exchange trading has been declared which materially adversely
impacts the United States securities markets, or (vi)&nbsp;if the Company shall have sustained a material loss by fire, flood, accident,
hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will,
in the Representative&rsquo;s opinion, make it inadvisable to proceed with the delivery of the Public Securities, or (vii)&nbsp;if the
Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii)&nbsp;if the Representative shall
have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse
material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed with the
offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Expenses</U>.
Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, in the event this Agreement
shall not be carried out for any reason whatsoever, within the time specified herein or any extensions thereof pursuant to the terms herein,
the Company shall be obligated to pay to the Representative its actual and accountable out of pocket expenses related to the transactions
contemplated herein then due and payable, (including the fees and disbursements of Golenbock up to $100,000.00), within fifteen (15) calendar
days of receipt by the Company of the documentation for such expenses, not to exceed $125,000.00 in the aggregate (<U>provided</U>, <U>however</U>,
that such expense cap in no way limits or impairs the indemnification and contribution provisions of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Indemnification</U>.
Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether
or not this Agreement is otherwise carried out, the provisions of Article&nbsp;VI shall not be in any way effected by such election or
termination or failure to carry out the terms of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement
(together with the other agreements and documents being delivered pursuant to or in connection with this Agreement), contain the entire
understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
Notwithstanding anything herein to the contrary, the Engagement Agreement, dated March&nbsp;4, 2024 (&ldquo;<U>Engagement Agreement</U>&rdquo;),
by and between the Company and the Representative, shall continue to be effective and the terms therein shall continue to survive and
be enforceable by the Representative in accordance with its terms, provided that, in the event of a conflict between the terms of the
Engagement Agreement and this Agreement, the terms of this Agreement shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via
e-mail attachment at the email address set forth on the signature pages&nbsp;attached hereto at or prior to 5:30 p.m.&nbsp;(New York City
time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered via
e-mail attachment at the e-mail address as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day or
later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP>) Trading Day following the date
of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and the Representative. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.5</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.6</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.7</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated
by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors,
officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting
in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in
the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If either party shall commence a Proceeding to enforce any
provisions of the Transaction Documents, then, in addition to the obligations of the Company under Article&nbsp;VI, the prevailing party
in such Proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred
with the investigation, preparation and prosecution of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.8</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the Option Closing, if any, and the delivery of the
Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.9</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.10</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.11</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Underwriters
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.12</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">If the last or appointed day for
the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be
taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.13</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.14</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><B><U>WAIVER
OF JURY TRIAL</U>. IN ANY PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE
LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY JURY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing correctly
sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose,
whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARSIGN
    TECHNOLOGIES CORPORATION</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Colin James Deller</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Colin James Deller</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8023 East 63<SUP>RD</SUP> Place, Suite&nbsp;101, Tulsa, Oklahoma 74133,
Attention: Jim Deller, Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copy to (which will not serve as notice):&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mitchell Silberberg&nbsp;&amp; Knupp LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">437 Madison Avenue, 25th Floor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Blake Baron, Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted on the date first above written.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Public Ventures, LLC&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As the Representative of the several&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters listed on Schedule I&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: Public Ventures, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Anthony DiGiandomenico</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Anthony DiGiandomenico</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Head of Investment Banking</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">14135 Midway Road, Suite&nbsp;G-150&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Addison, TX 75001&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Anthony DiGiandomenico, Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Copy to (which will not serve as notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Golenbock Eiseman Assor Bell&nbsp;&amp; Peskoe LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">711 Third Avenue, 17<SUP>th</SUP> Floor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;New York City, New York 10017&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Andrew D. Hudders, Email: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">Schedule
of Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Underwriters</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Closing Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Closing Warrants</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Closing Purchase Price</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-size: 10pt; text-align: justify">Public Ventures, LLC</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,620,760</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,620,760</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 17%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,251,099.20</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,620,760</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,620,760</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,251,099.20</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm2412212d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REDEEMABLE COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>clearsign
technologies Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 44%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
    <TD STYLE="width: 56%; padding-left: 177.75pt; font-size: 10pt; text-align: right; text-indent: -177.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: ______, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS REDEEMABLE COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.&nbsp;(New York City time) on _________,
2029 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from ClearSign Technologies Corporation,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section&nbsp;2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry
form and the Depository Trust Company or its nominee (&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered holder of this
Warrant, subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency
Agreement, in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;1</U></FONT>.&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms, which may not be specifically capitalized, have the meanings
indicated in this Section&nbsp;1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo; means the
board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form&nbsp;S-3 (File No.&nbsp;333-265967).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of April&nbsp;19, 2024 between the Company and Public Ventures, LLC as
the underwriter, as amended, modified or supplemented from time to time in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company
and the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;2</U></FONT>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date
and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment)
of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i)&nbsp;two
(2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(c)(i)&nbsp;herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States. No ink-original Notice of Exercise shall be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within two (2)&nbsp;Trading Days of the date on which the final
Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number
of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the
number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within
one (1)&nbsp;Business Day of receipt of such notice.&nbsp;<B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notwithstanding the foregoing in this
Section&nbsp;2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s)&nbsp;representing this Warrant held
in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made
pursuant to this Section&nbsp;2(a)&nbsp;by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction
form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable),
subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement,
in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $1.05, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">c)&nbsp;<U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and there is an effective registration statement permitting the issuance by the Company of the Warrant Shares to the Warrant Holder without
any securities law restrictions on resale, and otherwise by book-entry statement in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading Days after the delivery to the Company of the Notice of Exercise, (ii)&nbsp;one
(1)&nbsp;Trading Day after delivery of the aggregate Exercise Price to the Company and (iii)&nbsp;the number of Trading Days comprising
the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and
(ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such
exercise (based on the Exercise Price on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company
shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure
is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the
FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section&nbsp;2(c)(i)&nbsp;above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price
(including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence
the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Maintenance
of Commission Registration and Blue Sky</U>. At all times during which the Warrants are outstanding and the Company may be obligated to
issue Warrant Shares upon exercise of the Warrants, the Company will maintain an effective registration statement permitting the issuance
by the Company of the Warrant Shares to the Holder without any federal or state securities law restrictions on resale of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;3</U></FONT>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii)&nbsp;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&nbsp;combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&nbsp;issues by reclassification of
shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person other than any Subsidiary or any Affiliate
of the Company, whereby the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,
at least 50% of the voting power of the surviving entity immediately after such merger or consolidation; (ii)&nbsp;the Company (and all
of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets in one or a series of related transactions; (iii)&nbsp;any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock; (iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property; or (v)&nbsp;the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock
held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such
stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder, the number of shares
of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes of any such
exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
in accordance with the provisions of this Section&nbsp;3(b)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory
to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant prior to
such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but
taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares
of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section&nbsp;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as
a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email
to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least ten (10)&nbsp;calendar days
prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission,
in which case a notice shall not be required) stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form&nbsp;8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set
forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Voluntary
Adjustment By Company</U>. Subject to the rules&nbsp;and regulations of the Trading Market on which any of its securities are traded and
as applicable, provided that there is a current and effective registration statement permitting the issuance by the Company of the Warrant
Shares to the Warrant Holder without any securities law restrictions on resale, the Company may at any time during the term of this Warrant,
reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;4</U></FONT>.&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading Days of the date on which the Holder
delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may
be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New Warrants</U>.
If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined with other
Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations
in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section&nbsp;4(a), as
to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants
in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of
Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the
 &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;5</U></FONT>.&nbsp;<U>Redemption
of Warrants</U>. Notwithstanding the ownership limitations set forth in Section&nbsp;2(d)&nbsp;which will not be applicable in the event
of a redemption of the Warrants, at any time on and after the Initial Exercise Date and prior to the full exercise or the Termination
Date, the Company shall have the right to call the Warrants for redemption upon 30 days&rsquo; prior written or published notice at a
price of $0.01 per Warrant, provided however that the closing price of the Common Stock reported equals or exceeds $2.275 per share (as
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 Business Days within a 30 consecutive
Business Day period ending on the Business Day prior to the date on which the notice of redemption is sent to the holders of Warrants.
<FONT STYLE="background-color: white">The Holder shall have the right to exercise the Warrant prior to the date set forth in the Company&rsquo;s
notice of redemption (the &ldquo;<U>Redemption Date</U>&rdquo;). After the Redemption Date, all rights of the Holder shall terminate,
other than the right to receive the redemption price of $0.01 per Warrant, without interest. The redemption price shall not be subject
to adjustment upon the occurrence of certain events as described in this Warrant in Section&nbsp;3(a)&nbsp;or (g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;6</U></FONT>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(c)(i), except as expressly set
forth in Section&nbsp;3. In no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company further covenants that its
issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant
Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of this
Warrant will, upon exercise of this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
Notwithstanding the obligation of the Company pursuant to Section&nbsp;2(c)(vii), if upon an exercise of the Warrants the Warrant Shares
cannot be delivered by the Company because of a federal or state securities law legal limitation without restriction of any kind imposed
on the Warrant Shares, but the Company is able to deliver the Warrant Shares subject to restriction, then the Holder, at its option acknowledged
in a writing from the Holder, may accept the delivery of the Warrant Shares subject to restriction, and in such case, the Holder acknowledges
that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws. For an abundance of clarity, this Section&nbsp;6(f)&nbsp;is not intended to permit the Company to not fulfill
its obligations under Section&nbsp;2(c)(vii). Any failure to fulfill its obligations under Section&nbsp;2(c)(vii)&nbsp;will be deemed
a material default of this Warrant, and the Company will be liable to the Holder for any, loss, including but not limited to any loss
of profit, suffered by the Holder for its inability to exercise the Warrant and obtain the Warrant Shares or for its acceptance of the
Warrant Shares with restrictions. Acceptance of the Warrant Shares with restrictions will not constitute a waiver by the Holder to claiming
damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 8023 E. 63<SUP>rd</SUP> Place, Suite&nbsp;101, Tulsa, Oklahoma 74133 Attention:&nbsp;<B>Chief Financial Officer</B>,
or such other physical address, email address or address as the Company may specify for such purposes by notice to the Holders. Any and
all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the physical address, e-mail address
or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of (i)&nbsp;the time of transmission, if such notice or communication is delivered via e-mail at the
e-mail address set forth in this Section&nbsp;prior to 5:30 p.m.&nbsp;(New York City time) on any date, (ii)&nbsp;the next Trading Day
after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section&nbsp;on
a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (iii)&nbsp;the second Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or the fifth Trading Day following the
date of mailing, if sent by the United States Postal Service, postage prepaid, or (iv)&nbsp;upon actual receipt by the party to whom such
notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended and the provisions hereof may be waived with the written consent of the Company and holders of
a majority of the then outstanding Warrants (based on the number of Warrant Shares then underlying such Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o)&nbsp;<U>Warrant
Agency Agreement</U>. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency
Agreement, the provisions of this Warrant shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 50%"><B>THIS WARRANT IS NOT VALID FOR ANY PURPOSE UNLESS COUNTERSIGNED BY THE WARRANT AGENT BELOW.</B></TD>
  <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VSTOCK TRANSFER, LLC</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Warrant &ndash; ClearSign
Technologies Corporation</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>TO:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;CLEARSIGN
TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
shall take the form of lawful money of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="white-space: nowrap; text-align: justify; width: 18%">Name of Investing Entity:&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="white-space: nowrap; width: 35%"><I>Signature of Authorized Signatory of Investing Entity:&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 65%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 21%">Name of Authorized Signatory:&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 79%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 20%">Title of Authorized Signatory: </TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 80%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 5%">Date: </TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 95%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 28%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>tm2412212d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS WARRANT AND THE SECURITIES ISSUABLE UPON
EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR ANY OTHER
SECURITIES LAWS AND MAY&nbsp;NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1)&nbsp;AN EFFECTIVE
REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2)&nbsp;AN OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN ADDITION, THIS WARRANT AND THE SECURITIES
ISSUABLE UPON EXERCISE HEREOF MAY&nbsp;NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING,
SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF SUCH SECURITIES BY ANY PERSON
FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS IMMEDIATELY FOLLOWING THE DATE OF THE PUBLIC OFFERING OF THE COMPANY&rsquo;S SECURITIES
PURSUANT TO REGISTRATION STATEMENT NO.: 333-265967 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, EXCEPT IN ACCORDANCE WITH FINRA
RULE 5110(G)(2).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITER WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>_______ shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>______, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>UNDERWRITER WARRANT
</B>(this &ldquo;<B>Warrant</B>&rdquo;) of ClearSign Technologies Corporation, a corporation duly organized and validly existing under
the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), is being issued pursuant to that certain Underwriting Agreement,
dated April&nbsp;19, 2024 (the &ldquo;<B>Agreement</B>&rdquo;), between the Company and Public Ventures, LLC relating to a firm commitment
public offering (the &ldquo;<B>Offering</B>&rdquo;) of securities of the Company pursuant to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>FOR VALUE RECEIVED, </B>the
Company hereby grants to Public Ventures, LLC and its permitted successors and assigns (collectively, the &ldquo;<B>Holder</B>&rdquo;)
the right to purchase from the Company up to ______ shares (such shares underlying this Warrant, the &ldquo;<B>Warrant Shares</B>&rdquo;)
of common stock, $0.0001 par value, of the Company (the &ldquo;<B>Common Stock</B>&rdquo;), at a per share purchase price equal to $1.1375
(the &ldquo;<B>Exercise Price</B>&rdquo;)<B>, </B>subject to the terms, conditions and adjustments set forth below in this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Date
of Warrant Exercise</U>. This Warrant shall become exercisable one hundred eighty (180) days after the Base Date (the &ldquo;<B>Exercise
Date</B>&rdquo;). As used in this Warrant, the term &ldquo;<B>Base Date</B>&rdquo; shall mean ______, 2024. Except as permitted by applicable
rules&nbsp;of the Financial Industry Regulatory Authority,&nbsp;Inc. (&ldquo;<B>FINRA</B>&rdquo;), this Warrant and the underlying Warrant
Shares shall not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the securities by any person prior to the date that is
one hundred eighty (180) days immediately following the Base Date pursuant to FINRA Rule&nbsp;5110(e)(1), except as permitted under FINRA
Rule&nbsp;5110(e)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expiration
of Warrant</U>. This Warrant shall expire on the five (5)&nbsp;year anniversary of the Base Date (the &ldquo;<B>Expiration Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrant</U>. This Warrant shall be exercisable pursuant to the terms of this <U>Section&nbsp;3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Manner
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Warrant may only be exercised by the Holder hereof on or after the Exercise Date and on or prior to the Expiration Date, in accordance
with the terms and conditions hereof, in whole or in part (but not as to fractional shares) with respect to any portion of this Warrant,
during the Company&rsquo;s normal business hours on any day other than a Saturday or a Sunday or a day on which commercial banking institutions
in New York, New York are authorized by law to be closed (a &ldquo;<B>Business Day</B>&rdquo;), by surrender of this Warrant to the Company
at its office maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, accompanied by a written exercise notice in the form attached
as <U>Exhibit&nbsp;A</U> to this Warrant duly executed by the Holder, together with the payment of the aggregate Exercise Price for the
number of Warrant Shares purchased upon exercise of this Warrant. Upon surrender of this Warrant, the Company shall cancel this Warrant
document and shall, in the event of partial exercise, replace it with a new Warrant document in accordance with <U>Section&nbsp;3.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as provided for in <U>Section&nbsp;3.1(c)</U>&nbsp;below, each exercise of this Warrant must be accompanied by payment in full of the
aggregate Exercise Price in cash by check or wire transfer in immediately available funds for the number of Warrant Shares being purchased
by the Holder upon such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
aggregate Exercise Price for the number of Warrant Shares being purchased may also, in the sole discretion of the Holder, be paid in full
or in part on a &ldquo;cashless basis&rdquo; at the election of the Holder in the form of Warrant Shares withheld by the Company from
the Warrant Shares otherwise to be received upon exercise of this Warrant having an aggregate Fair Market Value on the date of exercise
equal to the aggregate Exercise Price of the Warrant Shares being purchased on a &ldquo;cashless&rdquo; basis by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Warrant,
the term &ldquo;<B>Fair Market Value</B>&rdquo; means with respect to a particular date, the average closing price of the Common Stock
for the five (5)&nbsp;Trading Days immediately preceding the applicable exercise herein as officially reported by the principal securities
exchange on which the Common Stock is then listed or admitted to trading, or, if the Common Stock is not listed or admitted to trading
on any securities exchange as determined in good faith by resolution of the Board of Directors of the Company, based on the best information
available to it. For purposes of this Warrant, (i)&nbsp;the term &ldquo;<B>Trading Day</B>&rdquo; means a day on which the Common Stock
is traded on a Trading Market, and (ii)&nbsp;the term &ldquo;<B>Trading Market</B>&rdquo; means any of the following markets or exchanges
on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq
Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To illustrate a cashless exercise
of this Warrant under <U>Section&nbsp;3.1(c)</U>&nbsp;(or for a portion thereof for which cashless exercise treatment is requested), the
calculation of such exercise shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">X = Y (A-B)/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in">X =</TD><TD>the number of Warrant Shares to be issued to the Holder (rounded to the nearest whole share).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">Y =</TD>
  <TD>the number of Warrant Shares with respect to which this Warrant is being exercised.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">A =</TD>
  <TD>the Fair Market Value of the Common Stock.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">B =</TD>
  <TD>the Exercise Price.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
purposes of Rule&nbsp;144 and sub-section (d)(3)(ii)&nbsp;thereof, it is intended, understood, and acknowledged that the Common Stock
issuable upon exercise of this Warrant in a cashless exercise transaction as described in <U>Section&nbsp;3.1(c)</U>&nbsp;above shall
be deemed to have been acquired at the time this Warrant was issued. Moreover, it is intended, understood, and acknowledged that the holding
period for the Common Stock issuable upon exercise of this Warrant in a cashless exercise transaction as described in <U>Section&nbsp;3.1(c)</U>&nbsp;above
shall be deemed to have commenced on the date this Warrant was issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>When
Exercise Effective</U>. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business
on the Business Day on which this Warrant shall have been duly surrendered to the Company, and, at such time, the Holder in whose name
any certificate or certificates for Warrant Shares shall be issuable upon exercise as provided in <U>Section&nbsp;3.3</U> hereof shall
be deemed to have become the holder or holders of record thereof of the number of Warrant Shares purchased upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Common Stock Certificates and New Warrant</U>. As soon as reasonably practicable after each exercise of this Warrant, in whole or in
part, and in any event within three (3)&nbsp;Business Days thereafter, the Company, at its expense (including the payment by it of any
applicable issue taxes), will cause to be issued in the name of and delivered to the Holder hereof or, subject to <U>Sections 9</U> and
<U>10</U> hereof, as the Holder (upon payment by the Holder of any applicable transfer taxes) may direct:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
book-entry statement (with appropriate restrictive legends, as applicable) for the number of duly authorized, validly issued, fully paid
and non-assessable Warrant Shares to which the Holder shall be entitled upon exercise; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant Shares
issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery of any Warrant
Shares as payment of the Exercise Price for such partial exercise of this Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and the Holder shall not have the right to exercise
any portion of this Warrant, pursuant to <U>Section&nbsp;3</U> or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates (as such term is defined
in Rule&nbsp;405 promulgated under the Securities Act), and any other persons acting as a group together with the Holder or any of the
Holder&rsquo;s Affiliates (such persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial
Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned
by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of
such Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would
be issuable upon (i)&nbsp;exercise of the remaining, non-exercised portion of such Warrant beneficially owned by the Holder or any of
its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or non-converted portion of any other securities
of the Company (including, without limitation, any other securities of the Company which would entitle the holder thereof to acquire at
any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of
Common Stock (&ldquo;<B>Common Stock Equivalents</B>&rdquo;)) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this <U>Section&nbsp;3.4</U>, beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of
the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and the rules&nbsp;and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this <U>Section&nbsp;3.4</U> applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this <U>Section&nbsp;3.4</U>, in determining
the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A)&nbsp;the Company&rsquo;s most recent periodic or annual report filed with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;),
as the case may be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of the Holder,
the Company shall within two (2)&nbsp;Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including such Warrant, by the Holder or its Affiliates or Attribution Parties since the date as
of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall
be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this <U>Section&nbsp;3.4</U>, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this <U>Section&nbsp;3.4</U> shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section&nbsp;3.4</U> to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U>. For so long as this Warrant is outstanding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mergers
or Consolidations</U>. If at any time after the date hereof there shall be a capital reorganization (other than a combination or subdivision
of Common Stock otherwise provided for herein) resulting in a reclassification to or change in the terms of securities issuable upon exercise
of this Warrant (a &ldquo;<B>Reorganization</B>&rdquo;), or a merger or consolidation of the Company with another corporation, association,
partnership, organization, business, individual, government or political subdivision thereof or a governmental agency (a &ldquo;<B>Person</B>&rdquo;
or the &ldquo;<B>Persons</B>&rdquo;) (other than (i)&nbsp;a merger with another Person which does not result in any reclassification or
change in the terms of securities issuable upon exercise of this Warrant or (ii)&nbsp;a merger effected exclusively for the purpose of
changing the name or domicile of the Company) (a &ldquo;<B>Merger</B>&rdquo;), then, as a part of such Reorganization or Merger, lawful
provision and adjustment shall be made so that the Holder shall thereafter be entitled to receive, upon exercise of this Warrant, the
number of shares of stock or any other equity or debt securities or property receivable upon such Reorganization or Merger by a holder
of the number of shares of Common Stock which might have been purchased upon exercise of this Warrant immediately prior to such Reorganization
or Merger. In any such case, appropriate adjustment shall be made in the application of the provisions of this Warrant with respect to
the rights and interests of the Holder after the Reorganization or Merger to the end that the provisions of this Warrant (including adjustment
of the Exercise Price then in effect and the number of Warrant Shares) shall be applicable after that event, as near as reasonably may
be, in relation to any shares of stock, securities, property or other assets thereafter deliverable upon exercise of this Warrant. The
provisions of this <U>Section&nbsp;4.1</U> shall similarly apply to successive Reorganizations and/or Mergers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Splits
and Subdivisions; Dividends</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant or the Public Warrants (as defined in the Agreement)), (ii)&nbsp;subdivides outstanding shares of Common Stock into a larger number
of shares, (iii)&nbsp;combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv)&nbsp;issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the
Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;4.2 shall become
effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Impairment</U>. The Company will not, by amendment of its certificate of incorporation or by-laws or through any consolidation, merger,
reorganization, transfer of assets, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all of
the terms and in the taking of all actions necessary or appropriate in order to protect the rights of the Holder against impairment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
as to Adjustments</U>. With respect to each adjustment pursuant to <U>Section&nbsp;4</U> of this Warrant, the Company, at its expense,
will promptly compute the adjustment or re-adjustment in accordance with the terms of this Warrant and furnish the Holder with a certificate
certified and confirmed by the Secretary or Chief Financial Officer of the Company setting forth, in reasonable detail, the event requiring
the adjustment or re-adjustment and the amount of such adjustment or re-adjustment, the method of calculation thereof and the facts upon
which the adjustment or re-adjustment is based, and the Exercise Price and the number of Warrant Shares or other securities purchasable
hereunder after giving effect to such adjustment or re-adjustment, which report shall be mailed by first class mail, postage prepaid,
or emailed to the Holder; provided, that the Company may satisfy the notice requirement set forth in this Section&nbsp;6 by filing such
notice with the Commission pursuant to a Current Report on Form&nbsp;8-K, Quarterly Report on Form&nbsp;10-Q or Annual Report on Form&nbsp;10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Shares</U>. The Company shall, solely for the purpose of effecting the exercise of this Warrant, at all times during the term of this
Warrant, reserve and keep available out of its authorized shares of Common Stock, free from all taxes, liens and charges with respect
to the issue thereof and not subject to preemptive rights of shareholders of the Company, such number of its shares of Common Stock as
shall from time to time be sufficient to effect in full the exercise of this Warrant. If at any time the number of authorized but unissued
shares of Common Stock shall not be sufficient to effect in full the exercise of this Warrant, in addition to such other remedies as shall
be available to Holder, the Company will promptly take such corporate action as may, in the opinion of its counsel, be necessary to increase
the number of authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including
without limitation, using its Reasonable Commercial Efforts (as defined below) to obtain the requisite shareholder approval necessary
to increase the number of authorized shares of Common Stock. The Company hereby represents and warrants that all shares of Common Stock
issuable upon proper exercise of this Warrant shall be duly authorized and, when issued and paid for upon proper exercise, shall be validly
issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
and Listing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definition
of Registrable Securities; Majority</U>. As used herein, the term &ldquo;<B>Registrable Securities</B>&rdquo; means any shares of Common
Stock issuable upon the exercise of this Warrant until the date (if any) on which such shares shall have been transferred or exchanged
and new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent
disposition of the shares shall not require registration or qualification under the Securities Act or any similar state law then in force.
For purposes of this Warrant, the term &ldquo;<B>Majority Holders</B>&rdquo; shall mean in excess of fifty percent (50%) of the then outstanding
Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Demand
Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company, upon written demand (&ldquo;<B>Demand Notice</B>&rdquo;) of the Majority Holders, agrees to register on one occasion all of the
Registrable Securities (a &ldquo;<B>Demand Right</B>&rdquo;). On such occasion, the Company will file a registration statement or a post-effective
amendment to the registration statement covering the Registrable Securities within forty-five (45) days after receipt of a Demand Notice
and use its Reasonable Commercial Efforts to have such registration statement or post-effective amendment declared effective as soon as
possible thereafter; <U>provided</U>, <U>however</U>, that the Company shall not be required to comply with a Demand Notice if the Company
has filed a registration statement with respect to which the Holder is entitled to piggyback registration rights pursuant to <U>Section&nbsp;8.3</U>
hereof and either: (i)&nbsp;the Holder has elected to participate in the offering covered by such registration statement or (ii)&nbsp;if
such registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such
registration statement has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may
be made at any time, on one (1)&nbsp;occasion only, during a period commencing 120 days after the Base Date and ending on the fifth year
of the Base Date. The Company covenants and agrees to give written notice of its receipt of any Demand Notice to all other registered
Holders of the Warrants and/or the Registrable Securities within ten days from the date of the receipt of any such Demand Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
fees and expenses attendant to registering the Registrable Securities pursuant to <U>Section&nbsp;8.2(a)</U>&nbsp;shall be borne as set
forth in <U>Section&nbsp;8.6</U>. For the avoidance of doubt, the holders of Registrable Securities shall pay any and all underwriting
commissions and the expenses of any legal counsel selected by them to represent them in connection with the sale of the Registrable Securities,
except as set forth in <U>Section&nbsp;8.6</U>. The Company agrees to use its Reasonable Commercial Efforts to qualify or register the
Registrable Securities in such states as are reasonably requested by the Majority Holder(s); <U>provided</U>, <U>however</U>, that in
no event shall the Company be required to register the Registrable Securities in a state in which such registration would cause (i)&nbsp;the
Company to be obligated to register, license or qualify to do business in such state, submit to general service of process in such state
or would subject the Company to taxation as a foreign corporation doing business in such jurisdiction or (ii)&nbsp;the principal stockholders
of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall use Reasonable Commercial Efforts
to cause any registration statement or post-effective amendment filed pursuant to the Demand Right granted under <U>Section&nbsp;8.2(a)</U>&nbsp;to
remain effective for a period of nine consecutive months from the effective date of such registration statement or post-effective amendment.
The Holders shall only use the prospectuses provided by the Company to sell the Registrable Securities covered by such registration statement,
and will immediately cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no
longer be used due to a material misstatement or omission. Notwithstanding the provisions of this <U>Section&nbsp;8.2(b)</U>, the Holder
shall be entitled to a demand registration under this Section&nbsp;on only one (1)&nbsp;occasion and such demand registration right shall
terminate in accordance with <U>Section&nbsp;8.2(a)</U>&nbsp;and FINRA Rule&nbsp;5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Incidental
Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
during the period of five (5)&nbsp;years after the Base Date, the Company proposes to register any of its securities under the Securities
Act (other than in connection with a transaction contemplated by Rule&nbsp;145(a)&nbsp;promulgated under the Securities Act or pursuant
to registration on Form&nbsp;S-4 or S-8 or any successor forms or in connection with securities issued pursuant to clirSPV LLC&rsquo;s
participation right granted in connection with that certain Stock Purchase Agreement dated July&nbsp;12, 2018, between the Company and
clirSVP LLC) whether for its own account or for the account of any holder or holders of its shares other than Registrable Securities (any
shares of such holder or holders (but not those of the Company and not Registrable Securities) with respect to any registration are referred
to herein as, &ldquo;<B>Other Shares</B>&rdquo;), the Company shall at each such time give prompt (but not less than thirty (30) days
prior to the anticipated effectiveness thereof) written notice to the holders of Registrable Securities of its intention to do so. The
holders of Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided herein by giving written notice within ten
(10)&nbsp;days after the receipt of any such notice (which request shall specify the Registrable Securities intended to be disposed of
by such holder). Except as set forth in <U>Section&nbsp;8.3(b)</U>, the Company will use its Reasonable Commercial Efforts to effect the
registration under the Securities Act of all of the Registrable Securities which the Company has been so requested to register by such
holder, to the extent required to permit the disposition of the Registrable Securities so to be registered, by inclusion of such Registrable
Securities in the registration statement which covers the securities which the Company proposes to register. In connection with such registration,
Company will file a registration statement with the Commission on Form&nbsp;S-3 or other appropriate form if necessary to comply with
General Instruction I.B.6. of Form&nbsp;S-3 and Commission interpretations thereof. The Company will pay all Registration Expenses in
connection with each registration of Registrable Securities pursuant to this <U>Section&nbsp;8.3</U>, but the holders of Registrable Securities
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by them to represent them in connection
with the sale of the Registrable Securities, except as set forth in <U>Section&nbsp;8.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Company at any time proposes to register any of its securities under the Securities Act as contemplated by this <U>Section&nbsp;8.3</U>
and such securities are to be distributed by or through one or more underwriters or a registered broker dealer, the Company will, if requested
by a holder of Registrable Securities, use its Reasonable Commercial Efforts to arrange for such underwriters or registered broker dealer
to include all the Registrable Securities to be offered and sold by such holder among the securities to be distributed by such underwriters
or registered broker dealer, provided that if the managing underwriter or registered broker dealer of such offering shall inform the Company
its belief (including as statement of the basis of that belief and the approximate number of Registrable Securities to be removed and
the number of any other shares included in the offering by persons other than the Company and whether or not they are being cut back and
by what amount, and the shares to be offered by the Company) that inclusion in such registration statement and/or distribution of all
or a specified number of such securities proposed to be distributed by such underwriters or registered broker dealer would interfere with
the successful marketing of the securities being distributed by such underwriters or registered broker dealer, then the Company may, upon
written notice to the holders of the Registrable Securities, reduce pro rata in accordance with the number of shares of Common Stock desired
to be included in such registration statement and/or distribution (if and to the extent stated by such managing underwriter or registered
broker dealer to be necessary to eliminate such effect) the number of such Registrable Securities the registration and/or distribution
of which shall have been requested by each holder thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Procedures</U>. Whenever the holders of Registrable Securities have properly requested that any Registrable Securities be registered pursuant
to the terms of this Warrant, the Company shall use its Reasonable Commercial Efforts to effect the registration for the resale of such
Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto the Company shall use its Commercially
Reasonable Efforts to, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its Reasonable Commercial Efforts to
cause such registration statement to become effective;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;notify
such holders of the effectiveness of each registration statement filed hereunder and prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection therewith as may be necessary to (i)&nbsp;use Reasonable
Commercial Efforts keep such registration statement effective and the prospectus included therein usable for a period commencing on the
date that such registration statement is initially declared effective by the SEC and ending on the earlier of (A)&nbsp;the date when all
Registrable Securities covered by such registration statement have been sold pursuant to the registration statement or cease to be Registrable
Securities, or (B)&nbsp;nine months from the effective date of the registration statement; and (ii)&nbsp;comply with the provisions of
the Securities Act with respect to the disposition of all securities covered by such registration statement during such period in accordance
with the intended methods of disposition by the sellers thereof set forth in such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[RESERVED];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;use
its Reasonable Commercial Efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such
jurisdictions as such holders reasonably request and do any and all other acts and things which may be reasonably necessary to enable
such holders to consummate the disposition in such jurisdictions of the Registrable Securities owned by such holders; provided, however,
that the Company shall not be required to: (i)&nbsp;qualify generally to do business in any jurisdiction where it would not otherwise
be required to qualify but for this subparagraph; (ii)&nbsp;subject itself to taxation in any such jurisdiction; or (iii)&nbsp;consent
to general service of process in any such jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;notify
such holders, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening of
any event as a result of which the prospectus included in such registration statement contains an untrue statement of a material fact
or omits any material fact necessary to make the statements therein, in light of the circumstances in which they are made, not materially
misleading, and, at the reasonable request of such holders, the Company shall prepare a supplement or amendment to such prospectus so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not contain an untrue statement
of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances in which
they are made, not materially misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;provide
a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;make
available for inspection by any underwriter participating in any disposition pursuant to such registration statement, and any attorney,
accountant or other agent retained by any such underwriter, all financial and other records, pertinent corporate documents and properties
of the Company, and cause the Company&rsquo;s officers, directors, managers, employees and independent accountants to supply all information
reasonably requested by any such underwriter, attorney, accountant or agent in connection with such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;otherwise
comply with all applicable rules&nbsp;and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable,
an earnings statement of the Company, which earnings statement shall satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Securities
Act and, at the option of the Company, Rule&nbsp;158 thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
the event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending or preventing
the use of any related prospectus or suspending the qualification of any Registrable Securities included in such registration statement
for sale in any jurisdiction, the Company shall use its Reasonable Commercial Efforts promptly to obtain the withdrawal of such order;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the offering is underwritten, use its Reasonable Commercial Efforts to furnish on the date that Registrable Securities are delivered to
the underwriters for sale pursuant to such registration, an opinion dated such date of counsel representing the Company for the purposes
of such registration, addressed to the underwriters covering such issues as are customarily addressed in opinions to underwriters in public
offerings and reasonably required by such underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing</U>.
The Company shall secure the listing of the Common Stock underlying this Warrant upon each national securities exchange or automated quotation
system upon which shares of Common Stock are then listed or quoted (subject to official notice of issuance) and shall use its Reasonable
Commercial Efforts to maintain such listing of shares of Common Stock. The Company shall at all times comply in all material respects
with the Company&rsquo;s reporting, filing and other obligations under the by-laws or rules&nbsp;of the Nasdaq Capital Market (or such
other national securities exchange or market on which the Common Stock may then be listed, as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expenses</U>.
The Company shall pay all Registration Expenses relating to the registration and listing obligations set forth in this <U>Section&nbsp;8</U>.
For purposes of this Warrant, the term &ldquo;<B>Registration Expenses</B>&rdquo; means: (a)&nbsp;all registration, filing and FINRA fees,
(b)&nbsp;all reasonable fees and expenses of complying with securities or blue sky laws, (c)&nbsp;all word processing, duplicating and
printing expenses, (d)&nbsp;the fees and disbursements of counsel for the Company and of its independent public accountants, including
the expenses of any special audits or &ldquo;cold comfort&rdquo; letters required by or incident to such performance and compliance, and
(e)&nbsp;fees and disbursements of one counsel for the selling holders of Registrable Securities up to $5,000. Registration Expenses shall
not include any underwriting discounts and commissions which may be incurred in the sale of any Registrable Securities and transfer taxes
of the selling holders of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Information
Provided by Holders</U>. Any holder of Registrable Securities included in any registration shall furnish to the Company such information
as the Company may reasonably request in writing, including, but not limited to, a completed and executed questionnaire requesting information
customarily sought of selling security holders, to enable the Company to comply with the provisions hereof in connection with any registration
referred to in this Warrant. The Holder agrees to suspend all sales of Registrable Securities pursuant to a registration statement filed
under <U>Section&nbsp;8.3</U> in the event the Company notifies Holder pursuant to <U>Section&nbsp;8.4(e)</U>&nbsp;that the prospectus
relating thereto is no longer current and will not resume sales under such registration statement until advised by the Company that the
prospectus has been appropriately supplemented or amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Net
Cash Settlement</U>. Notwithstanding anything herein to the contrary, in no event will the Holder hereof be entitled to receive a net-cash
settlement as liquidated damages in lieu of physical settlement in shares of Common Stock, regardless of whether the Common Stock underlying
this Warrant is registered pursuant to an effective registration statement; provided, however, that the foregoing will not preclude the
Holder from seeking other remedies at law or equity for breaches by the Company of its registration obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions
on Transfer</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictive
Legends</U>. This Warrant and each Warrant issued upon transfer or in substitution for this Warrant pursuant to <U>Section&nbsp;10</U>
hereof, each certificate for Common Stock issued upon the exercise of this Warrant and each Warrant issued upon transfer or in substitution
for this Warrant pursuant to <U>Section&nbsp;10</U> hereof and each certificate issued upon the transfer of any such Common Stock shall
be transferable only upon satisfaction of the conditions specified in this <U>Section&nbsp;9</U>. Each of the foregoing securities shall
be stamped or otherwise imprinted with a legend reflecting the restrictions on transfer set forth herein and any restrictions required
under the Securities Act or other applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Proposed Transfer</U>. Prior to any transfer of any securities which are not registered under an effective registration statement under
the Securities Act (&ldquo;<B>Restricted Securities</B>&rdquo;), which transfer may only occur if there is an exemption from the registration
provisions of the Securities Act and all other applicable securities laws, the Holder will give written notice to the Company of the Holder&rsquo;s
intention to effect a transfer (and shall describe the manner and circumstances of the proposed transfer). The following provisions shall
apply to any proposed transfer of Restricted Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
in the opinion of counsel for the Holder reasonably satisfactory to the Company the proposed transfer may be effected without registration
of the Restricted Securities under the Securities Act (which opinion shall state in detail the basis of the legal conclusions reached
therein), the Holder shall thereupon be entitled to transfer the Restricted Securities in accordance with the terms of the notice delivered
by the Holder to the Company. Each certificate representing the Restricted Securities issued upon or in connection with any transfer shall
bear the restrictive legends required by Section&nbsp;9.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the opinion called for in <U>clause (i)</U>&nbsp;above is not delivered, the Holder shall not be entitled to transfer the Restricted Securities
until either: (x)&nbsp;receipt by the Company of a further notice from such Holder pursuant to the foregoing provisions of this <U>Section&nbsp;9.2</U>
and fulfillment of the provisions of <U>clause (i)</U>&nbsp;above, or (y)&nbsp;such Restricted Securities have been effectively registered
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Other Transfer Restrictions</U>. Notwithstanding any other provision of this Warrant: (a)&nbsp;prior to the Exercise Date, this Warrant
or the Restricted Securities thereunder may only be transferred or assigned to the persons permitted under FINRA Rule&nbsp;5110(g), and
(b)&nbsp;subject at all times to FINRA Rule&nbsp;5110(g), no opinion of counsel shall be necessary for a transfer of Restricted Securities
by the holder thereof to any Person employed by or owning equity in the Holder, if the transferee agrees in writing to be subject to the
terms hereof to the same extent as if the transferee were the original purchaser hereof and such transfer is permitted under applicable
securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination
of Restrictions</U>. Except as set forth in <U>Section&nbsp;9.3</U> hereof and subject at all times to FINRA Rule&nbsp;5110(g), the restrictions
imposed by this <U>Section&nbsp;9</U> upon the transferability of Restricted Securities shall cease and terminate as to any particular
Restricted Securities: (a)&nbsp;which shall have been effectively registered under the Securities Act, or (b)&nbsp;when, in the opinion
of counsel for the Company, such restrictions are no longer required in order to insure compliance with the Securities Act or Section&nbsp;10
hereof. Whenever such restrictions shall cease and terminate as to any Restricted Securities, the Holder thereof shall be entitled to
receive from the Company, without expense (other than applicable transfer taxes, if any), new securities of like tenor not bearing the
applicable legends required by <U>Section&nbsp;9.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership,
Transfer, Sale and Substitution of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership
of Warrant</U>. The Company may treat any Person in whose name this Warrant is registered in the Warrant Register (as defined below) maintained
pursuant to <U>Section&nbsp;10.2(b)</U>&nbsp;hereof as the owner and holder thereof for all purposes, notwithstanding any notice to the
contrary, except that, if and when any Warrant is properly assigned in blank, the Company may (but shall not be obligated to) treat the
bearer thereof as the owner of such Warrant for all purposes, notwithstanding any notice to the contrary. Subject to Sections 9 and 10
hereof, this Warrant, if properly assigned, may be exercised by a new holder without a new Warrant first having been issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Office;
Exchange of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company will maintain its principal office at the location identified in the prospectus relating to the Offering or at such other offices
as set forth in the Company&rsquo;s most current filing (as of the date notice is to be given) under Exchange Act, or as the Company otherwise
notifies the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall cause to be kept at its office maintained pursuant to Section&nbsp;10.2(a)&nbsp;hereof a warrant register for the registration
and transfer of this Warrant (the &ldquo;<B>Warrant Register</B>&rdquo;). The name and address of the holder of this Warrant, the transfers
thereof and the name and address of the transferee of this Warrant shall be registered in such Warrant Register. The Person in whose name
this Warrant shall be so registered shall be deemed and treated as the owner and holder thereof for all purposes of this Warrant, and
the Company shall not be affected by any notice or knowledge to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the surrender of this Warrant, properly endorsed, for registration of transfer or for exchange at the office of the Company maintained
pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, the Company at its expense will (subject to compliance with Section&nbsp;9 hereof,
if applicable) execute and deliver to or upon the order of the Holder thereof a new Warrant of like tenor, in the name of such holder
or as such holder (upon payment by such holder of any applicable transfer taxes) may direct, calling in the aggregate on the face thereof
for the number of shares of Common Stock called for on the face of this Warrant so surrendered (after giving effect to any previous adjustment(s)&nbsp;to
the number of Warrant Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Warrant</U>. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this
Warrant and, in the case of any such loss, theft or destruction of this Warrant, upon delivery of indemnity reasonably satisfactory to
the Company in form and amount or, in the case of any mutilation, upon surrender of this Warrant for cancellation at the office of the
Company maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, the Company will execute and deliver, in lieu thereof, a new Warrant
of like tenor and dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Opinions</U>.
In connection with the sale of the Warrant Shares by Holder, if the Company&rsquo;s counsel reasonably determines such opinion is appropriate,
the Company agrees to cooperate with the Holder, and at the Company&rsquo;s expense, to have its counsel provide any legal opinions required
to remove the restrictive legends from the Warrant Shares in connection with a sale, transfer or legend removal request of Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Redemption</U>.
For the avoidance of doubt, the Company shall not be permitted to redeem this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights or Liabilities as Stockholder</U>. No Holder shall be entitled to vote or receive dividends or distributions or be deemed the holder
of any equity securities which may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to
confer upon the Holder, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon
any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise)
or to receive notice of meetings, or to receive dividends or distributions, or to share in the assets of the Company in the event of a
liquidation, dissolution or the winding up of the Company, until this Warrant shall have been exercised and the shares of Common Stock
purchasable upon the exercise hereof shall have become deliverable, as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any notice or other communication in connection with this Warrant shall be given in writing and directed to the parties hereto as follows:
(a)&nbsp;if to the Holder, at the address of the holder in the Warrant Register, or (b)&nbsp;if to the Company, to the attention of its
Chief Executive Officer and Chief Financial Officer at its office maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof; <I>provided,
</I>that the exercise of this Warrant shall also be effected in the manner provided in Section&nbsp;3 hereof. Notices shall be deemed
properly delivered and received when delivered to the notice party (i)&nbsp;if personally delivered, upon receipt or refusal to accept
delivery, (ii)&nbsp;if sent via email, the date of transmission if sent on a Business Day prior to 5:30 p.m.&nbsp;(New York City time),
or the next Business Day if sent on a day that is not a Business Day or at or after 5:30 p.m.&nbsp;(New York City time) on a Business
Day, (iii)&nbsp;if sent by a commercial overnight courier for delivery on the next Business Day, on the first Business Day after deposit
with such courier service, or (iv)&nbsp;if sent by registered or certified mail, five (5)&nbsp;Business Days after deposit thereof in
the U.S. mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Taxes</U>. The Company will pay all documentary stamp taxes attributable to the issuance of shares of Common Stock underlying this
Warrant upon exercise of this Warrant; <I>provided, however, </I>that the Company shall not be required to pay any tax which may be payable
in respect of any transfer involved in the transfer or registration of this Warrant or any certificate for shares of Common Stock underlying
this Warrant in a name other that of the Holder. The Holder is responsible for all other tax liability that may arise as a result of holding
or transferring this Warrant or receiving shares of Common Stock underlying this Warrant upon exercise hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.
This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party
against which enforcement of the change, waiver, discharge or termination is sought, or with the written consent of the Company and the
holders of outstanding Underwriter Warrants (as defined in the Agreement) then exercisable for a majority of the shares of Common Stock
issuable upon exercise of all outstanding Underwriter Warrants. This Warrant shall be construed and enforced in accordance with and governed
by the laws of the State of New York. Each of the parties consents to the exclusive jurisdiction of the Federal or state courts whose
districts encompass any part of the County of New York located in the City of New York, New York in connection with any dispute arising
under this Agreement and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on <I>forum
non conveniens, </I>to the bringing of any such proceeding in such jurisdictions. Each party to this Agreement irrevocably consents to
the service of process in any such proceeding by any manner permitted by law. The section headings in this Warrant are for purposes of
convenience only and shall not constitute a part hereof. When used herein, the term &ldquo;<B>Reasonable Commercial Efforts</B>&rdquo;
means, with respect to the applicable obligation of the Company, commercially reasonable efforts for similarly situated, publicly-traded
companies. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not
be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF, </B>the
Company has caused this Underwriter Warrant to be duly executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">CLEARSIGN TECHNOLOGIES CORPORATION</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF EXERCISE NOTICE<BR>
</B>[To be executed only upon exercise of Warrant]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To CLEARSIGN TECHNOLOGIES CORPORATION:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned registered holder of the within Warrant hereby irrevocably
exercises the Warrant pursuant to Section&nbsp;3.1 of the Warrant with respect to [_____] Warrant Shares, at an exercise price of $[____]
per share, and requests that the certificates for such Warrant Shares be issued, subject to Sections 9 and 10, in the name of and delivered
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned is hereby making payment for the Warrant Shares in
the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[check one]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by
cash in accordance with Section&nbsp;3.1(b)&nbsp;of the Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;via
cashless exercise in accordance with Section&nbsp;3.1(c)&nbsp;of the Warrant in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned hereby represents and warrants that it is, and has
been since its acquisition of the Warrant, the record and beneficial owner of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned is an &ldquo;accredited investor&rdquo; as defined
in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Print or Type Name</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 50%">(Signature must conform in all respects to name of holder as specified on the face of Warrant)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF ASSIGNMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[To be executed only upon transfer of Warrant]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For value received, the undersigned
registered holder of the within Warrant hereby sells, assigns and transfers unto <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </U>[include
name and addresses] the rights represented by the Warrant to purchase__________&nbsp;shares of Common Stock of CLEARSIGN
TECHNOLOGIES CORPORATION to which the Warrant relates, and appoints ______________, the
undersigned&rsquo;s attorney to make such transfer on the books of CLEARSIGN TECHNOLOGIES CORPORATION maintained for the purpose,
with full power of substitution in the premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Signature must conform in all respects to name of holder as specified on the face of Warrant)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signed in the presence of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Signature of Transferee)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signed in the presence of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>tm2412212d1_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY&nbsp;NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS PURCHASE WARRANT IS EXERCISABLE COMMENCING
[&bull;], 2024. VOID AFTER 5:00 P.M., EASTERN TIME, [&bull;], 2029.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>REDEEMABLE
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CLEARSIGN
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Issue Date: ___________, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 3.5in; text-indent: 0.5in">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: ________, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS REDEEMABLE COMMON STOCK
PURCHASE WARRANT (the &ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, ___________ or its assigns (the &ldquo;<B>Holder</B>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
_______, 2024<SUP>1</SUP>&nbsp;(the &ldquo;<B>Initial Exercise Date</B>&rdquo;) and on or prior to 5:00 p.m.&nbsp; (New York City time)
on _______, 2029 (the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter, to subscribe for and purchase from Clearsign Technologies
Corporation, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), up to ___ shares (as subject to adjustment hereunder, the &ldquo;<B>Warrant
Shares</B>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in&nbsp;<U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;1</U></FONT>.&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms, which may not be specifically capitalized, have the meanings
indicated in this&nbsp;<U>Section&nbsp;1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board
of Directors</B>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business
Day</B>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common
Stock</B>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>&nbsp;</SUP></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>NTD: To be 6 months from Initial Issue Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchase
Agreement</B>&rdquo; means that certain securities purchase agreement, dated as of April&nbsp;___, 2024, between the Company and the purchasers
party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rule&nbsp;144</B>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transfer
Agent</B>&rdquo; means VStock Transfer LLC, the current transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Redeemable Common Stock purchase warrants issued by the Company pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;2</U></FONT>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrant</U>. Subject to the provisions of&nbsp;<U>Section&nbsp;2(d)</U>&nbsp;herein, exercise of this Warrant may be made, in whole
or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of
Exercise in the form annexed hereto (the &ldquo;<B>Notice of Exercise</B>&rdquo;), and delivery of the aggregate Exercise Price of the
Warrant Shares specified in the applicable Notice of Exercise as specified in this&nbsp;<U>Section&nbsp;2(a)</U>. Within the earlier of
(i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in&nbsp;<U>Section&nbsp;2(d)(i)</U>&nbsp;herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in
the applicable Notice of Exercise by wire transfer of immediately available funds or cashier&rsquo;s check drawn on a United States bank.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. The Company may reasonably rely on the authenticity of the information provided by the Holder in the
Notice of Exercise and shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s)&nbsp;contained
on any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. Notwithstanding anything herein to the
contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the
Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within two (2)&nbsp;Trading Days of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder
shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable
number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and
the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)&nbsp;Business Day of receipt
of such notice.&nbsp;<B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[1.05], subject to adjustment hereunder (the &ldquo;<B>Exercise
Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company&rsquo;s transfer agent is then a participant
in such system and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B)&nbsp;the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule&nbsp;144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register
in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading Days
after the delivery to the Company of the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading Day after delivery of the aggregate Exercise
Price to the Company, and (iii)&nbsp;the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard
Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay, beginning one Trading Day after the
Warrant Share Delivery Date, to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the Exercise Price on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20
per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company
shall not be reasonable for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure
is caused solely by action or inaction of the Holder. The Company agrees to use reasonable commercial efforts to maintain a transfer agent
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to&nbsp;<U>Section&nbsp;2(c)(i)</U>&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">iv.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of&nbsp;<U>Section&nbsp;2(c)(i)</U>&nbsp;above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;),
then the Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price
(including reasonable and customary brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&nbsp;the amount
obtained by multiplying (1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with
the exercise at issue times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at
the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">v.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">vi.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<I><U>provided</U></I>,&nbsp;<I><U>however</U></I>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">vii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">viii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Signature</U>.
This&nbsp;<U>Section&nbsp;2</U>&nbsp;and the exercise form attached hereto set forth the totality of the procedures required of the Holder
in order to exercise this Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise this Warrant.
No additional legal opinion, other information or instructions shall be required of the Holder to exercise this Warrant. The Company shall
honor exercises of this Warrant and shall deliver Warrant Shares underlying this Warrant in accordance with the terms, conditions and
time periods set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to&nbsp;<U>Section&nbsp;2</U>&nbsp;or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i)&nbsp;exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties to the extent such issuance would exceed such limitation.&nbsp; Except as set forth
in the preceding sentence, for purposes of this&nbsp;<U>Section&nbsp;2(d)</U>, beneficial ownership shall be calculated in accordance
with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this&nbsp;<U>Section&nbsp;2(d)</U>&nbsp;applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall not have any obligation to verify or confirm the accuracy of such determination and neither of them shall have any liability for
any error made by the Holder or any other Person. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes
of this&nbsp;<U>Section&nbsp;2(d)</U>, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number
of outstanding shares of Common Stock as reflected in (A)&nbsp;the Company&rsquo;s most recent periodic or annual report filed with the
Commission, as the case may be, (B)&nbsp;a more recent public announcement by the Company, or (C)&nbsp;a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall
be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this&nbsp;<U>Section&nbsp;2(d)</U>, provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this&nbsp;<U>Section&nbsp;2(d)</U>&nbsp;shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP>&nbsp;day after
such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than
in strict conformity with the terms of this&nbsp;<U>Section&nbsp;2(d)</U>&nbsp;to correct this paragraph (or any portion hereof) which
may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;3</U></FONT>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii)&nbsp;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&nbsp;combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&nbsp;issues by reclassification of
shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person other than any Subsidiary or any Affiliate
of the Company, whereby the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,
at least 50% of the voting power of the surviving entity immediately after such merger or consolidation; (ii)&nbsp;the Company (and all
of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets in one or a series of related transactions; (iii)&nbsp;any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock; (iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property; or (v)&nbsp;the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock
held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such
stock or share purchase agreement or other business combination) (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder, the number of shares
of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes of any such
exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section&nbsp;3(b)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the
Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant prior to
such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but
taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares
of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section&nbsp;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section&nbsp;3</U>, the Company shall
promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to
the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as
a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email
to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least ten (10)&nbsp;calendar days
prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission,
in which case a notice shall not be required) stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form&nbsp;8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set
forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voluntary
Adjustment By Company</U>. Subject to the rules&nbsp;and regulations of the Trading Market on which any of its securities are traded and
as applicable, provided that there is a current and effective registration statement permitting the issuance by the Company of the Warrant
Shares to the Warrant Holder without any securities law restrictions on resale, the Company may at any time during the term of this Warrant,
reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;4</U></FONT>.&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading Days of the date on which the Holder
delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may
be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with&nbsp;<U>Section&nbsp;4(a)</U>, as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant
Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i)&nbsp;registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii)&nbsp;eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule&nbsp;144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee
of this Warrant, as the case may be, comply with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;5.
Redemption of Warrant</U></FONT>. Notwithstanding the ownership limitations set forth in Section&nbsp;2(d)&nbsp;which will not be applicable
in the event of a redemption of this Warrant, at any time on and after the Initial Exercise Date and prior to the full exercise or the
Termination Date, the Company shall have the right to call this Warrant for redemption upon 30 days&rsquo; prior written or published
notice at a price of $0.01 per Warrant, provided however that the closing price of the Common Stock reported equals or exceeds $____ [250%
of the offering price per share] per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the
like) for any 20 Business Days within a 30 consecutive Business Day period ending on the Business Day prior to the date on which the notice
of redemption is sent to the holders of Warrants. The Holder shall have the right to exercise the Warrant prior to the date set forth
in the Company&rsquo;s notice of redemption (the &ldquo;<B>Redemption Date</B>&rdquo;). After the Redemption Date, all rights of the Holder
shall terminate, other than the right to receive the redemption price of $0.01 per Warrant, without interest. The redemption price shall
not be subject to adjustment upon the occurrence of certain events as described in this Warrant in Section&nbsp;3(a)&nbsp;or (g). Notwithstanding
the foregoing, the Company may not give any notice of redemption or effect a redemption of this Warrant under this Section&nbsp;5 unless
the shares of Common Stock that may be issued upon the exercise of this Warrant subject to redemption are registered on an effective registration
statement that provides for the resale of such shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;6</U></FONT>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in&nbsp;<U>Section&nbsp;2</U>, except as expressly
set forth in&nbsp;<U>Section&nbsp;3</U>. In no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The Company covenants that,
during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares
to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company further covenants that its issuance of
this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon
the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of this Warrant
will, upon exercise of this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully
paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Except and to the extent as
waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times
in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company
will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Before taking any action which
would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company
shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or
bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail: </FONT>jim.deller@clearsign.com, or sent by a nationally recognized
overnight courier service, addressed to the Company, at 8023 E. 63rd Place, Suite&nbsp;101, Tulsa, Oklahoma 74133 Attention: Chief Financial
Officer, or such other physical address, email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the physical address, e-mail address
or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of (i)&nbsp;the time of transmission, if such notice or communication is delivered via e-mail at the
e-mail address set forth in this Section&nbsp;prior to 5:30 p.m.&nbsp;(New York City time) on any date, (ii)&nbsp;the next Trading Day
after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section&nbsp;on
a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (iii)&nbsp;the second Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or the fifth Trading Day following the
date of mailing, if sent by the United States Postal Service, postage prepaid, or (iv)&nbsp;upon actual receipt by the party to whom such
notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Warrant may be modified or amended and the provisions hereof may be waived with the written consent of the Company and holders of
a majority of the then outstanding Warrants (based on the number of Warrant Shares then underlying such Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CLEARSIGN TECHNOLOGIES CORPORATION</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#8239;&nbsp;&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 41%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">[Signature
Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">ClearSign
Technologies Corporation &ndash; Redeemable Private Warrant</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">TO: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;CLEARSIGN
TECHNOLOGIES CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
shall take the form of lawful money of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrant Shares shall be delivered to the following DWAC Account
Number or by physical delivery of a certificate to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT></TD>
    <TD STYLE="width: 80%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT></TD>
    <TD STYLE="width: 60%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="width: 70%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="width: 70%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 91%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ________________________,___</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>6
<FILENAME>tm2412212d1_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS WARRANT AND THE SECURITIES ISSUABLE UPON
EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR ANY OTHER
SECURITIES LAWS AND MAY&nbsp;NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1)&nbsp;AN EFFECTIVE
REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2)&nbsp;AN OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>______ shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>______ , 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>PLACEMENT AGENT WARRANT
</B>(this &ldquo;<B>Warrant</B>&rdquo;) of ClearSign Technologies Corporation, a corporation duly organized and validly existing under
the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), is being issued pursuant to that certain letter of intent between
the Company and Public Ventures LLC, dated [___], 2024 (the &ldquo;<B>Agreement</B>&rdquo;), relating to a private placement of securities
of the Company (the &ldquo;<B>Offering</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>FOR VALUE RECEIVED, </B>the
Company hereby grants to Public Ventures, LLC and its permitted successors and assigns (collectively, the &ldquo;<B>Holder</B>&rdquo;)
the right to purchase from the Company up to ______ shares (such shares underlying this Warrant, the &ldquo;<B>Warrant Shares</B>&rdquo;)
of common stock, $0.0001 par value, of the Company (the &ldquo;<B>Common Stock</B>&rdquo;), at a per share purchase price equal to $1.1375
(the &ldquo;<B>Exercise Price</B>&rdquo;)<B>, </B>subject to the terms, conditions and adjustments set forth below in this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Date
of Warrant Exercise</U>. This Warrant shall become exercisable one hundred eighty (180) days after the Base Date (the &ldquo;<B>Exercise
Date</B>&rdquo;). As used in this Warrant, the term &ldquo;<B>Base Date</B>&rdquo; shall mean ______, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expiration
of Warrant</U>. This Warrant shall expire on the five (5)&nbsp;year anniversary of the Base Date (the &ldquo;<B>Expiration Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrant</U>. This Warrant shall be exercisable pursuant to the terms of this <U>Section&nbsp;3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Manner
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Warrant may only be exercised by the Holder hereof on or after the Exercise Date and on or prior to the Expiration Date, in accordance
with the terms and conditions hereof, in whole or in part (but not as to fractional shares) with respect to any portion of this Warrant,
during the Company&rsquo;s normal business hours on any day other than a Saturday or a Sunday or a day on which commercial banking institutions
in New York, New York are authorized by law to be closed (a &ldquo;<B>Business Day</B>&rdquo;), by surrender of this Warrant to the Company
at its office maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, accompanied by a written exercise notice in the form attached
as <U>Exhibit&nbsp;A</U> to this Warrant duly executed by the Holder, together with the payment of the aggregate Exercise Price for the
number of Warrant Shares purchased upon exercise of this Warrant. Upon surrender of this Warrant, the Company shall cancel this Warrant
document and shall, in the event of partial exercise, replace it with a new Warrant document in accordance with <U>Section&nbsp;3.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as provided for in <U>Section&nbsp;3.1(c)</U>&nbsp;below, each exercise of this Warrant must be accompanied by payment in full of the
aggregate Exercise Price in cash by check or wire transfer in immediately available funds for the number of Warrant Shares being purchased
by the Holder upon such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
aggregate Exercise Price for the number of Warrant Shares being purchased may also, in the sole discretion of the Holder, be paid in full
or in part on a &ldquo;cashless basis&rdquo; at the election of the Holder in the form of Warrant Shares withheld by the Company from
the Warrant Shares otherwise to be received upon exercise of this Warrant having an aggregate Fair Market Value on the date of exercise
equal to the aggregate Exercise Price of the Warrant Shares being purchased on a &ldquo;cashless&rdquo; basis by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Warrant,
the term &ldquo;<B>Fair Market Value</B>&rdquo; means with respect to a particular date, the average closing price of the Common Stock
for the five (5)&nbsp;Trading Days immediately preceding the applicable exercise herein as officially reported by the principal securities
exchange on which the Common Stock is then listed or admitted to trading, or, if the Common Stock is not listed or admitted to trading
on any securities exchange as determined in good faith by resolution of the Board of Directors of the Company, based on the best information
available to it. For purposes of this Warrant, (i)&nbsp;the term &ldquo;<B>Trading Day</B>&rdquo; means a day on which the Common Stock
is traded on a Trading Market, and (ii)&nbsp;the term &ldquo;<B>Trading Market</B>&rdquo; means any of the following markets or exchanges
on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq
Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To illustrate a cashless exercise
of this Warrant under <U>Section&nbsp;3.1(c)</U>&nbsp;(or for a portion thereof for which cashless exercise treatment is requested), the
calculation of such exercise shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">X = Y (A-B)/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in">X =</TD><TD>the number of Warrant Shares to be issued to the Holder (rounded to the nearest whole share).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">Y =</TD>
  <TD>the number of Warrant Shares with respect to which
this Warrant is being exercised.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">A =</TD>
  <TD>the Fair Market Value of the Common Stock.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.4in">B =</TD>
  <TD>the Exercise Price.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
purposes of Rule&nbsp;144 and sub-section (d)(3)(ii)&nbsp;thereof, it is intended, understood, and acknowledged that the Common Stock
issuable upon exercise of this Warrant in a cashless exercise transaction as described in <U>Section&nbsp;3.1(c)</U>&nbsp;above shall
be deemed to have been acquired at the time this Warrant was issued. Moreover, it is intended, understood, and acknowledged that the holding
period for the Common Stock issuable upon exercise of this Warrant in a cashless exercise transaction as described in <U>Section&nbsp;3.1(c)</U>&nbsp;above
shall be deemed to have commenced on the date this Warrant was issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>When
Exercise Effective</U>. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business
on the Business Day on which this Warrant shall have been duly surrendered to the Company, and, at such time, the Holder in whose name
any certificate or certificates for Warrant Shares shall be issuable upon exercise as provided in <U>Section&nbsp;3.3</U> hereof shall
be deemed to have become the holder or holders of record thereof of the number of Warrant Shares purchased upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Common Stock Certificates and New Warrant</U>. As soon as reasonably practicable after each exercise of this Warrant, in whole or in
part, and in any event within three (3)&nbsp;Business Days thereafter, the Company, at its expense (including the payment by it of any
applicable issue taxes), will cause to be issued in the name of and delivered to the Holder hereof or, subject to <U>Sections 9</U> and
<U>10</U> hereof, as the Holder (upon payment by the Holder of any applicable transfer taxes) may direct:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
book-entry statement (with appropriate restrictive legends, as applicable) for the number of duly authorized, validly issued, fully paid
and non-assessable Warrant Shares to which the Holder shall be entitled upon exercise; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant Shares
issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery of any Warrant
Shares as payment of the Exercise Price for such partial exercise of this Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and the Holder shall not have the right to exercise
any portion of this Warrant, pursuant to <U>Section&nbsp;3</U> or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates (as such term is defined
in Rule&nbsp;405 promulgated under the Securities Act), and any other persons acting as a group together with the Holder or any of the
Holder&rsquo;s Affiliates (such persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial
Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned
by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of
such Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would
be issuable upon (i)&nbsp;exercise of the remaining, non-exercised portion of such Warrant beneficially owned by the Holder or any of
its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or non-converted portion of any other securities
of the Company (including, without limitation, any other securities of the Company which would entitle the holder thereof to acquire at
any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of
Common Stock (&ldquo;<B>Common Stock Equivalents</B>&rdquo;)) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this <U>Section&nbsp;3.4</U>, beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of
the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and the rules&nbsp;and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this <U>Section&nbsp;3.4</U> applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this <U>Section&nbsp;3.4</U>, in determining
the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A)&nbsp;the Company&rsquo;s most recent periodic or annual report filed with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;),
as the case may be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of the Holder,
the Company shall within two (2)&nbsp;Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including such Warrant, by the Holder or its Affiliates or Attribution Parties since the date as
of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall
be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this <U>Section&nbsp;3.4</U>, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this <U>Section&nbsp;3.4</U> shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section&nbsp;3.4</U> to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U>. For so long as this Warrant is outstanding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mergers
or Consolidations</U>. If at any time after the date hereof there shall be a capital reorganization (other than a combination or subdivision
of Common Stock otherwise provided for herein) resulting in a reclassification to or change in the terms of securities issuable upon exercise
of this Warrant (a &ldquo;<B>Reorganization</B>&rdquo;), or a merger or consolidation of the Company with another corporation, association,
partnership, organization, business, individual, government or political subdivision thereof or a governmental agency (a &ldquo;<B>Person</B>&rdquo;
or the &ldquo;<B>Persons</B>&rdquo;) (other than (i)&nbsp;a merger with another Person which does not result in any reclassification or
change in the terms of securities issuable upon exercise of this Warrant or (ii)&nbsp;a merger effected exclusively for the purpose of
changing the name or domicile of the Company) (a &ldquo;<B>Merger</B>&rdquo;), then, as a part of such Reorganization or Merger, lawful
provision and adjustment shall be made so that the Holder shall thereafter be entitled to receive, upon exercise of this Warrant, the
number of shares of stock or any other equity or debt securities or property receivable upon such Reorganization or Merger by a holder
of the number of shares of Common Stock which might have been purchased upon exercise of this Warrant immediately prior to such Reorganization
or Merger. In any such case, appropriate adjustment shall be made in the application of the provisions of this Warrant with respect to
the rights and interests of the Holder after the Reorganization or Merger to the end that the provisions of this Warrant (including adjustment
of the Exercise Price then in effect and the number of Warrant Shares) shall be applicable after that event, as near as reasonably may
be, in relation to any shares of stock, securities, property or other assets thereafter deliverable upon exercise of this Warrant. The
provisions of this <U>Section&nbsp;4.1</U> shall similarly apply to successive Reorganizations and/or Mergers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Splits
and Subdivisions; Dividends</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant or the Public Warrants (as defined in the Agreement)), (ii)&nbsp;subdivides outstanding shares of Common Stock into a larger number
of shares, (iii)&nbsp;combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv)&nbsp;issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the
Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;4.2 shall become
effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Impairment</U>. The Company will not, by amendment of its certificate of incorporation or by-laws or through any consolidation, merger,
reorganization, transfer of assets, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all of
the terms and in the taking of all actions necessary or appropriate in order to protect the rights of the Holder against impairment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
as to Adjustments</U>. With respect to each adjustment pursuant to <U>Section&nbsp;4</U> of this Warrant, the Company, at its expense,
will promptly compute the adjustment or re-adjustment in accordance with the terms of this Warrant and furnish the Holder with a certificate
certified and confirmed by the Secretary or Chief Financial Officer of the Company setting forth, in reasonable detail, the event requiring
the adjustment or re-adjustment and the amount of such adjustment or re-adjustment, the method of calculation thereof and the facts upon
which the adjustment or re-adjustment is based, and the Exercise Price and the number of Warrant Shares or other securities purchasable
hereunder after giving effect to such adjustment or re-adjustment, which report shall be mailed by first class mail, postage prepaid,
or emailed to the Holder; provided, that the Company may satisfy the notice requirement set forth in this Section&nbsp;6 by filing such
notice with the Commission pursuant to a Current Report on Form&nbsp;8-K, Quarterly Report on Form&nbsp;10-Q or Annual Report on Form&nbsp;10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Shares</U>. The Company shall, solely for the purpose of effecting the exercise of this Warrant, at all times during the term of this
Warrant, reserve and keep available out of its authorized shares of Common Stock, free from all taxes, liens and charges with respect
to the issue thereof and not subject to preemptive rights of shareholders of the Company, such number of its shares of Common Stock as
shall from time to time be sufficient to effect in full the exercise of this Warrant. If at any time the number of authorized but unissued
shares of Common Stock shall not be sufficient to effect in full the exercise of this Warrant, in addition to such other remedies as shall
be available to Holder, the Company will promptly take such corporate action as may, in the opinion of its counsel, be necessary to increase
the number of authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including
without limitation, using its Reasonable Commercial Efforts (as defined below) to obtain the requisite shareholder approval necessary
to increase the number of authorized shares of Common Stock. The Company hereby represents and warrants that all shares of Common Stock
issuable upon proper exercise of this Warrant shall be duly authorized and, when issued and paid for upon proper exercise, shall be validly
issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
and Listing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definition
of Registrable Securities; Majority</U>. As used herein, the term &ldquo;<B>Registrable Securities</B>&rdquo; means any shares of Common
Stock issuable upon the exercise of this Warrant until the date (if any) on which such shares shall have been transferred or exchanged
and new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent
disposition of the shares shall not require registration or qualification under the Securities Act or any similar state law then in force.
For purposes of this Warrant, the term &ldquo;<B>Majority Holders</B>&rdquo; shall mean in excess of fifty percent (50%) of the then outstanding
Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Demand
Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company, upon written demand (&ldquo;<B>Demand Notice</B>&rdquo;) of the Majority Holders, agrees to register on one occasion all of the
Registrable Securities (a &ldquo;<B>Demand Right</B>&rdquo;). This Demand Right shall be exercisable only in conjunction with the exercise
of a similar demand right applicable under the warrant issued on even date herewith as compensation for a firm commitment underwritten
offering by the Company in which Public Ventures, LLC acted as the underwriter. For the avoidance of doubt, Majority Holders will be determined
as to each separate warrant. On such occasion, the Company will file a registration statement or a post-effective amendment to the registration
statement covering the Registrable Securities within forty-five (45) days after receipt of a Demand Notice and use its Reasonable Commercial
Efforts to have such registration statement or post-effective amendment declared effective as soon as possible thereafter; <U>provided</U>,
<U>however</U>, that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration statement
with respect to which the Holder is entitled to piggyback registration rights pursuant to <U>Section&nbsp;8.3</U> hereof and either: (i)&nbsp;the
Holder has elected to participate in the offering covered by such registration statement or (ii)&nbsp;if such registration statement relates
to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement has been withdrawn
or until thirty (30) days after such offering is consummated. The demand for registration may be made at any time, on one (1)&nbsp;occasion
only, during a period commencing 120 days after the Base Date and ending on the fifth year of the Base Date. The Company covenants and
agrees to give written notice of its receipt of any Demand Notice to all other registered Holders of the Warrants and/or the Registrable
Securities within ten days from the date of the receipt of any such Demand Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
fees and expenses attendant to registering the Registrable Securities pursuant to <U>Section&nbsp;8.2(a)</U>&nbsp;shall be borne as set
forth in <U>Section&nbsp;8.6</U>. For the avoidance of doubt, the holders of Registrable Securities shall pay any and all underwriting
commissions and the expenses of any legal counsel selected by them to represent them in connection with the sale of the Registrable Securities,
except as set forth in <U>Section&nbsp;8.6</U>. The Company agrees to use its Reasonable Commercial Efforts to qualify or register the
Registrable Securities in such states as are reasonably requested by the Majority Holder(s); <U>provided</U>, <U>however</U>, that in
no event shall the Company be required to register the Registrable Securities in a state in which such registration would cause (i)&nbsp;the
Company to be obligated to register, license or qualify to do business in such state, submit to general service of process in such state
or would subject the Company to taxation as a foreign corporation doing business in such jurisdiction or (ii)&nbsp;the principal stockholders
of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall use Reasonable Commercial Efforts
to cause any registration statement or post-effective amendment filed pursuant to the Demand Right granted under <U>Section&nbsp;8.2(a)</U>&nbsp;to
remain effective for a period of nine consecutive months from the effective date of such registration statement or post-effective amendment.
The Holders shall only use the prospectuses provided by the Company to sell the Registrable Securities covered by such registration statement,
and will immediately cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no
longer be used due to a material misstatement or omission. Notwithstanding the provisions of this <U>Section&nbsp;8.2(b)</U>, the Holder
shall be entitled to a demand registration under this Section&nbsp;on only one (1)&nbsp;occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Incidental
Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
during the period of five (5)&nbsp;years after the Base Date, the Company proposes to register any of its securities under the Securities
Act (other than in connection with a transaction contemplated by Rule&nbsp;145(a)&nbsp;promulgated under the Securities Act or pursuant
to registration on Form&nbsp;S-4 or S-8 or any successor forms or in connection with securities issued pursuant to clirSPV LLC&rsquo;s
participation right granted in connection with that certain Stock Purchase Agreement dated July&nbsp;12, 2018, between the Company and
clirSVP LLC) whether for its own account or for the account of any holder or holders of its shares other than Registrable Securities (any
shares of such holder or holders (but not those of the Company and not Registrable Securities) with respect to any registration are referred
to herein as, &ldquo;<B>Other Shares</B>&rdquo;), the Company shall at each such time give prompt (but not less than thirty (30) days
prior to the anticipated effectiveness thereof) written notice to the holders of Registrable Securities of its intention to do so. The
holders of Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided herein by giving written notice within ten
(10)&nbsp;days after the receipt of any such notice (which request shall specify the Registrable Securities intended to be disposed of
by such holder). Except as set forth in <U>Section&nbsp;8.3(b)</U>, the Company will use its Reasonable Commercial Efforts to effect the
registration under the Securities Act of all of the Registrable Securities which the Company has been so requested to register by such
holder, to the extent required to permit the disposition of the Registrable Securities so to be registered, by inclusion of such Registrable
Securities in the registration statement which covers the securities which the Company proposes to register. In connection with such registration,
Company will file a registration statement with the Commission on Form&nbsp;S-3 or other appropriate form if necessary to comply with
General Instruction I.B.6. of Form&nbsp;S-3 and Commission interpretations thereof. The Company will pay all Registration Expenses in
connection with each registration of Registrable Securities pursuant to this <U>Section&nbsp;8.3</U>, but the holders of Registrable Securities
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by them to represent them in connection
with the sale of the Registrable Securities, except as set forth in <U>Section&nbsp;8.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Company at any time proposes to register any of its securities under the Securities Act as contemplated by this <U>Section&nbsp;8.3</U>
and such securities are to be distributed by or through one or more underwriters or a registered broker dealer, the Company will, if requested
by a holder of Registrable Securities, use its Reasonable Commercial Efforts to arrange for such underwriters or registered broker dealer
to include all the Registrable Securities to be offered and sold by such holder among the securities to be distributed by such underwriters
or registered broker dealer, provided that if the managing underwriter or registered broker dealer of such offering shall inform the Company
its belief (including as statement of the basis of that belief and the approximate number of Registrable Securities to be removed and
the number of any other shares included in the offering by persons other than the Company and whether or not they are being cut back and
by what amount, and the shares to be offered by the Company) that inclusion in such registration statement and/or distribution of all
or a specified number of such securities proposed to be distributed by such underwriters or registered broker dealer would interfere with
the successful marketing of the securities being distributed by such underwriters or registered broker dealer, then the Company may, upon
written notice to the holders of the Registrable Securities, reduce pro rata in accordance with the number of shares of Common Stock desired
to be included in such registration statement and/or distribution (if and to the extent stated by such managing underwriter or registered
broker dealer to be necessary to eliminate such effect) the number of such Registrable Securities the registration and/or distribution
of which shall have been requested by each holder thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Procedures</U>. Whenever the holders of Registrable Securities have properly requested that any Registrable Securities be registered pursuant
to the terms of this Warrant, the Company shall use its Reasonable Commercial Efforts to effect the registration for the resale of such
Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto the Company shall use its Commercially
Reasonable Efforts to, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its Reasonable Commercial Efforts to
cause such registration statement to become effective;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;notify
such holders of the effectiveness of each registration statement filed hereunder and prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection therewith as may be necessary to (i)&nbsp;use Reasonable
Commercial Efforts keep such registration statement effective and the prospectus included therein usable for a period commencing on the
date that such registration statement is initially declared effective by the SEC and ending on the earlier of (A)&nbsp;the date when all
Registrable Securities covered by such registration statement have been sold pursuant to the registration statement or cease to be Registrable
Securities, or (B)&nbsp;nine months from the effective date of the registration statement; and (ii)&nbsp;comply with the provisions of
the Securities Act with respect to the disposition of all securities covered by such registration statement during such period in accordance
with the intended methods of disposition by the sellers thereof set forth in such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[RESERVED];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;use
its Reasonable Commercial Efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such
jurisdictions as such holders reasonably request and do any and all other acts and things which may be reasonably necessary to enable
such holders to consummate the disposition in such jurisdictions of the Registrable Securities owned by such holders; provided, however,
that the Company shall not be required to: (i)&nbsp;qualify generally to do business in any jurisdiction where it would not otherwise
be required to qualify but for this subparagraph; (ii)&nbsp;subject itself to taxation in any such jurisdiction; or (iii)&nbsp;consent
to general service of process in any such jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;notify
such holders, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening of
any event as a result of which the prospectus included in such registration statement contains an untrue statement of a material fact
or omits any material fact necessary to make the statements therein, in light of the circumstances in which they are made, not materially
misleading, and, at the reasonable request of such holders, the Company shall prepare a supplement or amendment to such prospectus so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not contain an untrue statement
of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances in which
they are made, not materially misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;provide
a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;make
available for inspection by any underwriter participating in any disposition pursuant to such registration statement, and any attorney,
accountant or other agent retained by any such underwriter, all financial and other records, pertinent corporate documents and properties
of the Company, and cause the Company&rsquo;s officers, directors, managers, employees and independent accountants to supply all information
reasonably requested by any such underwriter, attorney, accountant or agent in connection with such registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;otherwise
comply with all applicable rules&nbsp;and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable,
an earnings statement of the Company, which earnings statement shall satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Securities
Act and, at the option of the Company, Rule&nbsp;158 thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
the event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending or preventing
the use of any related prospectus or suspending the qualification of any Registrable Securities included in such registration statement
for sale in any jurisdiction, the Company shall use its Reasonable Commercial Efforts promptly to obtain the withdrawal of such order;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the offering is underwritten, use its Reasonable Commercial Efforts to furnish on the date that Registrable Securities are delivered to
the underwriters for sale pursuant to such registration, an opinion dated such date of counsel representing the Company for the purposes
of such registration, addressed to the underwriters covering such issues as are customarily addressed in opinions to underwriters in public
offerings and reasonably required by such underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing</U>.
The Company shall secure the listing of the Common Stock underlying this Warrant upon each national securities exchange or automated quotation
system upon which shares of Common Stock are then listed or quoted (subject to official notice of issuance) and shall use its Reasonable
Commercial Efforts to maintain such listing of shares of Common Stock. The Company shall at all times comply in all material respects
with the Company&rsquo;s reporting, filing and other obligations under the by-laws or rules&nbsp;of the Nasdaq Capital Market (or such
other national securities exchange or market on which the Common Stock may then be listed, as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expenses</U>.
The Company shall pay all Registration Expenses relating to the registration and listing obligations set forth in this <U>Section&nbsp;8</U>.
For purposes of this Warrant, the term &ldquo;<B>Registration Expenses</B>&rdquo; means: (a)&nbsp;all registration, filing and FINRA fees,
(b)&nbsp;all reasonable fees and expenses of complying with securities or blue sky laws, (c)&nbsp;all word processing, duplicating and
printing expenses, (d)&nbsp;the fees and disbursements of counsel for the Company and of its independent public accountants, including
the expenses of any special audits or &ldquo;cold comfort&rdquo; letters required by or incident to such performance and compliance, and
(e)&nbsp;fees and disbursements of one counsel for the selling holders of Registrable Securities up to $5,000. Registration Expenses shall
not include any underwriting discounts and commissions which may be incurred in the sale of any Registrable Securities and transfer taxes
of the selling holders of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Information
Provided by Holders</U>. Any holder of Registrable Securities included in any registration shall furnish to the Company such information
as the Company may reasonably request in writing, including, but not limited to, a completed and executed questionnaire requesting information
customarily sought of selling security holders, to enable the Company to comply with the provisions hereof in connection with any registration
referred to in this Warrant. The Holder agrees to suspend all sales of Registrable Securities pursuant to a registration statement filed
under <U>Section&nbsp;8.3</U> in the event the Company notifies Holder pursuant to <U>Section&nbsp;8.4(e)</U>&nbsp;that the prospectus
relating thereto is no longer current and will not resume sales under such registration statement until advised by the Company that the
prospectus has been appropriately supplemented or amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Net
Cash Settlement</U>. Notwithstanding anything herein to the contrary, in no event will the Holder hereof be entitled to receive a net-cash
settlement as liquidated damages in lieu of physical settlement in shares of Common Stock, regardless of whether the Common Stock underlying
this Warrant is registered pursuant to an effective registration statement; provided, however, that the foregoing will not preclude the
Holder from seeking other remedies at law or equity for breaches by the Company of its registration obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions
on Transfer</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictive
Legends</U>. This Warrant and each Warrant issued upon transfer or in substitution for this Warrant pursuant to <U>Section&nbsp;10</U>
hereof, each certificate for Common Stock issued upon the exercise of this Warrant and each Warrant issued upon transfer or in substitution
for this Warrant pursuant to <U>Section&nbsp;10</U> hereof and each certificate issued upon the transfer of any such Common Stock shall
be transferable only upon satisfaction of the conditions specified in this <U>Section&nbsp;9</U>. Each of the foregoing securities shall
be stamped or otherwise imprinted with a legend reflecting the restrictions on transfer set forth herein and any restrictions required
under the Securities Act or other applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Proposed Transfer</U>. Prior to any transfer of any securities which are not registered under an effective registration statement under
the Securities Act (&ldquo;<B>Restricted Securities</B>&rdquo;), which transfer may only occur if there is an exemption from the registration
provisions of the Securities Act and all other applicable securities laws, the Holder will give written notice to the Company of the Holder&rsquo;s
intention to effect a transfer (and shall describe the manner and circumstances of the proposed transfer). The following provisions shall
apply to any proposed transfer of Restricted Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
in the opinion of counsel for the Holder reasonably satisfactory to the Company the proposed transfer may be effected without registration
of the Restricted Securities under the Securities Act (which opinion shall state in detail the basis of the legal conclusions reached
therein), the Holder shall thereupon be entitled to transfer the Restricted Securities in accordance with the terms of the notice delivered
by the Holder to the Company. Each certificate representing the Restricted Securities issued upon or in connection with any transfer shall
bear the restrictive legends required by Section&nbsp;9.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the opinion called for in <U>clause (i)</U>&nbsp;above is not delivered, the Holder shall not be entitled to transfer the Restricted Securities
until either: (x)&nbsp;receipt by the Company of a further notice from such Holder pursuant to the foregoing provisions of this <U>Section&nbsp;9.2</U>
and fulfillment of the provisions of <U>clause (i)</U>&nbsp;above, or (y)&nbsp;such Restricted Securities have been effectively registered
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination
of Restrictions</U>. The restrictions imposed by this <U>Section&nbsp;9</U> upon the transferability of Restricted Securities shall cease
and terminate as to any particular Restricted Securities: (a)&nbsp;which shall have been effectively registered under the Securities Act,
or (b)&nbsp;when, in the opinion of counsel for the Company, such restrictions are no longer required in order to insure compliance with
the Securities Act or Section&nbsp;10 hereof. Whenever such restrictions shall cease and terminate as to any Restricted Securities, the
Holder thereof shall be entitled to receive from the Company, without expense (other than applicable transfer taxes, if any), new securities
of like tenor not bearing the applicable legends required by <U>Section&nbsp;9.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership,
Transfer, Sale and Substitution of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ownership
of Warrant</U>. The Company may treat any Person in whose name this Warrant is registered in the Warrant Register (as defined below) maintained
pursuant to <U>Section&nbsp;10.2(b)</U>&nbsp;hereof as the owner and holder thereof for all purposes, notwithstanding any notice to the
contrary, except that, if and when any Warrant is properly assigned in blank, the Company may (but shall not be obligated to) treat the
bearer thereof as the owner of such Warrant for all purposes, notwithstanding any notice to the contrary. Subject to Sections 9 and 10
hereof, this Warrant, if properly assigned, may be exercised by a new holder without a new Warrant first having been issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Office;
Exchange of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company will maintain its principal office at the location identified in the prospectus relating to the Offering or at such other offices
as set forth in the Company&rsquo;s most current filing (as of the date notice is to be given) under Exchange Act, or as the Company otherwise
notifies the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall cause to be kept at its office maintained pursuant to Section&nbsp;10.2(a)&nbsp;hereof a warrant register for the registration
and transfer of this Warrant (the &ldquo;<B>Warrant Register</B>&rdquo;). The name and address of the holder of this Warrant, the transfers
thereof and the name and address of the transferee of this Warrant shall be registered in such Warrant Register. The Person in whose name
this Warrant shall be so registered shall be deemed and treated as the owner and holder thereof for all purposes of this Warrant, and
the Company shall not be affected by any notice or knowledge to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the surrender of this Warrant, properly endorsed, for registration of transfer or for exchange at the office of the Company maintained
pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, the Company at its expense will (subject to compliance with Section&nbsp;9 hereof,
if applicable) execute and deliver to or upon the order of the Holder thereof a new Warrant of like tenor, in the name of such holder
or as such holder (upon payment by such holder of any applicable transfer taxes) may direct, calling in the aggregate on the face thereof
for the number of shares of Common Stock called for on the face of this Warrant so surrendered (after giving effect to any previous adjustment(s)&nbsp;to
the number of Warrant Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Warrant</U>. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this
Warrant and, in the case of any such loss, theft or destruction of this Warrant, upon delivery of indemnity reasonably satisfactory to
the Company in form and amount or, in the case of any mutilation, upon surrender of this Warrant for cancellation at the office of the
Company maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof, the Company will execute and deliver, in lieu thereof, a new Warrant
of like tenor and dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Opinions</U>.
In connection with the sale of the Warrant Shares by Holder, if the Company&rsquo;s counsel reasonably determines such opinion is appropriate,
the Company agrees to cooperate with the Holder, and at the Company&rsquo;s expense, to have its counsel provide any legal opinions required
to remove the restrictive legends from the Warrant Shares in connection with a sale, transfer or legend removal request of Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Redemption</U>.
For the avoidance of doubt, the Company shall not be permitted to redeem this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights or Liabilities as Stockholder</U>. No Holder shall be entitled to vote or receive dividends or distributions or be deemed the holder
of any equity securities which may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to
confer upon the Holder, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon
any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise)
or to receive notice of meetings, or to receive dividends or distributions, or to share in the assets of the Company in the event of a
liquidation, dissolution or the winding up of the Company, until this Warrant shall have been exercised and the shares of Common Stock
purchasable upon the exercise hereof shall have become deliverable, as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any notice or other communication in connection with this Warrant shall be given in writing and directed to the parties hereto as follows:
(a)&nbsp;if to the Holder, at the address of the holder in the Warrant Register, or (b)&nbsp;if to the Company, to the attention of its
Chief Executive Officer and Chief Financial Officer at its office maintained pursuant to <U>Section&nbsp;10.2(a)</U>&nbsp;hereof; <I>provided,
</I>that the exercise of this Warrant shall also be effected in the manner provided in Section&nbsp;3 hereof. Notices shall be deemed
properly delivered and received when delivered to the notice party (i)&nbsp;if personally delivered, upon receipt or refusal to accept
delivery, (ii)&nbsp;if sent via email, the date of transmission if sent on a Business Day prior to 5:30 p.m.&nbsp;(New York City time),
or the next Business Day if sent on a day that is not a Business Day or at or after 5:30 p.m.&nbsp;(New York City time) on a Business
Day, (iii)&nbsp;if sent by a commercial overnight courier for delivery on the next Business Day, on the first Business Day after deposit
with such courier service, or (iv)&nbsp;if sent by registered or certified mail, five (5)&nbsp;Business Days after deposit thereof in
the U.S. mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Taxes</U>. The Company will pay all documentary stamp taxes attributable to the issuance of shares of Common Stock underlying this
Warrant upon exercise of this Warrant; <I>provided, however, </I>that the Company shall not be required to pay any tax which may be payable
in respect of any transfer involved in the transfer or registration of this Warrant or any certificate for shares of Common Stock underlying
this Warrant in a name other that of the Holder. The Holder is responsible for all other tax liability that may arise as a result of holding
or transferring this Warrant or receiving shares of Common Stock underlying this Warrant upon exercise hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.
This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party
against which enforcement of the change, waiver, discharge or termination is sought, or with the written consent of the Company and the
holders of outstanding Underwriter Warrants (as defined in the Agreement) then exercisable for a majority of the shares of Common Stock
issuable upon exercise of all outstanding Underwriter Warrants. This Warrant shall be construed and enforced in accordance with and governed
by the laws of the State of New York. Each of the parties consents to the exclusive jurisdiction of the Federal or state courts whose
districts encompass any part of the County of New York located in the City of New York, New York in connection with any dispute arising
under this Agreement and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on <I>forum
non conveniens, </I>to the bringing of any such proceeding in such jurisdictions. Each party to this Agreement irrevocably consents to
the service of process in any such proceeding by any manner permitted by law. The section headings in this Warrant are for purposes of
convenience only and shall not constitute a part hereof. When used herein, the term &ldquo;<B>Reasonable Commercial Efforts</B>&rdquo;
means, with respect to the applicable obligation of the Company, commercially reasonable efforts for similarly situated, publicly-traded
companies. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not
be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF, </B>the
Company has caused this Underwriter Warrant to be duly executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">CLEARSIGN TECHNOLOGIES CORPORATION</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A<BR>
FORM&nbsp;OF EXERCISE NOTICE<BR>
</B>[To be executed only upon exercise of Warrant]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To CLEARSIGN TECHNOLOGIES CORPORATION:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned registered holder of the within Warrant hereby irrevocably
exercises the Warrant pursuant to Section&nbsp;3.1 of the Warrant with respect to [_____] Warrant Shares, at an exercise price of $[____]
per share, and requests that the certificates for such Warrant Shares be issued, subject to Sections 9 and 10, in the name of and delivered
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned is hereby making payment for the Warrant Shares in
the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[check one]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by
cash in accordance with Section&nbsp;3.1(b)&nbsp;of the Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;via
cashless exercise in accordance with Section&nbsp;3.1(c)&nbsp;of the Warrant in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned hereby represents and warrants that it is, and has
been since its acquisition of the Warrant, the record and beneficial owner of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned is an &ldquo;accredited investor&rdquo; as defined
in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Print or Type Name</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 50%">(Signature must conform in all respects to name of holder as specified on the face of Warrant)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B<BR>
FORM&nbsp;OF ASSIGNMENT<BR>
</B>[To be executed only upon transfer of Warrant]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For value received, the undersigned registered holder of the within
Warrant hereby sells, assigns and transfers unto <U>&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;</U>&#8239;[include
name and addresses] the rights represented by the Warrant to purchase __________ shares of Common
Stock of CLEARSIGN TECHNOLOGIES CORPORATION to which the Warrant relates, and appoints ______________,
the undersigned&rsquo;s attorney to make such transfer on the books of CLEARSIGN TECHNOLOGIES CORPORATION maintained for the purpose,
with full power of substitution in the premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Signature must conform in all respects to name of holder as specified on the face of Warrant)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signed in the presence of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Signature of Transferee)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 50%">(Street Address)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 20%">(City)</TD>
  <TD STYLE="width: 15%">(State)</TD>
  <TD STYLE="width: 15%">(Zip Code)</TD>
  <TD STYLE="width: 30%">&nbsp;</TD></TR>
</TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signed in the presence of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>tm2412212d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CLEARSIGN TECHNOLOGIES CORPORATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">VStock
Transfer, LLC</FONT>, as</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrant Agent</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrant Agency Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of April&nbsp;____, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>WARRANT AGENCY AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">WARRANT AGENCY AGREEMENT,
dated as of April&nbsp;___, 2024 (&ldquo;<U>Agreement</U>&rdquo;), by and between ClearSign Technologies Corporation, a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and VStock Transfer, LLC, a New York limited liability trust company (&ldquo;<U>VStock</U>&rdquo;
or the &ldquo;<U>Warrant Agent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">W I T N E S S E T H</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">WHEREAS, pursuant to the
terms of that certain Underwriting Agreement, dated April&nbsp;19, 2024, by and between the Company and Public Ventures, LLC, as representative
of the underwriters named therein, the Company engaged in a public offering (the &ldquo;<U>Offering</U>&rdquo;) of: (i)&nbsp;[__] units
(the &ldquo;<U>Units</U>&rdquo;), with each Unit consisting of (a)&nbsp;one share of the Company&rsquo;s common stock, par value $0.0001
per share (the &ldquo;<U>Common Stock</U>&rdquo;), and (b)&nbsp;one accompanying common warrant to purchase Common Stock (the &ldquo;<U>Warrants&rdquo;</U>);
and (ii)&nbsp;the shares of Common Stock issuable upon exercise of the Warrants (the &ldquo;<U>Warrant Shares</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">WHEREAS, upon the terms and
subject to the conditions hereinafter set forth and pursuant to an effective registration statement on Form&nbsp;S-3 (File No.&nbsp;333-265967)
(as amended, the &ldquo;<U>Registration Statement</U>&rdquo;), and the terms and conditions of the Warrant Certificate (as defined below)
the Company wishes to issue Warrants in book entry form entitling the respective holders of the Warrants (the &ldquo;<U>Holders</U>&rdquo;,
which term shall include a Holder&rsquo;s transferees, successors and assigns and &ldquo;Holder&rdquo; shall include, if the Warrants
are held in &ldquo;street name&rdquo;, a Participant (as defined below) or a designee appointed by such Participant); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">WHEREAS, the Company wishes
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to act, in connection with the issuance, registration,
transfer, exchange, exercise and replacement of the Warrants and in the Warrant Agent&rsquo;s capacity as the Company&rsquo;s transfer
agent, the delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">NOW, THEREFORE, in consideration
of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;1. <U>Certain
Definitions</U>. For purposes of this Agreement, the following terms have the meanings indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&ldquo;<U>Affiliate</U>&rdquo;
has the meaning ascribed to it in Rule&nbsp;12b-2 under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which the Nasdaq Stock Market is authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&ldquo;<U>Close of
Business</U>&rdquo; on any given date means 5:00 p.m., New York City time, on such date; <U>provided</U>, <U>however</U>, that if such
date is not a Business Day, it means 5:00 p.m., New York City time, on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&ldquo;<U>Person</U>&rdquo;
means an individual, corporation, association, partnership, limited liability company, joint venture, trust, unincorporated organization,
government or political subdivision thereof or governmental agency or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp; &ldquo;<U>Warrant
Certificate</U>&rdquo; means a certificate in substantially the form attached as <U>Exhibit&nbsp;1-A </U>(as it relates to the Warrants)
hereto, representing such number of Warrant Shares (as defined above) as is indicated therein, provided that any reference to the delivery
of a Warrant Certificate in this Agreement shall include delivery of notice from the Depository or a Participant (each as defined below)
of the transfer or exercise of the Warrant in the form of a Global Warrant (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All other capitalized terms
used but not otherwise defined herein shall have the meaning ascribed to such terms in the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;2. <U>Appointment
of Warrant Agent</U>. The Company hereby appoints the Warrant Agent to act as agent for the Company in accordance with the express terms
or conditions hereof (and no implied terms and conditions), and the Warrant Agent hereby accepts such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;3. <U>Global
Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Warrants shall
be issuable in book entry form. All of the Warrants shall initially be represented by one or more Global Warrants (the &ldquo;<U>Global
Warrants</U>&rdquo; and, each, a &ldquo;<U>Global Warrant</U>&rdquo;), deposited with the Warrant Agent and registered in the name of
Cede&nbsp;&amp; Co., a nominee of The Depository Trust Company (the &ldquo;<U>Depository</U>&rdquo;), or as otherwise directed by the
Depository. Ownership of beneficial interests in the Warrants, shall be shown on, and the transfer of such ownership shall be effected
through, records maintained by (i)&nbsp;the Depository or its nominee for each Global Warrant or (ii)&nbsp;institutions that have accounts
with the Depository (such institution, with respect to a Warrant in its account, a &ldquo;<U>Participant</U>&rdquo;). For purposes of
Regulation SHO, a holder whose interest in a Global Warrant is a beneficial interest in certificate(s)&nbsp;representing such Warrant
held in book-entry form through the Depository shall be deemed to have exercised its interest in such Warrant upon instructing its broker
that is a Participant to exercise its interest in such Warrant, provided that in each such case payment of the applicable aggregate Exercise
Price is delivered by such Participant within the earlier of (i)&nbsp;two trading days and (ii)&nbsp;the number of trading days comprising
the Standard Settlement Period, in each case following such instruction. As used herein, &ldquo;Standard Settlement Period&rdquo; means
the standard settlement period, expressed in a number of trading days, on the Company&rsquo;s primary trading market with respect to the
Common Stock as in effect on the date of delivery of the Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;If the Depository
subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding
other arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have
the Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depository to deliver to the Warrant
Agent for cancellation each Global Warrant, and the Company shall instruct the Warrant Agent in writing to deliver to each Holder a Warrant
Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp; A Holder has the
right to elect at any time or from time to time a Warrant Exchange (as defined below) pursuant to a Warrant Certificate Request Notice
(as defined below). Upon written notice by a Holder to the Warrant Agent for the exchange of some or all of such Holder&rsquo;s Global
Warrants for a Warrant Certificate, evidencing the same number of Warrants, which request shall be in the form attached hereto as <U>Annex
A</U> (a &ldquo;<U>Warrant Certificate Request Notice</U>&rdquo; and the date of delivery of such Warrant Certificate Request Notice by
the Holder, the &ldquo;<U>Warrant Certificate Request Notice Date</U>&rdquo; and the deemed surrender upon delivery by the Holder of a
number of Global Warrants for the same number of Warrants evidenced by a Warrant Certificate, a &ldquo;<U>Warrant Exchange</U>&rdquo;),
the Warrant Agent shall promptly effect the Warrant Exchange and shall promptly issue and deliver, at the expense of the Company, to the
Holder a Warrant Certificate, for such number of Warrants in the name set forth in the Warrant Certificate Request Notice. Such Warrant
Certificate shall be dated the original issue date of the Warrants, shall be executed either manually or by .pdf via email signature by
an authorized signatory of the Company, and shall be in the form attached hereto as <U>Exhibit&nbsp;1-A</U>, and shall be reasonably acceptable
in all respects to such Holder. In connection with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant Agent to
deliver, the Warrant Certificate, to the Holder within ten (10)&nbsp;Business Days of the Warrant Certificate Request Notice pursuant
to the delivery instructions in the Warrant Certificate Request Notice (&ldquo;<U>Warrant Certificate Delivery Date</U>&rdquo;). If the
Company fails for any reason to deliver to the Holder the Warrant Certificate subject to the Warrant Certificate Request Notice by the
Warrant Certificate Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares evidenced by such Warrant Certificate (based on the Exercise Price on the date of the applicable Warrant Certificate
Request Notice), $10 per Business Day for each Business Day after such Warrant Certificate Delivery Date until such Warrant Certificate
is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange. In no event shall the Warrant
Agent be liable for the Company&rsquo;s failure to deliver the Warrant Certificate by the Warrant Certificate Delivery Date. The Company
covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed to be the holder
of the Warrant Certificate, as applicable, and, notwithstanding anything to the contrary set forth herein, the Warrant Certificate shall
be deemed for all purposes to contain all of the terms and conditions of the Warrants, evidenced by such Warrant Certificate, and the
terms of this Agreement, other than Sections 3(c)&nbsp;and 9 herein, shall not apply to the Warrants evidenced by the Warrant Certificate.
Notwithstanding anything to the contrary contained in this Agreement, in the event of inconsistency between any provision in this Agreement
and any provision in a Warrant Certificate, as it may from time to time be amended, the terms of such Warrant Certificate shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;4. <U>Form&nbsp;of
Warrant Certificates</U>. The Warrant Certificate, together with the form of election to purchase Common Stock (&ldquo;<U>Exercise Notice</U>&rdquo;)
and the form of assignment to be printed on the reverse thereof, shall be in the form of <U>Exhibit&nbsp;1-A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;5. <U>Countersignature
and Registration</U>. The Warrant Certificates shall be executed on behalf of the Company by its Chief Executive Officer, Chief Financial
Officer or Vice President, either manually or by .pdf via email signature. The Warrant Certificates shall be countersigned by the Warrant
Agent either manually or by .pdf via email signature and shall not be valid for any purpose unless so countersigned. In case any officer
of the Company who shall have signed any of the Warrant Certificates shall cease to be such officer of the Company before countersignature
by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be countersigned by the Warrant
Agent, issued and delivered with the same force and effect as though the Person who signed such Warrant Certificate had not ceased to
be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by any Person who, at the actual date
of the execution of such Warrant Certificate, shall be a proper officer of the Company to sign such Warrant Certificate, although at the
date of the execution of this Agreement any such Person was not such an officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Warrant Agent will keep
or cause to be kept, at its office designated for such purposes, books for registration and transfer of the Global Warrants or Warrant
Certificates issued hereunder. Such books shall show the names and addresses of the respective Holders of the Global Warrants or Warrant
Certificates, the number of warrants evidenced on the face of each such Global Warrants or Warrant Certificate and the date of each such
Global Warrants or Warrant Certificate. The Warrant Agent will create a special account for the issuance of Global Warrants and Warrant
Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;6. <U>Transfer,
Split Up, Combination and Exchange of Warrant Certificates; Mutilated, Destroyed, Lost or Stolen Warrant Certificates</U>. With respect
to the Global Warrant, subject to the provisions of the Warrant Certificate, and the last sentence of this first paragraph of Section&nbsp;6
and subject to applicable law, rules&nbsp;or regulations, or any &ldquo;stop transfer&rdquo; instructions the Company may give to the
Warrant Agent, at any time after the closing date of the Offering, and at or prior to the Close of Business on the Termination Date (as
such term is defined in the Warrant Certificate), any Warrant Certificate or Warrant Certificates or Global Warrant or Global Warrants
may be transferred, split up, combined or exchanged for another Warrant Certificate or Warrant Certificates or Global Warrant or Global
Warrants, entitling the Holder to purchase a like number of shares of Common Stock as the Warrant Certificate or Warrant Certificates
or Global Warrant or Global Warrants surrendered then entitled such Holder to purchase. Any Holder desiring to transfer, split up, combine
or exchange any Warrant Certificate or Global Warrant shall make such request in writing delivered to the Warrant Agent and shall surrender
the Warrant Certificate or Warrant Certificates, together with the required form of assignment and certificate duly executed and properly
completed and such other documentation as the Warrant Agent may reasonably request, to be transferred, split up, combined or exchanged
at the office of the Warrant Agent designated for such purpose, provided that no such surrender is applicable to the Holder of a Global
Warrant. Any requested transfer of Warrants, whether in book-entry form or certificate form, shall be accompanied by evidence of authority
of the party making such request that may be reasonably required by the Warrant Agent. Thereupon the Warrant Agent shall, subject to the
last sentence of this first paragraph of Section&nbsp;6, countersign and deliver to the Person entitled thereto a Warrant Certificate
as so requested. The Company may require payment from the Holder of a sum sufficient to cover any tax or governmental charge that may
be imposed in connection with any transfer, split up, combination or exchange of Warrant Certificates. The Warrant Agent shall not have
any duty or obligation to take any action under any section of this Agreement that requires the payment of taxes and/or charges unless
and until it is satisfied that all such payments have been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon receipt by the Warrant
Agent of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of a Warrant Certificate, which evidence
shall include an affidavit of loss, or in the case of mutilated certificates, the certificate or portion thereof remaining, and, in case
of loss, theft or destruction, of indemnity or security reasonably acceptable to the Company and the Warrant Agent, and satisfaction of
any other reasonable requirements established by Section&nbsp;8-405 of the Uniform Commercial Code as in effect in the State of Delaware,
and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender to the Warrant
Agent and cancellation of the Warrant Certificate if mutilated, the Company will make and deliver a new Warrant Certificate of like tenor
to the Warrant Agent for delivery to the Holder in lieu of the Warrant Certificate so lost, stolen, destroyed or mutilated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company shall provide
to the Warrant Agent an opinion of counsel on or prior to the issuance of Warrants to set up a reserve of Warrant Shares for the outstanding
Warrants. The opinion shall state that all Warrants or Warrant Shares, as applicable, are, (i)&nbsp;registered under the Securities Act
of 1933, as amended, and (ii)&nbsp;upon issuance will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;7. <U>Exercise
of Warrants; Exercise Price; Termination Date</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&nbsp;The Warrants shall
be exercisable commencing on the Initial Exercise Date. The Warrants shall cease to be exercisable on the Termination Date (as such term
is defined in the Warrant Certificate). Subject to the foregoing and to Section&nbsp;7(b)&nbsp;below, the Holder of a Warrant may exercise
the Warrant, in whole or in part upon surrender of the Warrant Certificate, if required, with the properly completed and duly executed
Exercise Notice and payment of the Exercise Price, which may be made, at the option of the Holder, by wire transfer or by certified or
official bank check in United States dollars, to the Warrant Agent at the office of the Warrant Agent designated for such purposes. In
the case of the Holder of a Global Warrant, the Holder shall deliver the duly executed Exercise Notice and the payment of the Exercise
Price as described herein. Notwithstanding any other provision in this Agreement, a holder whose interest in a Global Warrant is a beneficial
interest in a Global Warrant held in book-entry form through the Depository (or another established clearing corporation performing similar
functions) shall effect exercises by delivering to the Depository (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that is required by the Depository (or such other clearing
corporation, as applicable). The Company acknowledges that the bank accounts maintained by the Warrant Agent in connection with the services
provided under this Agreement will be in its name and that the Warrant Agent may receive investment earnings in connection with the investment
at Warrant Agent risk and for its benefit of funds held in those accounts from time to time. Neither the Company nor the Holders will
receive interest on any deposits or Exercise Price. No ink-original Exercise Notice shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Exercise Notice be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Upon the Warrant
Agent&rsquo;s receipt of a Warrant Certificate, at or prior to the Close of Business on the Termination Date set forth in such Warrant
Certificate, with the executed Exercise Notice and payment of the Exercise Price for the shares to be purchased and an amount equal to
any applicable tax, or governmental charge referred to in Section&nbsp;6 by wire transfer, or by certified check or bank draft payable
to the order of the Company (or, in the case of the Holder of a Global Warrant, the delivery of the executed Exercise Notice and the payment
of the Exercise Price and any other applicable amounts as set forth herein), the Warrant Agent shall cause the Warrant Shares underlying
such Warrant Certificate, or Global Warrant, to be delivered to or upon the order of the Holder of such Warrant Certificate, or Global
Warrant, registered in such name or names as may be designated by such Holder, no later than the Warrant Share Delivery Date (as such
term is defined in the Warrant Certificate). If the Company is then a participant in the DWAC system of the Depository and there is an
effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder. For the avoidance
of doubt, if the Company becomes obligated to pay any amounts to any Holders pursuant to Sections 2(c)(i)&nbsp;or 2(c)(iii)&nbsp;of the
Warrant Certificate, such obligation shall be solely that of the Company and not that of the Warrant Agent. Notwithstanding anything else
to the contrary in this Agreement, if any Holder fails to duly deliver payment to the Warrant Agent of an amount equal to the aggregate
Exercise Price of the Warrant Shares to be purchased upon exercise of such Holder&rsquo;s Warrant as set forth in Section&nbsp;7(a)&nbsp;hereof
by the Warrant Share Delivery Date, the Warrant Agent will not be obligated to deliver such Warrant Shares (via DWAC or otherwise) until
following receipt of such payment, and the applicable Warrant Share Delivery Date shall be deemed extended by one day for each day (or
part thereof) until such payment is delivered to the Warrant Agent<FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The Warrant Agent
shall deposit all funds received by it in payment of the Exercise Price for all Warrants in the account of the Company maintained with
the Warrant Agent for such purpose (or to such other account as directed by the Company in writing) and shall advise the Company via email
at the end of each day on which exercise notices are received, or funds for the exercise of any Warrant are received, of the amount so
deposited to its account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;In case the Holder
of any Warrant Certificate shall exercise fewer than all Warrants evidenced thereby, upon the request of the Holder, a new Warrant Certificate
evidencing the number of Warrants equivalent to the number of Warrants remaining unexercised may be issued by the Warrant Agent to the
Holder of such Warrant Certificate or to his duly authorized assigns in accordance with Section&nbsp;2(c)(ii)&nbsp;of the Warrant Certificate,
subject to the provisions of Section&nbsp;6 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;8. <U>Cancellation
and Destruction of Warrant Certificates</U>. All Warrant Certificates surrendered for the purpose of exercise, transfer, split up, combination
or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Warrant Agent for cancellation or in canceled
form, or, if surrendered to the Warrant Agent, shall be canceled by it, and no Warrant Certificates shall be issued in lieu thereof except
as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the Warrant Agent for cancellation and
retirement, and the Warrant Agent shall so cancel and retire any other Warrant Certificate purchased or acquired by the Company otherwise
than upon the exercise thereof. The Warrant Agent shall cancel such Warrant Certificates in accordance with its policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;9. <U>Certain
Representations; Reservation and Availability of Shares of Common Stock or Cash</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;This Agreement has
been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by the Warrant
Agent, constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance with its terms,
and the Warrants have been duly authorized, executed and issued by the Company and, assuming due execution thereof by the Warrant Agent
pursuant hereto and payment therefor by the Holders, constitute valid and legally binding obligations of the Company enforceable against
the Company in accordance with their terms and entitled to the benefits hereof; in each case except as enforceability may be limited by
bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors&rsquo; rights generally or
by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;As of the date hereof,
the authorized capital stock of the Company consists of (i)&nbsp;62,500,000 shares of Common Stock, of which 39,043,023 shares of Common
Stock are issued and outstanding, (ii)&nbsp;2,000,000 shares of preferred stock, 0 of which are issued and outstanding. There are no other
outstanding obligations, warrants, options or other rights to subscribe for or purchase from the Company any class of capital stock of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The Company covenants
and agrees that it will cause to be reserved and kept available out of its authorized and unissued shares of Common Stock or its authorized
and issued shares of Common Stock held in its treasury, free from preemptive rights, the number of shares of Common Stock that will be
sufficient to permit the exercise in full of all outstanding Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The Warrant Agent
covenants and agrees that it will create the reserve in accordance with Section&nbsp;9(c)&nbsp;hereof for the issuance of Common Stock
upon the exercise of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The Company further
covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges which may be payable
in respect of the original issuance or delivery of the Warrant Certificates or certificates evidencing Common Stock upon exercise of the
Warrants. The Company shall not, however, be required to pay any tax or governmental charge which may be payable in respect of any transfer
involved in the transfer or delivery of Warrant Certificates or the issuance or delivery of certificates for Common Stock in a name other
than that of the Holder of the Warrant Certificate evidencing Warrants surrendered for exercise or to issue or deliver any certificate
for shares of Common Stock upon the exercise of any Warrants until any such tax or governmental charge shall have been paid (any such
tax or governmental charge being payable by the Holder of such Warrant Certificate at the time of surrender) or until it has been established
to the Company&rsquo;s and the Warrant Agent&rsquo;s reasonable satisfaction that no such tax or governmental charge is due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;10. <U>Common
Stock Record Date</U>. Each Person in whose name any certificate for shares of Common Stock is issued (or to whose broker&rsquo;s account
is credited shares of Common Stock through the DWAC system) upon the exercise of Warrants shall for all purposes be deemed to have become
the holder of record for the Common Stock represented thereby on, and such certificate shall be dated, the date on which submission of
the Exercise Notice was made, provided that the Warrant Certificate evidencing such Warrant was duly surrendered (but only if required
herein) and payment of the Exercise Price (and any applicable transfer taxes) was received on or prior to the Warrant Share Delivery Date;
<U>provided</U>, <U>however</U>, that, if the date of submission of the Exercise Notice is a date upon which the Common Stock transfer
books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate
shall be dated, the next succeeding day on which the Common Stock transfer books of the Company are open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;11. <U>Adjustment
of Exercise Price, Number of Shares of Common Stock or Number of the Company Warrants</U>. The Exercise Price, the number of shares covered
by each Warrant and the number of Warrants outstanding are subject to adjustment from time to time as provided in Section&nbsp;3 of the
Warrant Certificate. In the event that at any time, as a result of an adjustment made pursuant to Section&nbsp;3 of the Warrant Certificate,
the Holder of any Warrant thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than
shares of Common Stock, thereafter the number of such other shares so receivable upon exercise of any Warrant shall be subject to adjustment
from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the shares contained
in Section&nbsp;3 of the Warrant Certificate, and the provisions of Sections 7, 11 and 12 of this Agreement with respect to the shares
of Common Stock shall apply on like terms to any such other shares. All Warrants originally issued by the Company subsequent to any adjustment
made to the Exercise Price pursuant to the Warrant Certificate shall evidence the right to purchase, at the adjusted Exercise Price, the
number of shares of Common Stock purchasable from time to time hereunder upon exercise of the Warrants, all subject to further adjustment
as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;12. <U>Certification
of Adjusted Exercise Price or Number of Shares of Common Stock</U>. Whenever the Exercise Price or the number of shares of Common Stock
issuable upon the exercise of each Warrant Certificate is adjusted as provided in Section&nbsp;11 or 13, the Company shall (a)&nbsp;promptly
prepare a certificate setting forth the Exercise Price of each Warrant Certificate, as so adjusted, and a brief, reasonably detailed statement
of the facts accounting for such adjustment, (b)&nbsp;promptly file with the Warrant Agent and with each transfer agent for the Common
Stock a copy of such certificate and (c)&nbsp;instruct the Warrant Agent, at the Company&rsquo;s expense, to send a brief summary thereof
to each Holder of a Warrant Certificate. The Warrant Agent shall be fully protected in relying on such certificate and on any adjustment
or statement therein contained and shall have no duty or liability with respect to and shall not be deemed to have knowledge of any such
adjustment or any such event unless and until it shall have received such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;13. <U>Fractional
Shares of Common Stock</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company shall
not issue fractions of Warrants or distribute Warrant Certificates which evidence fractional Warrants. Whenever any fractional Warrant
would otherwise be required to be issued or distributed, the actual issuance or distribution shall reflect a rounding of such fraction
to the nearest whole Warrant (rounded up).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Company shall
not issue fractions of shares of Common Stock upon exercise of Warrants or distribute stock certificates which evidence fractional shares
of Common Stock. Whenever any fraction of a share of Common Stock would otherwise be required to be issued or distributed, the actual
issuance or distribution in respect thereof shall be made in accordance with Section&nbsp;2(c)(iv)&nbsp;of the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;14. <U>Concerning the Warrant Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company agrees
to pay to the Warrant Agent, pursuant to the fee schedule mutually agreed upon by the parties hereto and provided separately on the date
hereof, for all services rendered by it hereunder and, from time to time, its reasonable expenses and counsel fees and other disbursements
incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance
of its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Company covenants
and agrees to indemnify and to hold the Warrant Agent harmless against any costs, expenses (including reasonable fees and expenses of
its legal counsel), losses or damages, which may be paid, incurred or suffered by or to which it may become subject, arising from or out
of, directly or indirectly, any claims or liability resulting from its actions or omissions as Warrant Agent pursuant hereto; provided,
that such covenant and agreement does not extend to, and the Warrant Agent shall not be indemnified with respect to, such costs, expenses,
losses and damages incurred or suffered by the Warrant Agent as a result of, or arising out of, its gross negligence, bad faith, or willful
misconduct (each as determined by a final non-appealable court of competent jurisdiction). Notwithstanding anything in this Agreement
to the contrary, any liability of the Warrant Agent under this Agreement will be limited to the amount of annual fees paid by the Company
to the Warrant Agent during the twelve (12) months immediately preceding the event for which recovery from the Warrant Agent is being
sought. The costs and expenses incurred by the Warrant Agent in enforcing this right of indemnification shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp; Upon the assertion
of a claim for which the Company may be required to indemnify the Warrant Agent, the Warrant Agent shall promptly notify the Company of
such assertion, and shall keep the other party reasonably advised with respect to material developments concerning such claim. However,
failure to give such notice shall not affect the Warrant Agent&rsquo;s right to and the Company&rsquo;s obligations for indemnification
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;Neither party to
this Agreement shall be liable to the other party for any consequential, indirect, punitive, special, liquidated or incidental damages
under any provisions of this Agreement or for any consequential, indirect, punitive, special, liquidated or incidental damages arising
out of any act or failure to act hereunder even if that party has been advised of or has foreseen the possibility of such damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;Notwithstanding anything
contained herein to the contrary, the rights and obligations of the parties set forth in this Section&nbsp;14 shall survive termination
of this Agreement, the expiration of the Warrants and/or the resignation, removal or replacement of the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;15. <U>Purchase
or Consolidation or Change of Name of Warrant Agent</U>. Any Person into which the Warrant Agent or any successor Warrant Agent may be
merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Warrant Agent or any
successor Warrant Agent shall be party, or any Person succeeding to the stock transfer or other shareholder services business of the Warrant
Agent or any successor Warrant Agent, shall be the successor to the Warrant Agent under this Agreement without the execution or filing
of any paper or any further act on the part of any of the parties hereto, provided that such Person would be eligible for appointment
as a successor Warrant Agent under the provisions of Section&nbsp;17. In case at the time such successor Warrant Agent shall succeed to
the agency created by this Agreement any of the Warrant Certificates shall have been countersigned but not delivered, any such successor
Warrant Agent may adopt the countersignature of the predecessor Warrant Agent and deliver such Warrant Certificates so countersigned;
and in case at that time any of the Warrant Certificates shall not have been countersigned, any successor Warrant Agent may countersign
such Warrant Certificates either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all
such cases, such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In case at any time the name
of the Warrant Agent shall be changed and at such time any of the Warrant Certificates shall have been countersigned but not delivered,
the Warrant Agent may adopt the countersignature under its prior name and deliver Warrant Certificates so countersigned; and in case at
that time any of the Warrant Certificates shall not have been countersigned, the Warrant Agent may countersign such Warrant Certificates
either in its prior name or in its changed name; and in all such cases, such Warrant Certificates shall have the full force provided in
the Warrant Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;16. <U>Duties
of Warrant Agent</U>. The Warrant Agent undertakes the duties and obligations imposed by this Agreement upon the following express terms
and conditions (and no implied terms and conditions), by all of which the Company, by its acceptance hereof, shall be bound and shall
not assume any obligations or relationship of agency or trust with any of the Holders of the Warrants or any other Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Warrant Agent
may consult with legal counsel selected by it (who may be legal counsel for the Company), and the opinion and advice of such counsel shall
be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in accordance with such
opinion or advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Whenever in the performance
of its duties under this Agreement the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established
by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein
specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by the Chief Executive Officer,
Chief Financial Officer or Vice President of the Company; and such certificate shall be full authorization and protection to the Warrant
Agent, and the Warrant Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it under
the provisions of this Agreement in reliance upon such certificate. The Warrant Agent shall have no duty to act without such a certificate
as set forth in this Section&nbsp;16(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Subject to the limitation
set forth in Section&nbsp;14, the Warrant Agent shall be liable hereunder only for its own gross negligence, bad faith or willful misconduct
(each as determined in a final, non-appealable judgment of a court of competent jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The Warrant Agent
shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Warrant Certificates
(including in the case of any notation in book-entry form to reflect ownership), except its countersignature thereof, by the Company or
be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The Warrant Agent
shall not have any liability or be under any responsibility in respect of the validity of this Agreement or the execution and delivery
hereof (except the due execution hereof by the Warrant Agent) or in respect of the validity or execution of any Warrant Certificate (except
its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this
Agreement or in any Warrant Certificate; nor shall it be responsible for the adjustment of the Exercise Price or the making of any change
in the number of shares of Common Stock required under the provisions of Section&nbsp;11 or 13 or responsible for the manner, method or
amount of any such change or adjustment or the ascertaining of the existence of facts that would require any such adjustment or change
(except with respect to the exercise of Warrants evidenced by Warrant Certificates after actual notice of any adjustment of the Exercise
Price); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any
shares of Common Stock to be issued pursuant to this Agreement or any Warrant Certificate or as to whether any shares of Common Stock
will, when issued, be duly authorized, validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;Each party hereto
agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such
further and other acts, instruments and assurances as may reasonably be required by the other party hereto for the carrying out or performing
by any party of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;The Warrant Agent
is hereby authorized to accept instructions with respect to the performance of its duties hereunder from the Chief Executive Officer,
Chief Financial Officer or Vice President of the Company, and to apply to such officers for advice or instructions in connection with
its duties, and it shall not be liable and shall be indemnified and held harmless for any action taken or suffered to be taken by it in
good faith in accordance with instructions of any such officer, provided Warrant Agent carries out such instructions without gross negligence,
bad faith or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;The Warrant Agent
and any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Warrants or other securities
of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money
to the Company or otherwise act as fully and freely as though it were not Warrant Agent under this Agreement. Nothing herein shall preclude
the Warrant Agent from acting in any other capacity for the Company or for any other Person. In the event that the Warrant Agent seeks
to exercise a Warrant, and provides the Company with (i)&nbsp;an opinion of counsel to the effect that a public sale or transfer of the
Common Stock issuable upon exercise of the Warrant may be made without registration under the 1933 Act and such sale or transfer is effected
or (ii)&nbsp;the Purchaser provides reasonable assurances that the Securities can be sold pursuant to an effective registration statement
under the Securities Act of 1933, as amended, Rule&nbsp;144, Section&nbsp;4(a)(1), or other applicable exemption, the Company shall permit
the transfer, and, in the case of the Common Stock issuable upon exercise of the Warrant, promptly instruct its transfer agent to issue
one or more certificates, free from restrictive legend, in such name and in such denominations as specified by the Holder. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder by vitiating the intent and purpose
of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this Section&nbsp;16(h)&nbsp;may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this Section, that the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any breach
and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;The Warrant Agent
may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through
its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any
such attorney or agents or for any loss to the Company resulting from any such act, default, neglect or misconduct, absent gross negligence
or bad faith in the selection and continued employment thereof (which gross negligence and bad faith must be determined by a final, non-appealable
judgment of a court of competent jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;The Warrant Agent
shall not be obligated to expend or risk its own funds or to take any action that it believes would expose or subject it to expense or
liability or to a risk of incurring expense or liability, unless it has been furnished with assurances of repayment or indemnity satisfactory
to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)&nbsp;The Warrant Agent shall not be liable
or responsible for any failure of the Company to comply with any of its obligations relating to any registration statement filed with
the Securities and Exchange Commission or this Agreement, including without limitation obligations under applicable regulation or law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l)&nbsp;The Warrant Agent may rely on and be fully
authorized and protected in acting or failing to act upon (a)&nbsp;any guaranty of signature by an &ldquo;eligible guarantor institution&rdquo;
that is a member or participant in the Securities Transfer Agents Medallion Program or other comparable &ldquo;signature guarantee program&rdquo;
or insurance program in addition to, or in substitution for, the foregoing; or (b)&nbsp;any law, act, regulation or any interpretation
of the same even though such law, act, or regulation may thereafter have been altered, changed, amended or repealed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m)&nbsp;In the event the Warrant Agent believes
any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document
received by the Warrant Agent hereunder, the Warrant Agent, may, in its sole discretion, refrain from taking any action, and shall be
fully protected and shall not be liable in any way to Company, the holder of any Warrant or any other Person for refraining from taking
such action, unless the Warrant Agent receives written instructions signed by the Company which eliminates such ambiguity or uncertainty
to the satisfaction of Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(n)&nbsp;This Section&nbsp;16 shall survive the
expiration of the Warrants, the termination of this Agreement and the resignation, replacement or removal of the Warrant Agent. The costs
and expenses incurred in enforcing this right of indemnification shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;17. <U>Change
of Warrant Agent</U>. The Warrant Agent may resign and be discharged from its duties under this Agreement upon thirty (30) days&rsquo;
notice in writing sent to the Company and, in the event that the Warrant Agent or one of its affiliates is not also the transfer agent
for the Company, to each transfer agent of the Common Stock. In the event the transfer agency relationship in effect between the Company
and the Warrant Agent terminates, the Warrant Agent will be deemed to have resigned automatically and be discharged from its duties under
this Agreement as of the effective date of such termination, and the Company shall be responsible for sending any required notice thereunder.
The Company may remove the Warrant Agent or any successor Warrant Agent upon thirty (30) days&rsquo; notice in writing, sent to the Warrant
Agent or successor Warrant Agent, as the case may be, and to each transfer agent of the Common Stock, and to the Holders of the Warrant
Certificates. If the Warrant Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint
a successor to the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after such removal
or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Warrant Agent or by the Holder
of a Warrant Certificate (who shall, with such notice, submit this Warrant Certificate for inspection by the Company), then the Holder
of any Warrant Certificate may apply to any court of competent jurisdiction for the appointment of a new Warrant Agent, provided that,
for purposes of this Agreement, the Company shall be deemed to be the Warrant Agent until a new warrant agent is appointed. Any successor
Warrant Agent, whether appointed by the Company or by such a court, shall be a Person, other than a natural person, organized and doing
business under the laws of the United States or of a state thereof, in good standing, which is authorized under such laws to exercise
stock transfer powers and is subject to supervision or examination by federal or state authority and which has at the time of its appointment
as Warrant Agent a combined capital and surplus of at least $50,000,000. After appointment, the successor Warrant Agent shall be vested
with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant Agent without further act or deed;
but the predecessor Warrant Agent shall deliver and transfer to the successor Warrant Agent any property at the time held by it hereunder,
and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose but such predecessor Warrant Agent shall
not be required to make any additional expenditure (without prompt reimbursement by the Company) or assume any additional liability in
connection with the foregoing. Not later than the effective date of any such appointment, the Company shall file notice thereof in writing
with the predecessor Warrant Agent and each transfer agent of the Common Stock and mail a notice thereof in writing to the Holders of
the Warrant Certificates. However, failure to give any notice provided for in this Section&nbsp;17, or any defect therein, shall not affect
the legality or validity of the resignation or removal of the Warrant Agent or the appointment of the successor Warrant Agent, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;18. <U>Issuance
of New Warrant Certificates</U>. Notwithstanding any of the provisions of this Agreement or of the Warrants to the contrary, the Company
may, at its option, issue new Warrant Certificates evidencing Warrants in such form as may be approved by its Board of Directors to reflect
any adjustment or change in the Exercise Price per share and the number or kind or class of shares of stock or other securities or property
purchasable under the several Warrant Certificates made in accordance with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;19. <U>Notices</U>.
Notices or demands authorized by this Agreement to be given or made (i)&nbsp;by the Warrant Agent or by the Holder of any Warrant Certificate
to or on the Company, (ii)&nbsp;by the Company or by the Holder of any Warrant Certificate to or on the Warrant Agent or (iii)&nbsp;by
the Company or the Warrant Agent to the Holder of any Warrant Certificate, shall be deemed given when in writing (a)&nbsp;on the date
delivered, if delivered personally, (b)&nbsp;on the first Business Day following the deposit thereof with Federal Express or another recognized
overnight courier, if sent by Federal Express or another recognized overnight courier, (c)&nbsp;on the fourth Business Day following the
mailing thereof with postage prepaid, if mailed by registered or certified mail (return receipt requested), and (d)&nbsp;the time of transmission,
if such notice or communication is delivered via e-mail attachment at or prior to 5:30 p.m.&nbsp;(New York City time) on a Business Day
and (e)&nbsp;the next Business Day after the date of transmission, if such notice or communication is delivered via e-mail attachment
on a day that is not a Business Day or later than 5:30 p.m.&nbsp;(New York City time) on any Business Day, in each case to the parties
at the following addresses (or at such other address for a party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">If to the Company, to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">ClearSign Technologies Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">8023 East 63<SUP>rd</SUP> Place, Suite&nbsp;101</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Tulsa, Oklahoma</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">E-mail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Attention: Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">With a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Mitchell Silberberg&nbsp;&amp; Knupp LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">437 Madison Ave., 25th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">E-mail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Attention:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">If to the Warrant Agent, to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">VStock Transfer,
LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">18 Lafayette Place</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">Woodmere, NY 11598</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">Attn: Relationship Management</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For any notice delivered by email to be deemed
given or made, such notice must be followed by notice sent by overnight courier service to be delivered on the next Business Day following
such email, unless the recipient of such email has acknowledged via return email receipt of such email.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;If to the Holder
of any Warrant Certificate, to the address of such Holder as shown on the registry books of the Company. Any notice required to be delivered
by the Company to the Holder of any Warrant may be given by the Warrant Agent on behalf of the Company. Notwithstanding any other provision
of this Agreement, where this Agreement provides for notice of any event to a Holder of any Warrant, such notice shall be sufficiently
given if given to the Depository (or its designee) pursuant to the procedures of the Depository or its designee. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;20. <U>Supplements
and Amendments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company and the
Warrant Agent may from time to time supplement or amend this Agreement without the approval of any Holders of Global Warrants in order
to (i)&nbsp;add to the covenants and agreements of the Company for the benefit of the Holders of the Global Warrants, (ii)&nbsp;to surrender
any rights or power reserved to or conferred upon the Company in this Agreement, (iii)&nbsp;to <FONT STYLE="background-color: white">cure
any ambiguity, (iv)&nbsp;to correct or supplement any provision contained herein which may be defective or inconsistent with any other
provisions herein, or (v)&nbsp;to make any other provisions with regard to matters or questions arising hereunder which the Company and
the Warrant Agent may deem necessary or desirable</FONT>, provided that such addition, correction or surrender shall not adversely affect
the interests of the Holders of the Global Warrants or Warrant Certificates in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;In addition to the
foregoing, with the consent of Holders of Warrants entitled, upon exercise thereof, to receive not less than a majority of the shares
of Common Stock issuable thereunder, the Company and the Warrant Agent may modify this Agreement for the purpose of adding any provisions
to or changing in any manner or eliminating any of the provisions of this Agreement or modifying in any manner the rights of the Holders
of the Global Warrants; <U>provided</U>, <U>however</U>, that that (i)&nbsp;if any amendment, modification or waiver disproportionately
and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall
also be required and (ii)&nbsp;no modification of the terms (including but not limited to the adjustments described in Section&nbsp;11)
upon which the Warrants are exercisable or reducing the percentage required for consent to modification of this Agreement may be made
without the consent of the Holder of each outstanding warrant certificate affected thereby; <U>provided further</U>, <U>however</U>, that
no amendment hereunder shall affect any terms of any Warrant Certificate issued in a Warrant Exchange. As a condition precedent to the
Warrant Agent&rsquo;s execution of any amendment, the Company shall deliver to the Warrant Agent a certificate from a duly authorized
officer of the Company that states that the proposed amendment complies with the terms of this Section&nbsp;20. No supplement or amendment
to this Agreement shall be effective unless duly executed by the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;21. <U>Successors</U>.
All covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit
of their respective successors and assigns hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;22. <U>Benefits
of this Agreement</U>. Nothing in this Agreement shall be construed to give any Person other than the Company, the Holders of Warrant
Certificates and the Warrant Agent any legal or equitable right, remedy or claim under this Agreement; but this Agreement shall be for
the sole and exclusive benefit of the Company, the Warrant Agent and the Holders of the Warrant Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;23. <U>Governing
Law; Jurisdiction</U>. This Agreement and each Warrant Certificate issued hereunder shall be governed by, and construed in accordance
with, the laws of the State of New York without giving effect to the conflicts of law principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the
courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to
such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that
such courts represent an inconvenience forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;24. <U>Counterparts</U>.
This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original,
and all such counterparts shall together constitute but one and the same instrument. A signature to this Agreement transmitted electronically
shall have the same authority, effect and enforceability as an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;25. <U>Captions</U>.
The captions of the sections of this Agreement have been inserted for convenience only and shall not control or affect the meaning or
construction of any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;26.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of
this Agreement; provided, however, that if such prohibited and invalid provision shall adversely affect the rights, immunities, liabilities,
duties or obligations of the Warrant Agent, the Warrant Agent shall be entitled to resign immediately upon written notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;27.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Conflicts</U>.
To the extent any provision of this Agreement conflicts with the express provisions of the Warrant Certificate, the provisions of the
Warrant Certificate shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;28.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Force
Majeure</U>. Notwithstanding anything to the contrary contained herein, the Warrant Agent will not be liable for any delays or failures
in performance resulting from acts beyond its reasonable control, including, without limitation, acts of God, terrorist acts, shortage
of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures or mechanical
difficulties with information storage or retrieval systems, labor difficulties, war, or civil unrest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;29.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. The parties hereto acknowledge that there are no agreements or understandings, written or oral, between them with respect
to matters contemplated hereunder other than as set forth herein and the Warrant Certificates, that this Agreement and the Warrant Certificates
contain the entire agreement between them with respect to the subject matter hereof and thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;30.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees;
Expenses</U>. As consideration for the services provided by VStock (the &ldquo;<U>Services</U>&rdquo;), the Company shall pay to VStock
the fees set forth on <U>Schedule 1</U> hereto (the &ldquo;<U>Fees</U>&rdquo;). If the Company requests that VStock provide additional
services not contemplated hereby, the Company shall pay to VStock fees for such services at VStock&rsquo;s reasonable and customary rates,
such fees to be governed by the terms of a separate agreement to be mutually agreed to and entered into by the Parties at such time (the
 &ldquo;<U>Additional Service Fee</U>&rdquo;; together with the Fees, the &ldquo;<U>Service Fees</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall reimburse VStock for all reasonable and documented expenses incurred by VStock (including, without limitation, reasonable
and documented fees and disbursements of counsel) in connection with the Services (the &ldquo;<U>Expenses</U>&rdquo;); <U>provided</U>,
<U>however</U>, that VStock reserves the right to request advance payment for any out-of-pocket expenses. The Company agrees to pay all
Service Fees and Expenses within thirty (30) days following receipt of an invoice from VStock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees and acknowledges that VStock may adjust the Service Fees annually, on or about each anniversary date of this Agreement,
by the annual percentage of change in the latest Consumer Price Index of All Urban Consumers United States City Average, as published
by the U.S. Department of Labor, Bureau of Labor Statistics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
termination of this Agreement for any reason, VStock shall assist the Company with the transfer of records of the Company held by VStock.
VStock shall be entitled to reasonable additional compensation and reimbursement of any Expenses for the preparation and delivery of such
records to the successor agent or to the Company, and for maintaining records and/or Stock Certificates that are received after the termination
of this Agreement (the &ldquo;<U>Record Transfer Services</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; width: 47%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VSTOCK TRANSFER, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annex A: Form&nbsp;of Warrant Certificate Request
Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WARRANT CERTIFICATE REQUEST NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">To: VStock Transfer, LLC, as Warrant
Agent for ClearSign Technologies Corporation (the &ldquo;Company&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The undersigned Holder of _______ _______
Common Stock Purchase Warrants (&ldquo;Warrants&rdquo;) in the form of _______ _______ Global Warrants issued by the Company hereby elects
to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Name of Holder of _______ ______ Warrants in form of Global Warrants: ___________________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Name of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants): ________________________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Number of Warrants in name of Holder in form of Global Warrants: ___________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>Number of Warrants for which Warrant Certificate shall be issued: __________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Number of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate,
if any: ___________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">_______ _______ Warrant Certificate shall be delivered to
the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The undersigned hereby acknowledges
and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate, the Holder is deemed to have surrendered
the number of Warrants in form of Global Warrants in the name of the Holder equal to the number of Warrants evidenced by the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Name of Investing Entity: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>Signature of Authorized Signatory of Investing Entity</I>:
______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Name of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Title of Authorized Signatory: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Date: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit&nbsp;1-A: Form&nbsp;of Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<FONT STYLE="background-color: yellow"><B>FORM&nbsp;OF
COMMON WARRANT TO BE INSERTED</B></FONT>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Schedule 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Fees</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 85%">Monthly Warrant Administration Fee (per Warrant Issue) &nbsp;</TD>
    <TD STYLE="text-align: right; width: 15%">&nbsp; $____.00</TD>
    </TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt"><B><U>EXCHANGE OF WARRANTS INTO COMMON SHARES</U></B></TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">Per Manual Exercise of Warrants (until established on DTC WARR System)</TD>
    <TD STYLE="font-size: 10pt; text-align: right">$____.00</TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B><U>SPECIAL SERVICES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Services not included herein (including, without
limitation, trustee and custodial services, exchange/tender offer services and stock dividend disbursement services) but requested by
the Company may be subject to additional charges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B><U>Out-of-pocket Expenses</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All customary out-of-pocket expenses will be billed
in addition to the foregoing fees. These charges include, but are not limited to, printing and stationery, freight and materials delivery,
postage and handling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing fees apply to services ordinarily
rendered by _______ and are subject to reasonable adjustment based on final review of documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>tm2412212d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;of Lock-Up Agreement &ndash; ClearSign
Technologies Corporation (Directors and Officers)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 70%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 30%">________, 2024</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Ventures, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14135 Midway Road, Suite&nbsp;G150</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addison, TX 75001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that Public Ventures, LLC (the &ldquo;<B>Underwriter</B>&rdquo;) proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) with ClearSign Technologies Corporation, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), providing for
the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;),
and warrants, each warrant to purchase one share of Common Stock (the &ldquo;<B>Warrants</B>,&rdquo; and together with the Common Stock,
the &ldquo;<B>Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce the Underwriter
to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent
of the Underwriter, the undersigned will not, during the period commencing on the date of the Underwriting Agreement and ending six (6)&nbsp;months
thereafter (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (1)&nbsp;offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer
or dispose of, directly or indirectly, any Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock,
whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power
of disposition (unless such securities are subject to a separate lock up agreement) (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;);
(2)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of the Lock-Up Securities, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery
of Lock-Up Securities, in cash or otherwise; (3)&nbsp;make any demand for or exercise any right with respect to the registration of any
Lock-Up Securities, except as set forth in any agreements with the Company prior to the date hereof, if any; or (4)&nbsp;publicly disclose
the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating
to any Lock-Up Securities. Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities
without the prior written consent of the Underwriter in connection with (a)&nbsp;transactions relating to Lock-Up Securities acquired
in open market transactions after the completion of the Public Offering; <U>provided</U> that no filing under Section&nbsp;16(a)&nbsp;of
the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), shall be required or shall be voluntarily made
during the Lock-Up Period in connection with subsequent sales of Lock-Up Securities acquired in such open market transactions; (b)&nbsp;transfers
of Lock-Up Securities (i)&nbsp;as a <I>bona fide</I> gift, by will or intestacy, (ii)&nbsp;transfers or dispositions by operation of law,
such as pursuant to a qualified domestic order, as required by a divorce settlement or other court order, or (iii)&nbsp;to a family member
or trust for the benefit of a family member (for purposes of this lock-up agreement, &ldquo;<B>family member</B>&rdquo; means any relationship
by blood, marriage or adoption, not more remote than first cousin); (c)&nbsp;transfers of Lock-Up Securities to a charity or educational
institution; (d)&nbsp;if the undersigned, or a family member, directly or indirectly, controls a corporation, partnership, limited liability
company or other business entity, any transfers of Lock-Up Securities to such business entity or to any shareholder, partner or member
of, or owner of similar equity interests in, the undersigned, as the case may be; or (e)&nbsp;the sales of Common Stock to cover the payment
of the exercise prices or the payment of taxes associated with the exercise or vesting of equity awards under any equity compensation
plan of the Company; <U>provided</U> that in the case of any transfer pursuant to the foregoing clauses (b), (c)&nbsp;or (d), (i)&nbsp;any
such transfer shall not involve a disposition for value, (ii)&nbsp;each transferee shall sign and deliver to the Underwriter a lock-up
agreement substantially in the form of this lock-up agreement and (iii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act
shall be required or shall be voluntarily made. The undersigned also agrees and consents to the entry of stop transfer instructions with
the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s Lock-Up Securities except in compliance
with this lock-up agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees that
the foregoing restrictions shall be equally applicable to any Securities that the undersigned may purchase in the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No provision in this lock-up
agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of any securities exercisable
or exchangeable for or convertible into Common Stock, as applicable; <U>provided</U> that the undersigned does not transfer the Common
Stock acquired on such exercise, exchange or conversion during the Lock-Up Period, unless otherwise permitted pursuant to the terms of
this lock-up agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of a so-called
 &ldquo;10b5-1&rdquo; plan at any time (other than the entry into or modification of such a plan in such a manner as to cause the sale
of any Lock-Up Securities within the Lock-Up Period) or a sale of 100% of the Company&rsquo;s outstanding Common Stock in connection with
a merger or reorganizaiton or acquisition of all the assets of the Company (other than for redomestication) where the Company is not the
surviving entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Company and the Underwriter are relying upon this lock-up agreement in proceeding toward consummation of the Public Offering.
The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs,
legal representatives, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that, if the Underwriting Agreement is not executed by July&nbsp;30, 2024, or if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder,
then this lock-up agreement shall be void and of no further force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whether or not the Public
Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant to
an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Name - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Name of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Title of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>tm2412212d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;of Lock-Up Agreement &ndash; ClearSign
Technologies Corporation (clirSPV, LLC)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 70%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 30%">________, 2024</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Ventures, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14135 Midway Road, Suite&nbsp;G150</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addison, TX 75001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that Public Ventures, LLC (the &ldquo;<B>Underwriter</B>&rdquo;) proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) with ClearSign Technologies Corporation, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), providing for
the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;),
and warrants, each warrant to purchase Common Stock (the &ldquo;<B>Warrants</B>,&rdquo; and together with the Common Stock, the &ldquo;<B>Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce the Underwriter
to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent
of the Underwriter, the undersigned will not, during the period commencing on the date of the Underwriting Agreement and ending on December&nbsp;31,
2024 (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (1)&nbsp;offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or
dispose of, directly or indirectly, any Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock,
whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power
of disposition (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;); (2)&nbsp;enter into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction
described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of the Lock-Up Securities, in cash or otherwise; (3)&nbsp;make
any demand for or exercise any right with respect to the registration of any Lock-Up Securities, except as set forth in any agreements
with the Company prior to the date hereof; or (4)&nbsp;publicly disclose the intention to make any offer, sale, pledge or disposition,
or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities. Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the prior written consent of the Underwriter
in connection with (a)&nbsp;transactions relating to Lock-Up Securities acquired in open market transactions after the completion of the
Public Offering; <U>provided</U> that no filing under Section&nbsp;16(a)&nbsp;of the Securities Exchange Act of 1934, as amended (the
 &ldquo;<B>Exchange Act</B>&rdquo;), shall be required or shall be voluntarily made in connection with subsequent sales of Lock-Up Securities
acquired in such open market transactions; (b)&nbsp;transfers of Lock-Up Securities (i)&nbsp;as a <I>bona fide</I> gift, by will or intestacy,
(ii)&nbsp;by operation of law, such as pursuant to a qualified domestic order or as required by a divorce settlement, or (iii)&nbsp;to
a family member or trust for the benefit of a family member (for purposes of this lock-up agreement, &ldquo;<B>family member</B>&rdquo;
means any relationship by blood, marriage or adoption, not more remote than first cousin); (c)&nbsp;transfers of Lock-Up Securities to
a charity or educational institution; or (d)&nbsp;if the undersigned, directly or indirectly, controls a corporation, partnership, limited
liability company or other business entity, any transfers of Lock-Up Securities to any shareholder, partner or member of, or owner of
similar equity interests in, the undersigned, as the case may be; <U>provided</U> that in the case of any transfer pursuant to the foregoing
clauses (b), (c)&nbsp;or (d), (i)&nbsp;any such transfer shall not involve a disposition for value, (ii)&nbsp;each transferee shall sign
and deliver to the Underwriter a lock-up agreement substantially in the form of this lock-up agreement and (iii)&nbsp;no filing under
Section&nbsp;16(a)&nbsp;of the Exchange Act shall be required or shall be voluntarily made. The undersigned also agrees and consents to
the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s
Lock-Up Securities except in compliance with this lock-up agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the restrictions
of the immediately preceding paragraph hereof, during the Lock-up Period clirSPV will be permitted to sell in the public market only,
shares of Common Stock that it owns over which it has dispositive power, as long as the net per share price at which the shares of Common
Stock are sold exceeds two times the per share price in the Public Offering and the aggregate number of shares of Common Stock sold per
day does not exceed 15% of the daily volume of the shares of Common Stock on that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees that
the foregoing restrictions shall be equally applicable to any Securities that the undersigned may purchase in the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No provision in this lock-up
agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of any securities exercisable
or exchangeable for or convertible into Common Stock, as applicable; <U>provided</U> that the undersigned does not transfer the Common
Stock acquired on such exercise, exchange or conversion during the Lock-Up Period, unless otherwise permitted pursuant to the terms of
this lock-up agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of a so-called
 &ldquo;10b5-1&rdquo; plan at any time (other than the entry into or modification of such a plan in such a manner as to cause the sale
of any Lock-Up Securities within the Lock-Up Period) or a sale of 100% of the Company&rsquo;s outstanding Common Stock in connection with
a merger or corporate reorganization or acquisition of all the assets of the Company (other tthant for redomestication) where the Company
is not the surviving entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Company and the Underwriter are relying upon this lock-up agreement in proceeding toward consummation of the Public Offering.
The undersigned further understands that the lock up provisions of this lock-up agreement is irrevocable and, excluding the third paragraph
hereof, shall be binding upon the undersigned&rsquo;s heirs, legal successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that, if the Underwriting Agreement is not executed by July&nbsp;30, 2024, or if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder,
then this lock-up agreement shall be void and of no further force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whether or not the Public
Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant to
an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Name - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Name of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">(Title of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>tm2412212d1_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of April&nbsp;19, 2024, between ClearSign Technologies Corporation, a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages&nbsp;hereto (each, including its successors and
assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section&nbsp;5 of the Securities
Act (as defined below) contained in Section&nbsp;4(a)(2)&nbsp;thereof and/or Regulation D thereunder, the Company desires to issue and
sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;in consideration
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this&nbsp;<U>Section&nbsp;1.1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;&nbsp;means
any action, suit, inquiry, notice of violation, proceeding or investigation pending or threatened before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state, county, local or foreign).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;&nbsp;means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Applicable Laws</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(ff)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Auditor</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorizations</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Beneficial Ownership
Limitation</U>&rdquo; means 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of the Securities on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;&nbsp;means
the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;&nbsp;means
any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions
in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bylaws</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Charter</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>clirSPV Shares</U>&rdquo;
means securities issued pursuant to clirSPV LLC&rsquo;s participation right granted in connection with the clirSPV SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>clirSPV SPA</U>&rdquo;
means that certain Stock Purchase Agreement dated July&nbsp;12, 2018, between the Company and clirSVP LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;&nbsp;means
the closing of the purchase and sale of the Units pursuant to&nbsp;<U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;&nbsp;means
the Trading Day on which all of the Subscription Documents have been executed and delivered by the applicable parties thereto, and all
conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&rsquo;s obligations
to deliver the Shares, the Pre-funded Warrants and the Warrants, in each case, have been satisfied or waived, but in no event later than
the third Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;&nbsp;means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;&nbsp;means
the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Unit</U>&rdquo;
means each unit consisting of (a)&nbsp;two Shares and (b)&nbsp;three Common Warrants, each to purchase one Warrant Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Unit Subscription
Amount</U>&rdquo;&nbsp;means, as to each Purchaser, the aggregate amount to be paid for Common Units purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Common Unit Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Warrants</U>&rdquo;
means, collectively, the redeemable common warrants to purchase Common Stock issued to each Purchaser pursuant to this Agreement, which
Common Warrants shall be exercisable commencing the date that is six months after the date of issuance and have a term of exercise equal
to five years, in the form of&nbsp;<U>Exhibit&nbsp;C</U>&nbsp;attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Warrant
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;&nbsp;means
Mitchell Silberberg&nbsp;&amp; Knupp LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disqualification
Events</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(qq)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness Period</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;5.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Environmental Laws</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(dd)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event Date</U>&rdquo;
shall have the meaning ascribed to such terms in&nbsp;<U>Section&nbsp;5.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;&nbsp;means
the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance of (a)&nbsp;shares of Common Stock, equity awards or other securities of the Company under any equity compensation
plan or stock or option plan of the Company or pursuant to another type of arrangement for services rendered or to be rendered to the
Company, duly adopted for such purpose by a majority of the Board of Directors (including, in the case of plans or arrangements relating
to employee compensation, the consent of the majority of the non-employee members of the Board of Directors) or a majority of the members
(who are the non-employee members) of a committee established for such purpose for services rendered or to be rendered to the Company,
(b)&nbsp;securities upon the exercise or exchange of or conversion of or vesting of any securities exercisable or exchangeable for or
convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not
been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price
or conversion price of such securities or to extend the term of such securities, (c)&nbsp;any clirSPV Shares and (d)&nbsp;securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule&nbsp;144) and carry no registration rights
that require or permit the filing of any registration statement in connection therewith within 120 days following the Closing Date, and
provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but, unless approved by Public Ventures, LLC, which approval shall not be
unreasonably withheld, conditioned or delayed, shall not include a transaction in which the Company is issuing securities primarily for
the purpose of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal Reserve
Board</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(hh)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FINRA</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;&nbsp;shall
have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Governmental Entity</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial Filing
Date</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;5.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(cc)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Investor Questionnaire</U>&rdquo;&nbsp;means
the investor questionnaire attached hereto as&nbsp;<U>Exhibit&nbsp;A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-up Agreement</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;4.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Change</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Nasdaq</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Common Unit
Purchase Price</U>&rdquo;&nbsp;equals $1.85, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement but before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-funded
Unit Purchase Price</U>&rdquo; equals $1.83, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement but before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;&nbsp;means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means Public Ventures, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent&rsquo;s
Counsel</U>&rdquo; means Golenbock Eiseman Assor Bell&nbsp;&amp; Peskoe, LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-funded Unit</U>&rdquo;
means each unit consisting of (a)&nbsp;one Pre-funded Warrant to purchase two Pre-funded Warrant Shares and (b)&nbsp;three Warrants,
each Warrant to purchase one Common Warrant Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-funded Unit
Subscription Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Pre-funded Units purchased hereunder
as specified below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Pre-funded
Unit Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-funded Warrants</U>&rdquo;
means, collectively, the pre-funded warrants to purchase Common Stock issued to each Purchaser of Pre-funded Units pursuant to this Agreement,
which Pre-funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of&nbsp;<U>Exhibit&nbsp;D</U>&nbsp;attached
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon exercise of the Pre-funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;&nbsp;means
an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable Securities</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;5.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;5.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;&nbsp;means
Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from time
to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;&nbsp;means
Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from time
to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Sarbanes-Oxley
Act</U>&rdquo;&nbsp;shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(u)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;&nbsp;means
all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange
Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof, including the exhibits thereto and documents incorporated by
reference therein, during the twelve months preceding the date hereof, or such shorter period as the Company was required by law or regulation
to file such material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means, for each Purchaser, the Shares (or Pre-funded Warrants in lieu thereof) and the Warrants purchased pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;&nbsp;means
the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling Stockholder
Questionnaire</U>&rdquo; means the selling stockholder questionnaire attached hereto as&nbsp;<U>Exhibit&nbsp;E</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;&nbsp;means
the shares of Common Stock issued to Purchasers of Common Units pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;&nbsp;means
all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
the location and/or reservation of borrowable shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Solicitor</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(qq)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;&nbsp;means,
as to each Purchaser, the Common Unit Subscription Amount and/or the Pre-funded Unit Subscription Amount, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Documents</U>&rdquo;&nbsp;means
this Agreement, any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;&nbsp;shall
have the meaning ascribed to such term in&nbsp;<U>Section&nbsp;3.1(v)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;&nbsp;means
a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;&nbsp;means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE
American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or
OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;&nbsp;means
VStock Transfer, LLC, the current transfer agent of the Company, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriting Agreement</U>&rdquo;
means the underwriting agreement dated as of the date hereof between the Company and Public Ventures, LLC, as underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Units</U>&rdquo;
means, collectively, the Common Units and the Pre-funded Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means, collectively, the Common Warrant Shares and the Pre-funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $5,000,000 of Common Units;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that, to the extent a Purchaser determines,
in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together
with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation,
or as such Purchaser may otherwise choose, in lieu of purchasing Common Units, such Purchaser may elect to purchase Pre-funded Units;&nbsp;<I>provided</I>,&nbsp;<I>further</I>,
that the number of Shares and Pre-funded Warrants sold pursuant to this Agreement shall not exceed 19.9% of the Company&rsquo;s issued
and outstanding shares of Common Stock at the time of Closing, on a pre-transaction basis. On or prior to the Closing Date, each Purchaser
shall deliver to the Company (unless the Company and the Purchasers agree to wire transfer to a separate account specified in writing
by the parties), via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount, which funds shall
be held at such account in escrow pending Closing. When the aggregate Subscription Amount for all Purchasers has been received by the
Company, the Company shall deliver to each Purchaser its respective Shares, Common Warrants and Pre-funded Warrants, as applicable, as
determined pursuant to&nbsp;<U>Section&nbsp;2.2(a)</U>, and the Company and each Purchaser shall deliver the other items set forth in&nbsp;<U>Section&nbsp;2.2</U>.
Upon satisfaction of the covenants and conditions set forth in&nbsp;<U>Sections 2.2</U>&nbsp;and&nbsp;<U>2.3</U>, the Closing shall occur
remotely via the electronic exchange of documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
applicable for such Purchaser, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to issue in
book entry form the Shares being purchased hereunder, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
applicable for such Purchaser, a Pre-funded Warrant registered in the name of such Purchaser to purchase up to the number of shares of
Common Stock to be purchased hereunder, with an exercise price per share equal to $0.0001, subject to adjustment as set forth therein,
a PDF copy of which shall be provided to each such Purchaser on the Closing Date, with the original Pre-funded Warrant to be delivered
to the applicable Purchaser within five (5)&nbsp;Business Days of Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Common
Warrants registered in the name of such Purchaser to purchase up to the number of shares of Common Stock equal to 150% of such Purchaser&rsquo;s
Shares and/or 150% of such Purchaser&rsquo;s Pre-funded Warrants, as applicable, with an exercise price equal to $1.05, per Common Warrant
subject to adjustment as set forth therein, a PDF copy of which shall be provided to each such Purchaser on the Closing Date, with the
original Common Warrant to be delivered to the applicable Purchaser within five (5)&nbsp;Business Days of Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
legal opinion of Company Counsel, in form and substance satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
certificate of the Company&rsquo;s Chief Executive Officer and its Chief Financial Officer, in form and substance satisfactory to the
Placement Agent; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
certificate of the Company, signed by the Company&rsquo;s Secretary, in form and substance satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
to the Company, a completed Investor Questionnaire;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">to the Company, a completed Selling
                                            Stockholder Questionnaire;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the Company, this Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;such
Purchaser&rsquo;s Subscription Amount, which shall be paid by wire transfer of immediately available funds, payable to the account specified
in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Change,
in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Change, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by each Purchaser of the items set forth in&nbsp;<U>Section&nbsp;2.2(b)</U>&nbsp;of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Change,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Change, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by the Company of the items set forth in&nbsp;<U>Section&nbsp;2.2(a)</U>&nbsp;of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;there
shall have been no Material Adverse Change with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Units at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Exchange Listing</U>. The Common Stock is listed on The Nasdaq Capital Market (the &ldquo;<U>Nasdaq</U>&rdquo;), and the Company has
taken no action designed to, or likely to have the effect of, delisting the Common Stock from the Nasdaq, nor has the Company received
any notification that the Nasdaq is contemplating terminating such listing, except as described in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Material Adverse Change</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as otherwise
specifically stated therein or a subsequent SEC Report filed prior to the date hereof: (i)&nbsp;there has been no material adverse change
in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate,
that has had or that would reasonable be expected to result in a material adverse in the condition (financial or otherwise), results
of operations, business, assets, properties or prospects of the Company (a &ldquo;<U>Material Adverse Change</U>&rdquo;); (ii)&nbsp;there
have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement or the Underwriting
Agreement, other than transactions that are not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP
or disclosed in the SEC Reports; and (iii)&nbsp;no officer or director of the Company has resigned from any position with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosures
in Commission Filings</U>. The Company has made all filings with the Commission required under the Exchange Act for the twelve months
preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) on a timely
basis or has received a valid extension of such time of filing and has filed any such filings prior to the expiration of any such extension.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Independent
Accountants</U>. To the Company&rsquo;s knowledge, BPM CPA LLP (the &ldquo;<U>Auditor</U>&rdquo;), whose report is filed with the Commission
as part of the SEC Reports, is an independent registered public accounting firm as required by the Securities Act and the Public Company
Accounting Oversight Board. The Auditor has not, during the periods covered by the financial statements included in the SEC Reports,
provided to the Company any prohibited non-audit services, as such term is used in Section&nbsp;10A(g)&nbsp;of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Financial
Statements,&nbsp;etc</U>. The financial statements, including the notes thereto and supporting schedules, included in the SEC Reports,
fairly present, in all material respects, the financial position and the results of operations of the Company at the dates and for the
periods to which they apply; and such financial statements have been prepared in conformity with U.S. generally accepted accounting principles
(&ldquo;<U>GAAP</U>&rdquo;), consistently applied throughout the periods involved (provided that unaudited interim financial statements
are subject to year-end audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes required
by GAAP); and the supporting schedules, if any, included in the SEC Reports present fairly, in all material respects, the information
required to be stated therein. Except as disclosed in the SEC Reports, (a)&nbsp;the Company has not incurred any material liabilities
or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business, other
than liabilities, obligations and transactions that are not required to be reflected in the Company&rsquo;s financial statements pursuant
to GAAP or disclosed in the SEC Reports, (b)&nbsp;the Company has not declared or paid any dividends or made any distribution of any
kind with respect to its capital stock, (c)&nbsp;there has not been any change in the capital stock of the Company, and (d)&nbsp;issued
any equity securities to any officer, director or Affiliate, except pursuant to existing equity compensation plan or other stock plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Capital; Options,&nbsp;etc</U>. The Company had, at the date or dates indicated in the SEC Reports, the duly authorized, issued and outstanding
capitalization as set forth therein. Except as set forth in, or contemplated by the Subscription Documents or the SEC Reports, on the
Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued
shares of Common Stock or any security convertible or exercisable into shares of Common Stock, or any contracts or commitments to issue
or sell shares of Common Stock or any such options, warrants, rights or convertible securities, other than the participation rights granted
in connection with the clirSVP SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Outstanding
Securities</U>. Except as disclosed in the SEC Reports, all issued and outstanding securities of the Company issued prior to the transactions
contemplated by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof
have no rights of rescission or the ability to force the Company to repurchase such securities with respect thereto, and are not subject
to personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights,
rights of first refusal or rights of participation of any holders of any security of the Company or similar contractual rights granted
by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in
the Subscription Documents and the SEC Reports. The offers and sales of the outstanding shares of Common Stock, options, warrants and
other rights to purchase or exchange such securities for shares of Common Stock were at all relevant times either registered under the
Securities Act and the applicable state securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations and warranties
of the purchasers of such securities, exempt from such registration requirements. The description of the Company&rsquo;s stock option,
stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder, as described in the SEC Reports,
accurately and fairly present, in all material respects, the information required to be shown with respect to such plans, arrangements,
options and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Securities
Sold Pursuant to this Agreement</U>. The Shares have been duly authorized for issuance and sale and, when issued and delivered by the
Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof
are not and will not be subject to personal liability by reason of being such holders; except for the participation rights granted in
connection with the clirSPV SPA, the Shares and the Warrants are not and will not be subject to the preemptive rights of any holders
of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for
the authorization, issuance and sale of the Shares and the Warrants has been duly and validly taken. The Shares and the Warrants conform
in all material respects to all statements with respect thereto contained in the Subscription Documents and SEC Reports, as applicable.
All corporate action required to be taken for the authorization, issuance and sale of the Warrants has been duly and validly taken; the
Warrant Shares have been duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when
paid for and issued upon exercise in accordance with the Warrants, such shares of Common Stock will be validly issued, fully paid and
non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; and such shares
of Common Stock will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights
granted by the Company, except for the participation rights granted in connection with the clirSPV SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Rights of Third Parties</U>. Except as set forth in the SEC Reports, the rights applicable to the clirSPV Shares, the rights of Public
Ventures, LLC, or&nbsp;<U>Section&nbsp;5.1</U>&nbsp;of this Agreement, no holders of any securities of the Company or any options, warrants,
rights or other securities exercisable for or convertible or exchangeable into securities of the Company have the right to require the
Company to register the sale or resale of any such securities of the Company under the Securities Act or to include any such securities
in any registration statement to be filed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Validity
and Binding Effect of Agreement</U>. The execution, delivery and performance of this Agreement and the Warrants have been duly and validly
authorized by the Company, and, when executed and delivered, will constitute valid and binding agreements of the Company, enforceable
against the Company in accordance with their respective terms, except: (i)&nbsp;as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii)&nbsp;as enforceability of any indemnification
or contribution provision may be limited under the federal or state securities laws; and (iii)&nbsp;that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Conflicts,&nbsp;etc</U>. The execution, delivery and performance by the Company of this Agreement and the Warrants and all ancillary
documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance by the Company with
the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i)&nbsp;result
in a material breach of, or conflict with any of the terms and provisions of, or constitute a material default under, or result in the
creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any
Subsidiary pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement or any other agreement or instrument to which
the Company or any Subsidiary is a party or as to which any property of the Company or any Subsidiary is a party; (ii)&nbsp;result in
any violation of the provisions of the Company&rsquo;s certificate of incorporation (as the same may be amended or restated from time
to time, the &ldquo;<U>Charter</U>&rdquo;) or the Company&rsquo;s bylaws (as the same may be amended or restated from time to time, the
 &ldquo;<U>Bylaws</U>&rdquo;); or (iii)&nbsp;violate any existing applicable law, rule, regulation, judgment, order or decree of any governmental
or regulatory agency, body or court, domestic or foreign, having jurisdiction over the Company or any of its assets or business (each,
a &ldquo;<U>Governmental Entity</U>&rdquo;) as of the date hereof, except for breaches, conflicts, defaults or violations etc. with respect
to which consents or waivers have already been obtained and are in full force and effect, and, in the case of clauses&nbsp;<U>(i)</U>&nbsp;or&nbsp;<U>(iii)</U>,
as would not result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Defaults; Violations</U>. No material default exists, and, to the knowledge of the Company, no event has occurred that, with the lapse
of time or the giving of notice, or both, would constitute a default, in the due performance and observance of any term, covenant or
condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement
or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company or any
Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of the properties or assets of the Company or
any Subsidiary is subject, except as would not result in a Material Adverse Effect. Neither the Company nor any Subsidiary is (i)&nbsp;in
violation of any term or provision of its Charter or Bylaws, or (ii)&nbsp;in violation of any franchise, license, permit, applicable
law, rule, regulation, judgment or decree of any Governmental Entity, except in the case of clause&nbsp;<U>(ii)</U>, such as would not
result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Corporate
Power</U>. The Company has all requisite corporate power and authority, as of the date hereof and the Closing Date, to conduct its business
as described in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company (A)&nbsp;possesses the licenses, permits, certificates, authorizations, consents and approvals (collectively, &ldquo;<U>Authorizations</U>&rdquo;)
issued by the appropriate Governmental Entities necessary to conduct its business as currently conducted as described in the SEC Reports,
and (B)&nbsp;has obtained all necessary Authorizations from other persons necessary to conduct its business, except, in each case of&nbsp;<U>clauses
(A)</U>&nbsp;and&nbsp;<U>(B)</U>, (i)&nbsp;as described in the SEC Reports or (ii)&nbsp;to the extent that any failure to possess any
Authorizations, provide any notice, make any filing, or obtain any Authorizations would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Change. Neither of the Company and the Subsidiary is in violation of, or in default under,
any Authorizations, except as would not reasonably be expected to result in a Material Adverse Change. All of the Authorizations are
valid and in full force and effect, except when the invalidity of such Authorizations or the failure of such Authorizations to be in
full force and effect would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change. The
Company has not received any written notice of proceedings relating to the revocation or modification of any Authorization which, individually
or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transactions
Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and the Warrants and to carry
out the provisions and conditions hereof, and all Authorizations required in connection therewith have been obtained, except for Authorizations
with respect to applicable federal and state securities laws and the rules&nbsp;and regulations of the Financial Industry Regulatory
Authority,&nbsp;Inc. (&ldquo;<U>FINRA</U>&rdquo;) and Nasdaq. No authorization of, and no filing with, any Governmental Entity is required
for the valid issuance, sale and delivery of the Shares or the Warrants and the consummation of the transactions and agreements contemplated
by this Agreement and the Warrants and as contemplated by the Subscription Documents, except with respect to applicable federal and state
securities laws and the rules&nbsp;and regulations of FINRA and Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Litigation;
Governmental Proceedings</U>. Except as disclosed in the SEC reports, there is no judicial, regulatory, arbitral or other legal or governmental
proceeding or other litigation or arbitration, domestic or foreign, pending to which the Company or any of its Subsidiaries is a party
or of which any property, operations or assets of the Company or any of its Subsidiaries is the subject. To the Company&rsquo;s knowledge,
no such proceeding, litigation or arbitration is threatened or contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Good
Standing</U>. Each of the Company and each Subsidiary has been duly organized and is validly existing as a corporation and is in good
standing under the laws of its jurisdiction of incorporation as of the date hereof, and is duly qualified to do business and is in good
standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification,
except where the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material
Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.
The Company and its Subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in
such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business,
and all such insurance is in full force and effect. The Company does not have any reason to believe that it or any of its Subsidiaries
will not be able (A)&nbsp;to renew, if desired, its existing insurance coverage as and when such policies expire or (B)&nbsp;to obtain
comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and not at
a cost that is materially more significant. Since January&nbsp;1, 2022, The Company has not been denied any insurance coverage that it
has sought or for which it has applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Fees</U>. Other than the fees and expenses payable to Public Ventures, LLC, no brokerage or finder&rsquo;s fees or commissions are or
will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Subscription Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Forward-Looking
Statements</U>. No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the
Exchange Act) contained in the SEC Reports has been made or reaffirmed without a reasonable basis or has been disclosed other than in
good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Officers&rsquo;
Certificate</U>. Any certificate pursuant to this Agreement signed by any duly authorized officer of the Company and delivered to the
Purchaser shall be deemed a representation and warranty by the Company to the Purchaser as to the matters covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsidiaries</U>.
All of the outstanding shares of capital stock and/or equity interests of each Subsidiary have been duly authorized and validly issued,
are fully paid and non-assessable and, except to the extent set forth in the SEC Reports, are owned by the Company directly or indirectly
through one or more wholly-owned subsidiaries, free and clear of any claim, lien, encumbrance, security interest, restriction upon voting
or transfer or any other claim of any third party. Except as disclosed in the SEC Reports, no director, officer, or key employee of the
Company holds any direct equity, debt or other pecuniary interest in any Subsidiary or, to the best of the Company&rsquo;s knowledge,
any individual or entity with whom the Company or any Subsidiary does business or with which it is in privity of contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Board
of Directors</U>. The Board of Directors is comprised of the persons set forth in the SEC Reports. The qualifications of the persons
serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act and the rules&nbsp;promulgated
thereunder applicable to the Company and the rules&nbsp;of the Trading Market. At least one member of the Board of Directors qualifies
as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act and the rules&nbsp;promulgated thereunder and
the rules&nbsp;of the Trading Market. In addition, except as disclosed in the SEC Reports, at least a majority of the persons serving
on the Board of Directors qualify as &ldquo;independent&rdquo; as defined under the rules&nbsp;of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosure
Controls</U>. Except as described in the SEC Reports, the Company has developed and currently maintains disclosure controls and procedures
that comply with Rule&nbsp;13a-15 or 15d-15 under the Exchange Act, and such controls and procedures are effective to ensure that information
required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules&nbsp;and forms and includes, without limitation, controls
and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the Company&rsquo;s management, including its principal executive and principal financial
officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance</U>.
The Company has taken all commercially reasonable actions to ensure that it is in compliance in all material respects with all provisions
of the Sarbanes-Oxley Act and all rules&nbsp;and regulations promulgated thereunder or implementing the provisions thereof that are then
in effect and with which the Company is required to comply. The Company has not, directly or indirectly, including through any Subsidiary,
extended credit, arranged to extend credit, or renewed any extension of credit, in the form of a personal loan, to or for any executive
officer of the Company or any of its Subsidiaries, or to or for any family member or affiliate of any director or executive officer of
the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accounting
Controls</U>. The Company maintains systems of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules&nbsp;13a-15
and 15d-15 under the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision
of, its principal executive and principal financial officer, or persons performing similar functions, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles and includes those policies and procedures that: (1)&nbsp;pertain to the maintenance of records
that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2)&nbsp;provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations
of management and directors of the Company; and (3)&nbsp;provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the Company&rsquo;s assets that could have a material effect on the financial statements. Except as
disclosed in the SEC Reports, the Company is not aware of any material weaknesses in its internal controls. The Company&rsquo;s auditors
and the Audit Committee of the Board of Directors have been advised of: (i)&nbsp;all significant deficiencies and material weaknesses
in the design or operation of internal controls over financial reporting which are known to the Company&rsquo;s management and that have
adversely affected or are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report
financial information; and (ii)&nbsp;any fraud known to the Company&rsquo;s management, whether or not material, that involves management
or other employees who have a significant role in the Company&rsquo;s internal controls over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Investment Company Status</U>. The Company is not and, after giving effect to the transactions contemplated hereby, will not be, required
to register as an &ldquo;investment company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Labor Disputes</U>. No labor dispute with the employees of the Company or any Subsidiary exists or, to the knowledge of the Company or
the Subsidiary, is imminent. The Company is not aware that any key employee or significant group of employees of the Company or any Subsidiary
plans to terminate employment with the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Intellectual
Property Rights</U>. The Company and each of its Subsidiaries owns or possesses, and will continue to own or possess immediately following
the Closing in all material respects, legally enforceable rights to use all patents, patent rights, inventions, trademarks, trademark
applications, trade names, service marks, copyrights, copyright applications, licenses, software, know-how and other similar rights and
proprietary knowledge as presently conducted (collectively, &ldquo;<U>Intellectual Property Rights</U>&rdquo;) necessary for the conduct
of their respective businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">There are no inventorship challenges,
opposition or nullity proceedings or interferences declared, commenced, provoked, or, to the Company&rsquo;s knowledge, threatened with
respect to any patents or patent applications owned or licensed by the Company (excluding for the avoidance of doubt, normal processing
of any patent or patent application before applicable patent authorities). To the Company&rsquo;s knowledge, no person or entity (including
any current or former employee or consultant of the Company) is infringing, violating or misappropriating any of the Intellectual Property
Rights owned or licensed by the Company. To the Company&rsquo;s knowledge, neither the conduct nor sales nor use of any products or services
offered by the Company infringes, violates, or constitutes a misappropriation of any Intellectual Property Rights of a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company and its Subsidiaries
have complied with their duty of candor and disclosure to the United States Patent and Trademark Office and any relevant foreign patent
office with respect to all Intellectual Property Right registrations filed by or on behalf of the Company or any of its Subsidiaries
and have made no material misrepresentation in such applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">All assignments of Intellectual
Property Rights owned by the Company and its Subsidiaries have been properly executed and recorded, except for such deficiencies as would
not materially affect the enforceability thereof. To the Company&rsquo;s knowledge, all Intellectual Property Rights owned and licensed
by the Company is valid and enforceable. All issuance, renewal, maintenance and other payments that are or have become due with respect
to Intellectual Property Rights owned by the Company and used by the Company in the conduct of its business as presently conducted have
been timely paid by or on behalf of the Company. Except as disclosed in the SEC Reports, there are no third party joint owners of any
Intellectual Property Rights owned by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company has not used open
source materials, in a manner that grants, to any third party, any rights or immunities under Intellectual Property Rights owned by the
Company (including using any open source materials that require, as a condition of exploitation of such open source materials, that other
software incorporated into, derived from or distributed with such open source materials be (i)&nbsp;disclosed or distributed in source
code form, (ii)&nbsp;licensed for the purpose of making derivative works, or (iii)&nbsp;redistribute at no charge or minimal charge).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Each employee of the Company
or any of its Subsidiaries who is engaged in the creation and development of inventions, discoveries or improvements to the Company&rsquo;s
product portfolio has executed a written agreement expressly assigning to the Company or its relevant Subsidiary all of such employee&rsquo;s
right, title and interest in any inventions, discoveries, or improvements, whether or not patentable, invented, created, developed, conceived
or reduced to practice during the term of such employee&rsquo;s employment and related to the work performed by such person for the Company
or its relevant Subsidiary, and all Intellectual Property Rights therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Taxes</U>.
The Company and its Subsidiaries have filed all material federal, state, local and foreign tax returns which are required to be filed
through the date hereof, which returns are true and correct in all material respects, or has received timely extensions thereof, and
has paid all taxes shown on such returns and all assessments received by the Company to the extent that the same are material and have
become due. There are no material tax audits or investigations pending; nor are there any material proposed additional tax assessments
against either the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with Environmental Laws</U>. Except as disclosed in the SEC Reports: (i)&nbsp;the Company and each of its Subsidiaries is in compliance
in all material respects with all rules, laws and regulation relating to the use, treatment, storage and disposal of toxic substances
and protection of health or the environment (&ldquo;Environmental Laws&rdquo;) which are applicable to its business; (ii)&nbsp;neither
the Company nor any of its Subsidiaries has received any notice from any governmental authority or third party of an asserted claim under
Environmental Laws; (iii)&nbsp;the Company and each of its Subsidiaries has received all permits, licenses or other approvals required
of it under applicable Environmental Laws to conduct its business and is in compliance in all material respects with all terms and conditions
of any such permit, license or approval; (iv)&nbsp;to the knowledge of the Company, no facts currently exist that will require either
Company or its Subsidiaries to make future material capital expenditures to comply with Environmental Laws; and (v)&nbsp;no property
which is or has been owned, leased or occupied by either of the Company or its Subsidiaries has been designated as a &ldquo;Superfund
site&rdquo; pursuant to the Comprehensive Environmental Response, Compensation of Liability Act of 1980, as amended (42 U.S.C. Section&nbsp;9601,
et. seq.) (&ldquo;CERCLA&rdquo;), or otherwise designated as a contaminated site under applicable state or local law. Neither the Company
nor its Subsidiaries has been named as a &ldquo;potentially responsible party&rdquo; under CERCLA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with Laws</U>. Each of the Company and each Subsidiary: (A)&nbsp;is and at all times has been in material compliance with all statutes,
rules, or regulations applicable to the conduct of the business of the Company or the Subsidiary (collectively, the &ldquo;<U>Applicable
Laws</U>&rdquo;), except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (B)&nbsp;has
not received any written warning letter, untitled letter or other correspondence or notice from any other Governmental Entity alleging
or asserting noncompliance with any Applicable Laws or any Authorizations, except as could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Change; (C)&nbsp;possesses all material Authorizations and such Authorizations are valid and in
full force and effect and the Company is not in material violation of any term of any such Authorizations, except as could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Change; (D)&nbsp;has not received notice of any written claim,
action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party
alleging that any of the Company&rsquo;s activities is in violation of any Applicable Laws or Authorizations and has no knowledge that
any such Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding,
except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (E)&nbsp;has not received
written notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations
and has no knowledge that any such governmental authority is considering such action, except as could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Change; and (F)&nbsp;has filed, obtained, maintained or submitted all material reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws
or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or
amendments were complete and correct on the date filed (or were corrected or supplemented by a subsequent submission), except as could
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Industry
Data</U>.&nbsp; The statistical and market-related data included in the SEC Reports are based on or derived from sources that the Company
reasonably and in good faith believes are reliable and accurate or represent the Company&rsquo;s good faith estimates that are made on
the basis of data derived from such sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Margin
Securities</U>. None of the Company nor any Subsidiary owns any &ldquo;margin securities&rdquo; as that term is defined in Regulation
U of the Board of Governors of the Federal Reserve System (the&nbsp;<U>&ldquo;Federal Reserve Board</U>&rdquo;), and none of the proceeds
of the Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose
of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose
which might cause any of the shares of Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation
T, U or X of the Federal Reserve Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Integration</U>.
None of the Company nor any Subsidiary or Affiliates, nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the offering contemplated
in this Agreement to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration
of the offering of any such securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Title
to Real and Personal Property</U>. The Company and its Subsidiaries own or lease all such properties as are necessary and material to
the conduct of its business as presently operated as described in the SEC Reports. The Company and its Subsidiaries have good and marketable
title to all personal property owned by them, free and clear of all liens, charges or encumbrances except such as are described in the
SEC Reports or such as would not (individually or in the aggregate) have a Material Adverse Change. Except as disclosed in the SEC Reports,
any real property and buildings held under lease or sublease by the Company and its Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material to, and do not interfere with, the use made and proposed to be made of
such property and buildings by the Company and its Subsidiaries. Neither the Company nor any of its Subsidiaries has received any notice
of any claim adverse to its ownership of any real or personal property or of any claim against the continued possession of any real property,
whether owned or held under lease or sublease by the Company or its Subsidiaries, that would have a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidentiality
and Non-Competition Agreements</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the Company
or any Subsidiary is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any
employer or prior employer that could materially affect his ability to be and act in his respective capacity of the Company or any Subsidiary
or be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Diligence
Materials</U>. The Company has provided to the Purchaser or the Placement Agent&rsquo;s Counsel all materials responsive in all material
respects to the diligence requests, if any, submitted to the Company or its counsel by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nasdaq
Listing Rules</U>. Except as set forth in the SEC Reports, the Company is, and after giving effect to the offering contemplated by this
Agreement will be, in compliance in all material respects with all applicable corporate governance requirements set forth in the Nasdaq
Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exchange
Act Reports</U>. The Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(a), 13(e), 14 and
15(d)&nbsp;of the Exchange Act during the 12 months preceding the date hereof, or such shorter period as the Company was required by
law or regulation to file such material (except to the extent that Section&nbsp;15(d)&nbsp;requires reports to be filed pursuant to Sections
13(d)&nbsp;and 13(g)&nbsp;of the Exchange Act, whichs shall be governed by the next clause of this sentence); and the Company has filed
in a timely manner all reports required to be filed pursuant to Sections 13(d)&nbsp;and 13(g)&nbsp;of the Exchange Act during the 12
months preceding the date hereof, or such shorter period as the Company was required by law or regulation to file such material, except
where the failure to timely file could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Change
or affect the Company&rsquo;s ability to use Form&nbsp;S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Information
Provided</U>. The Company confirms that, to its knowledge, with the exception of the proposed sale of the Shares and the Warrants under
this Agreement and the Subscription Documents relating thereto, and the other transactions set forth herein and therein, neither the
Company nor any other persons acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that constitutes material, nonpublic information. The Purchasers acknowledge and agree that until public disclosure of the proposed sale
of the Shares and Warrants under this Agreement, the Purchasers will be restricted by the insider trading prohibitions under the Exchange
Act from trading or &ldquo;tipping&rdquo; on the basis of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
 &ldquo;Bad Actor&rdquo; Disqualification</U>. The Company has exercised commercially reasonable care, in accordance with Commission rules&nbsp;and
guidance, and has conducted a factual inquiry, the nature and scope of which reflect reasonable care under the relevant facts and circumstances,
to determine whether any Covered Person (as defined below) is subject to any of the &ldquo;bad actor&rdquo; disqualifications described
in Rule&nbsp;506(d)(1)(i)&nbsp;to (viii)&nbsp;under the Securities Act (&ldquo;<U>Disqualification Events</U>&rdquo;). To the Company&rsquo;s
knowledge, after conducting such sufficiently diligent factual inquiries, no Covered Person is subject to a Disqualification Event, except
for a Disqualification Event covered by Rule&nbsp;506(d)(2)&nbsp;or (d)(3)&nbsp;under the Securities Act. The Company has complied, to
the extent applicable, with any disclosure obligations under Rule&nbsp;506(e)&nbsp;under the Securities Act. &ldquo;<U>Covered Persons</U>&rdquo;
are those persons specified in Rule&nbsp;506(d)(1)&nbsp;under the Securities Act, including the Company; any predecessor or affiliate
of the Company; any director, executive officer, other officer participating in the offering, general partner or managing member of the
Company; any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on the basis of
voting power; any promoter (as defined in Rule&nbsp;405 under the Securities Act) connected with the Company in any capacity at the time
of the sale of the Shares and the Warrants; and any person that has been or will be paid (directly or indirectly) remuneration for solicitation
of purchasers in connection with the sale of the Shares and the Warrants (a &ldquo;<U>Solicitor</U>&rdquo;), any general partner or managing
member of any Solicitor, and any director, executive officer or other officer participating in the offering of any Solicitor or general
partner or managing member of any Solicitor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization;
Authority</U>. Each Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise to carry
out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by such Purchaser of the transactions
contemplated by this Agreement have been duly authorized by all necessary corporate, partnership, limited liability company, investment
management or similar action, as applicable, on the part of such Purchaser. Each Subscription Document to which it is a party has been
duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid
and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii)&nbsp;as enforceability
of any indemnification or contribution provision may be limited under the federal or state securities laws; and (iii)&nbsp;that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefor may be brought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Purpose</U>. Each Purchaser is acquiring the Securities for its own account for investment only and not with a view towards, or for resale
in connection with, the public sale or distribution thereof. Each Purchaser acknowledges that the Shares will be issued in book entry
form with a notation of restriction and the Warrants will be issued in registered form with a notation of restriction, in each case as
set forth in&nbsp;<U>Section&nbsp;4.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities, and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accredited
Investor Status</U>.&nbsp; Each Purchaser is an &ldquo;accredited investor&rdquo; as that term is defined in Rule&nbsp;501(a)&nbsp;of
Regulation D, as promulgated under the Securities Act and has delivered to the Company a completed Investor Questionnaire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reliance
on Exemptions</U>.&nbsp; Each Purchaser understands that the Shares&nbsp;and the Warrants are being offered and sold to it in reliance
on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is
relying in part upon the truth and accuracy of, and each Purchaser&rsquo;s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of each Purchaser set forth herein in order to determine the availability of such exemptions and the
eligibility of each Purchaser to acquire the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Information</U>.
Each Purchaser and its representatives, if any, have been furnished with all materials relating to the business, finances and operations
of the Company and other information each Purchaser deemed material to making an informed investment decision regarding its purchase
of the Securities, which have been requested by each Purchaser.&nbsp; Purchaser acknowledges that it has reviewed a copy of the Subscription
Documents, including the SEC Reports.&nbsp;Each Purchaser and its advisors, if any, have been afforded the opportunity to ask questions
of the Company and its management. Neither such inquiries, nor any other due diligence investigations conducted by any Purchaser or its
advisors, if any, or its representatives, shall modify, amend or affect each Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in&nbsp;<U>Section&nbsp;3.1</U>.&nbsp; Each Purchaser understands that its investment in the Securities, involves
a high degree of risk.&nbsp; Each Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an
informed investment decision with respect to its acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General
Solicitation</U>.&nbsp; Each Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company
Affiliated Investors</U>. Each Purchaser acknowledges that certain officers and directors of the Company may purchase Shares and the
Warrants pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Governmental Review</U>. Each Purchaser understands that no United States federal or state governmental authority has passed on or made
any recommendation or endorsement of the Shares and the Warrants, or the fairness or suitability of the investment in the Shares and
the Warrants, nor have such governmental authorities passed upon or endorsed the merits of the offering of the Shares and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, each Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Other than to other Persons party to
this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal
and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it
in connection with this transaction (including the existence and terms of this transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
and Restrictive Legend</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Shares and the Warrants may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of Shares or the Warrants other than pursuant to an effective registration statement, the Company may require the transferor thereof
to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance
of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such
transferred Shares or Warrants under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchasers agree to a restrictive notation on the Shares to be issued in book entry form as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THESE SECURITIES HAVE BEEN ACQUIRED FROM THE
ISSUER WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;) AND ARE RESTRICTED SECURITIES
AS THAT TERM IS DEFINED UNDER RULE 144, PROMULGATED UNDER THE SECURITIES ACT. THESE SECURITIES MAY&nbsp;NOT BE SOLD, PLEDGED, TRANSFERRED,
DISTRIBUTED, OR OTHERWISE DISPOSED OF IN ANY MANNER UNLESS SUCH TRANSACTION IS (I)&nbsp;REGISTERED UNDER THE SECURITIES ACT, (II)&nbsp;UNLESS
SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT, OR (III)&nbsp;SOLD PURSUANT TO A VALID EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS
AS EVIDENCED BY AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE ISSUER, STATING THAT THE TRANSFER DOES NOT INVOLVE A TRANSACTION
REQUIRING REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Purchasers agree to a restrictive notation on the Warrants to be issued in book entry form as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY&nbsp;NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Shares and the Warrants in a manner that
would require the registration under the Securities Act of the sale of the Shares and the Warrants or that would be integrated with the
offer or sale of the Shares and the Warrants for purposes of the rules&nbsp;and regulations of any Trading Market such that it would
require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing
of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Securities
Laws Disclosure; Publicity</U>. No later than the Trading Day immediately following the Closing Date, the Company shall file a Current
Report on Form&nbsp;8-K (the &ldquo;<U>Announcement 8-K</U>&rdquo;), including the Subscription Documents with the Commission. From and
after the filing of the Announcement 8-K, the Company represents to the Purchasers that it shall have publicly disclosed all material,
non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers,
directors, employees or agents in connection with the transactions contemplated by the Subscription Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Shares and the Warrants hereunder for general working capital
and for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at
all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
the Shares and the Warrants pursuant to this Agreement and the Warrants Shares in connection with any exercise of the Warrants pursuant
to the terms of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares on such Trading Market and promptly secure the listing of all of the Shares on such Trading Market. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will take reasonably commercial efforts to continue the listing and trading of its Common
Stock on a Trading Market and to comply in all material respects with the Company&rsquo;s reporting, filing and other obligations under
the bylaws or rules&nbsp;of the Trading Market. The Company agrees to use commercially reasonable best efforts to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any of its Affiliates acting on its behalf or pursuant to any understanding with it will execute any purchases, sales or effect any
other transactions, including Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of
this Agreement and ending at such time that the transactions contemplated by the Subscription Documents are first publicly announced
pursuant to the filing of the Announcement 8-K as described above. Each Purchaser, severally and not jointly with the other Purchasers,
covenants that until such time as the transactions contemplated by the Subscription Documents are publicly disclosed by the Company pursuant
to the filing of the Announcement 8-K, such Purchaser will maintain the confidentiality of the existence and terms of this transaction
and the information included in the Subscription Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Form&nbsp;D;
Blue Sky Filings</U>. The Company agrees to timely file a Form&nbsp;D with respect to the Shares and the Warrants as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Shares and the Warrants for, sale to the Purchasers at
the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence
of such actions promptly upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;From
the date hereof until December&nbsp;31, 2024, neither the Company nor any Subsidiary (other than to the Company) shall issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or file
any registration statement or amendment or supplement thereto, other than (i)&nbsp;the Prospectus Supplement or any other amendments
and supplements to the Registration Statement in connection with the Offering, (ii)&nbsp;a registration statement on Form&nbsp;S-8, (iii)&nbsp;a
registration statement covering the Common Stock underlying the Underwriter Warrants or (iv)&nbsp;a registration statement covering the
clirSPV Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;From
the date hereof until December&nbsp;31, 2024, the Company shall be prohibited from effecting or entering into an agreement to effect
any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof)
involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i)&nbsp;issues
or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional
shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate or other price that is based upon, and/or
varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or
equity securities or (B)&nbsp;with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any
agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price
regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently
canceled. Any Underwriter shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy
shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
the foregoing, this Section&nbsp;4.9 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has caused to be delivered to the Placement Agent prior to the date of this Agreement a letter, in the form of&nbsp;<U>Exhibit&nbsp;B</U>&nbsp;hereto
(the &ldquo;<U>Lock-up Agreement</U>&rdquo;), from each of the Company&rsquo;s directors and executive officers as well as any shareholders
deemed to be affiliates through their ownership of the Company&rsquo;s Common Stock. The Company will enforce the terms of each Lock-up
Agreement and issue stop-transfer instructions to the transfer agent for the Common Stock with respect to any transaction or contemplated
transaction that would constitute a breach of or default under the applicable Lock-up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stabilization</U>.
Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Placement Agent),
has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected
to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Shares or the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V<BR>
REGISTRATION RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Procedures and Expenses; Liquidated Damages for Certain Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall prepare and file with the Commission, as promptly as reasonably practicable following Closing, but in no event later than
30 days following the date hereof (the &ldquo;<U>Initial Filing Date</U>&rdquo;), a registration statement on Form&nbsp;S-1 covering
the resale of the Registrable Securities (as defined below) (the &ldquo;<U>Registration Statement</U>&rdquo;) and use its commercially
reasonable efforts, subject to receipt of all necessary information from the Purchasers, as soon as reasonably practicable thereafter
but in no event later than 45 days following the date hereof (90 days in the event of a review of the Registration Statement by the Commission),
to effect such registration and any related qualification or compliance with respect to all Registrable Securities held by the Purchasers.
For purposes of this Agreement, the term &ldquo;<U>Registrable Securities</U>&rdquo; shall mean (i)&nbsp;the Shares; (ii)&nbsp;the Warrant
Shares and (iii)&nbsp;any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or
similar event with respect to the foregoing;&nbsp;<I><U>provided, however</U></I>, that any such Registrable Securities shall cease to
be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration
Statement hereunder with respect thereto) for so long as (a)&nbsp;a Registration Statement with respect to the sale of such Registrable
Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by
the Purchaser in accordance with such effective Registration Statement, (b)&nbsp;such Registrable Securities have been previously sold
in accordance with Rule&nbsp;144, or (c)&nbsp;such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule&nbsp;144 as set forth in a written opinion letter to such effect, addressed,
delivered and acceptable to the Transfer Agent and the affected Purchasers (assuming that such securities and any securities issuable
upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no
time held by any Affiliate of the Company), as reasonably determined by the Company, upon the advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall, during the Effectiveness Period (as defined below), use commercially reasonable efforts to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prepare
and file with the Commission such amendments and supplements to the Registration Statement and the prospectus used in connection therewith
(the &ldquo;<U>Prospectus</U>&rdquo;) as may be necessary or advisable to keep the Registration Statement current and effective for the
resale of the Registrable Securities held by a Purchaser for a period ending on the earlier of (i)&nbsp;the second anniversary of the
Closing Date, (ii)&nbsp;the date on which all Registrable Securities may be sold pursuant to Rule&nbsp;144 during any three-month period
without the requirement for the Company to be in compliance with the current public information required under Rule&nbsp;144(c)(1)&nbsp;or
(iii)&nbsp;such time as all Registrable Securities have been sold pursuant to a registration statement or Rule&nbsp;144 (collectively,
the &ldquo;<U>Effectiveness Period</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;furnish
to each Purchaser with respect to the Registrable Securities registered under the Registration Statement such number of copies of the
Registration Statement and the Prospectus (including supplemental prospectuses) filed with the Commission in conformance with the requirements
of the Securities Act and other such documents as such Purchaser may reasonably request, in order to facilitate the public sale or other
disposition of all or any of the Registrable Securities by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;make
any necessary blue sky filings;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;pay
the expenses incurred by the Company and the Purchasers in complying with Article&nbsp;V, including, all registration and filing fees,
FINRA fees, exchange listing fees, printing expenses, fees and disbursements of counsel for the Company, blue sky fees and expenses and
the expense of any special audits incident to or required by any such registration (but excluding attorneys&rsquo; fees of any Purchaser
and any and all underwriting discounts and selling commissions applicable to the sale of Registrable Securities by the Purchasers);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;advise
the Purchasers, promptly after it shall receive notice or obtain knowledge of the issuance of any stop order by the Commission delaying
or suspending the effectiveness of the Registration Statement or of the initiation of any proceeding for that purpose; and it will promptly
use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal at the earliest possible moment
if such stop order should be issued; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1.25in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;with
a view to making available to the Purchaser the benefits of Rule&nbsp;144 and any other rule&nbsp;or regulation of the Commission that
may at any time permit the Purchasers to sell Registrable Securities to the public without registration, the Company covenants and agrees
to: (i)&nbsp;make and keep public information available, as such term is understood and defined in Rule&nbsp;144, until the earlier of
(A)&nbsp;such date as all of the Registrable Securities qualify to be resold immediately pursuant to Rule&nbsp;144 or any other rule&nbsp;of
similar effect during any three-month period without the requirement for the Company to be in compliance with the current public information
required under Rule&nbsp;144(c)(1)&nbsp;or (B)&nbsp;such date as all of the Registrable Securities shall have been resold pursuant to
Rule&nbsp;144 (and may be further resold without restriction); (ii)&nbsp;file with the Commission in a timely manner all reports and
other documents required of the Company under the Securities Act and under the Exchange Act; and (iii)&nbsp;furnish to any Purchaser
upon request, as long as such Purchaser owns any Registrable Securities, (A)&nbsp;a written statement by the Company as to whether it
has complied with the reporting requirements of the Securities Act and the Exchange Act, (B)&nbsp;a copy of the Company&rsquo;s most
recent Annual Report on Form&nbsp;10-K or Quarterly Report on Form&nbsp;10-Q, and (C)&nbsp;such other information as may be reasonably
requested in order to avail the Purchaser of any rule&nbsp;or regulation of the Commission that permits the selling of any such Registrable
Securities without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company understands
that the Purchasers disclaim being an underwriter, but acknowledges that a determination by the Commission that a Purchaser is deemed
an underwriter shall not relieve the Company of any obligations it has hereunder. The Company will not name any Purchaser as an underwriter
in a Registration Statement or Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;the Registration Statement is not filed on or prior to the Initial Filing Date, or (ii)&nbsp;the Company fails to file with
the Commission a request for acceleration of the Registration Statement in accordance with Rule&nbsp;461 under the Securities Act, within
five Trading Days after the date the Company is first notified (orally or in writing) by the Commission that the Registration Statement
will not be &ldquo;reviewed&rdquo; or will not be subject to further review or comment, or (iii)&nbsp;prior to the effective date of
the Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by
the Commission in respect of such Registration Statement within 21 days after the receipt of comments by or notice from the Commission
that such amendment or resolution of such comments is required in order for such Registration Statement to be declared effective, or
(iv)&nbsp;there occurs the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose or (v)&nbsp;at any time during
the period commencing from the six-month anniversary of the date hereof and ending at such time that all of the Registrable Securities
may be resold during any three-month period without the requirement for the Company to be in compliance with the current public information
required under Rule&nbsp;144(c)(1), the Company shall fail to satisfy the current public information requirement under Rule&nbsp;144(c)&nbsp;(any
of the foregoing being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i)&nbsp;and (v), the date on which
such Event occurs, and for purpose of clause (ii)&nbsp;the date on which such five Trading Day period is exceeded, and for purpose of
clause (iii)&nbsp;the date which such 21-day period is exceeded, being the &ldquo;<U>Event Date</U>&rdquo;), then except during any period
of time during which the Registrable Securities may be resold pursuant to Rule&nbsp;144 without volume limitations, in addition to any
other rights the Purchasers may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each
such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall
pay to each Purchaser an amount in cash, as liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the purchase
price paid by such Purchaser with respect to the Registrable Securities affected by such Event and held by such Purchaser on such Event
Date or monthly anniversary thereof, up to a maximum of 5.0% of the purchase price for such Registrable Securities provided that such
maximum shall not apply if the applicable Event is the Event described in clause (v). If the Company fails to pay any liquidated damages
pursuant to this&nbsp;<U>Section&nbsp;5.1(c)</U>&nbsp;in full within seven days after the date payable, the Company will pay interest
thereon at a rate of 12% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Purchasers,
accruing daily from the date such liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The
liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of
an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been
consummated on or before May&nbsp;15, 2024;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fees
and Expenses</U>. Except as expressly set forth in the Subscription Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Shares or Warrants to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. The Subscription Documents, together with the exhibits and schedules thereto, contain the entire understanding of the
parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a)&nbsp;the date of transmission, if such notice or communication is delivered via
email attachment at the email address as set forth on the signature pages&nbsp;attached hereto at or prior to 5:30 p.m.&nbsp;(New York
City time) on a Trading Day, (b)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered
via email attachment at the or email address as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading
Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP>) Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to
whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;attached
hereto. To the extent that any notice provided pursuant to any Subscription Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required</FONT>. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations
of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of
such adversely affected Purchaser. Any amendment effected in accordance with this&nbsp;<U>Section&nbsp;6.5</U>&nbsp;shall be binding
upon each Purchaser and holder of Shares or Warrants and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Shares or Warrants, provided that such transferee agrees in writing to be bound, with respect to the transferred Shares
or Warrants, by the provisions of the Subscription Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the
Company in&nbsp;<U>Section&nbsp;3.1</U>&nbsp;and the representations and warranties of the Purchasers in&nbsp;<U>Section&nbsp;3.2</U>.
This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in this&nbsp;<U>Section&nbsp;6.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Subscription Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Subscription Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Subscription Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Subscription Documents, then the prevailing party
in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Shares and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Subscription Documents, whenever any Purchaser exercises a right, election, demand or option under a Subscription Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right)</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays,&nbsp;etc.</U>&nbsp;If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Subscription Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Subscription Documents or any amendments thereto. In addition, each and every reference
to share prices and shares of Common Stock in any Subscription Document shall be subject to adjustment for reverse and forward stock
splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement
but before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>WAIVER
OF JURY TRIAL.&nbsp;<FONT STYLE="text-transform: uppercase">EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE
UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES.</FONT>&nbsp;ACCORDINGLY,&nbsp;IN ANY ACTION, SUIT, OR PROCEEDING
IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT
PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARSIGN
    TECHNOLOGIES CORPORATION</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Colin James Deller&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearSign
    Technologies Corporation</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 39%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Colin
    James Deller</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8023
    East 63RD Place, Suite&nbsp;101</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Chief
    Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tulsa,
    Oklahoma 74133</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Chief Executive Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With a copy to (which shall not constitute
    notice):</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitchell
    Silberberg&nbsp;&amp; Knupp LLP</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">437
    Madison Ave., 25th Floor</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10022</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Blake Baron</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO CLEARSIGN TECHNOLOGIES
CORPORATION SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Purchaser:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; width: 53%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Schwartzberg&nbsp;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized
    Signatory of Purchaser</I></FONT>:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address of Authorized
    Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">andrew@tritonps.com&nbsp;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Notice to Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Delivery of Shares and Warrants to Purchaser
    (if not same as address for notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Social Security Number or Taxpayer ID of Purchaser:&nbsp;&nbsp;<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 82%; margin-left: 1.5in">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 81%; text-align: left; padding-bottom: 1pt">Common Unit Subscription
    Amount:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">5,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Common Shares:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,405,405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Common Warrants:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,108,108</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Pre-funded Unit Subscription Amount:</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Pre-funded Warrants:</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Common Warrants:</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker </FONT><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT>&nbsp;4.99% or <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT>&nbsp;9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT>&nbsp;Notwithstanding
anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of the above-signed to purchase the
securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell
such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)&nbsp;the Closing
shall occur on the third (3<SUP>rd</SUP>) Trading Day following the date of this Agreement and (iii)&nbsp;any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i)&nbsp;above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INVESTOR QUESTIONNAIRE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORMS&nbsp;OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF COMMON WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING STOCKHOLDER QUESTIONNAIRE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>11
<FILENAME>tm2412212d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ClearSign Technologies Corporation Announces
Pricing of $9.3 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>TULSA, Okla., April, 19, 2024 /PRNewswire/
-- ClearSign Technologies Corporation (Nasdaq: CLIR) </B>(&quot;ClearSign&quot; or the &quot;Company&quot;), an emerging leader in industrial
combustion and sensing technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, today
announced the pricing of an underwritten public offering of 4,620,760 shares of its common stock and redeemable warrants to purchase up
to an aggregate of 4,620,760 shares of its common stock at a public offering price of $0.91 per share and $0.01 per accompanying warrant.
The warrants will have an exercise price of $1.05 per share, are exercisable immediately upon issuance and redeemable upon certain conditions
and will expire five years following the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the offering, ClearSign has
granted the underwriters a 45-day option to purchase up to an additional 15% of shares of common stock or shares of common stock and accompanying
warrants at the public offering prices, less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a private placement to be completed concurrently
with the completion of the public offering, ClearSign will issue to an accredited investor an aggregate of 5,405,405 shares of common
stock (or pre-funded warrants in lieu thereof) and redeemable warrants to purchase up to 8,108,108 shares of common stock. The offering
prices in the private placement are $0.91 per share and $0.015 per one and a half warrant. The redeemable warrants issued in the private
placement will be exercisable at an exercise price of $1.05 per share, will be exercisable beginning six months after issuance, redeemable
upon certain conditions and expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Ventures, LLC is acting as the sole book-running
manager for the public offering and as a placement agent for the private placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ClearSign expects to receive aggregate gross proceeds
from the public and private offering, excluding the exercise of the underwriters&rsquo; overallotment option, of approximately $9.3 million,
excluding underwriting and placement agent discounts and commissions and other offering-related expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Both offerings are expected to close on or about
April&nbsp;23, 2024, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ClearSign intends to use the net proceeds from
the offerings for working capital, research and development, marketing and sales, and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities in the public offering are being
offered pursuant to a prospectus supplement and an accompanying base prospectus forming part of a shelf registration statement on Form&nbsp;S-3
(File No.&nbsp;333-265967), which was previously filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) and became effective
on August&nbsp;12, 2022. A preliminary prospectus supplement and accompanying base prospectus relating to the public offering was filed
with the SEC and is available on the SEC&rsquo;s website at www.sec.gov. A final prospectus supplement relating to the public offering
will be filed with the SEC and will be available on the SEC&rsquo;s website located at www.sec.gov. When available, copies of the final
prospectus supplement and the accompanying base prospectus may be obtained for free by contacting Public Ventures, LLC, 14135 Midway Rd,
Suite&nbsp;G-150, Addison, TX, 75001, by email at info@publicventures.com or by telephone at (945) 262-9010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The private placement is being conducted pursuant
to the exemption from registration provided in Section&nbsp;4(a)(2)&nbsp;under the Securities Act of 1933 and/or Rule&nbsp;506(b)&nbsp;promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release does not constitute an offer
to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About ClearSign Technologies Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ClearSign Technologies Corporation designs and develops products and
technologies for the purpose of improving key performance characteristics of industrial and commercial systems, including&nbsp;operational
performance, energy efficiency, emission reduction, safety and overall cost-effectiveness. Our patented technologies, embedded in established
OEM products as ClearSign Core&trade; and ClearSign Eye&trade;&nbsp;and other sensing configurations, enhance the performance of combustion
systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining),
commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit&nbsp;www.clearsign.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary note on forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements in this press release that are not based on historical
fact are &quot;forward-looking statements.&quot; You can find many (but not all) of these statements by looking for words such as &quot;approximates,&quot;
 &quot;believes,&quot; &quot;hopes,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;estimates,&quot; &quot;projects,&quot; &quot;intends,&quot;
 &quot;plans,&quot; &quot;would,&quot; &quot;should,&quot; &quot;could,&quot; &quot;may,&quot; &quot;will&quot; or other similar expressions.
While management has based any forward-looking statements included in this press release on its current expectations on the Company's
strategy, plans, intentions, performance, or future occurrences or results, the information on which such expectations were based may
change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks,
uncertainties and other factors, many of which are outside of the Company&rsquo;s control, that could cause actual results to materially
differ from such statements. Such risks, uncertainties and other factors include, but are not limited to: general business and economic
conditions,&nbsp;the ability to satisfy the closing conditions related to the public offering and private placement and the overall timing
and completion of such offerings closing conditions, the ability to successfully complete installations of the Company&rsquo;s products,
whether the letter of intent sent to California Boiler results in purchase orders from the customer, whether changes in greenhouse gas
emission control applicable federal and state laws and regulations,&nbsp;the performance of the Company&rsquo;s management and employees,
the ability to obtain financing, competition, whether ClearSign&rsquo;s technology will be accepted and adopted and other factors identified
in the Company&rsquo;s Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission and available at&nbsp;www.sec.gov&nbsp;and
other factors that are detailed in the Company&rsquo;s periodic and current reports available for review at&nbsp;www.sec.gov. Furthermore,
the Company operates in a competitive environment where new and unanticipated risks may arise. Accordingly, investors should not place
any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and, except as may
be required by law, undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently
occur or of which we hereafter become aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information: </B>Matthew Selinger, Firm IR Group for
ClearSign, +1 415-572-8152, mselinger@firmirgroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>clir-20240419.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaeP+bOdzZR+OYkxtmB1bUla7yoqQiS0lyRwfOnW8bUJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:clir="http://clearsign.com/20240419" elementFormDefault="qualified" targetNamespace="http://clearsign.com/20240419">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://clearsign.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="clir-20240419_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="clir-20240419_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>clir-20240419_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>clir-20240419_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://clearsign.com/role/Cover" xlink:href="clir-20240419.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://clearsign.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139961540013584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 19,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLEARSIGN TECHNOLOGIES CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001434524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2056298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8023 E. 63rd Place, Suite 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tulsa<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">74133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">236-6461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLIR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *=%DU@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "G19-8U^B+*N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NND*$E'7"XC3)B$Q"<0M2KPMHOFCQ*C=VY.6K1."!^ 8^Y?/
MGR6W*@CE(SY''S"2P70SVMXEH<*:'8F" $CJB%:F,B=<;NY]M)+R,QX@2/4A
M#PAU5=V!19):DH0)6(2%R+I6*Z$B2O+QC-=JP8?/V,\PK0![M.@H 2\YL&Z:
M&$YCW\(5,,$(HTW?!=0+<:[^B9T[P,[),9DE-0Q#.:SF7-Z!P]MV\S*O6QB7
M2#J%^5<R@DX!U^PR^77U\+A[8EU=U4U1-06_W_%:-+>"\_?)]8??5=AZ;?;F
M'QM?!+L6?MU%]P502P,$%     @ IT636)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MFP?@_D9*_7%BMJKE?QH&_P)02P,$%     @ IT636)^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *=%DUAH,=+(2 0  '40   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "G19-8GZ ;\+$"  #B#   #0              @ &,#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *=%DUB7BKL<P    !,"   +
M  "  6@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *=%DUBJQ"(6,P$  "("
M   /              "  5$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "G19-8)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "G19-899!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2412212d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://clearsign.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clir-20240419.xsd</File>
    <File>clir-20240419_lab.xml</File>
    <File>clir-20240419_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2412212d1_8k.htm">tm2412212d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2412212d1_8k.htm": {
   "nsprefix": "clir",
   "nsuri": "http://clearsign.com/20240419",
   "dts": {
    "schema": {
     "local": [
      "clir-20240419.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "clir-20240419_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clir-20240419_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2412212d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://clearsign.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412212d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412212d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001104659-24-049160-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-049160-xbrl.zip
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MR,21%G+_8>44#W:M7%. _L>2.T:_7&O375PM_;R\?DU=+A<*L=(B;[I(TT]
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MI6H&E<;@J^"=08YO+PQH@'&3H2,B(/0&V(1N..21* _]@(I@5(OV='Z6'K(
MDOCS_IX\$*'>.UB27?99[NBIXPQC0*SKL[?!S3%/YGH#@X#PK6ZA4[T4U2M
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M?]8XW_9UZ?1#_<Z=?OC26%\-'^2N*P'!3G._JE8J*WMQJ <VJ4<%;.C'77B
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M,23L5,-V?5[+)] 6FXOOMSP#3< ( +\!T0?+I%.^E[]I)6V_QE<.0&METI_
M@%A>C),S_@,W64=HP$OQ19&Q(EL5H97 V()=[@MN R@8BV%!M!YP0UN@%(L_
M=U5!Y,E!&'04O,A9LA6C"R5-WY(3F'N/,Z2(DH,YY@^E#!#X8Q-A -NGP1Q0
MG%?3T^%ZT'9GFX[2)06[7#]P?4,KD!E:(#@ATCQ,;K"2[8CHH94:$3T;'>4%
M?Y8<FB_$ 4A#SA2239"@$M)M"@4$AZ;3,?=IH%-?E*A.K1%GCM\JA7JE#/RM
MHASU)R/LY;@AFTI*BPG84.ZYL%.@MFR7,Z@[1OY0=DWJ&Y[5IZ:H)^68NX6>
M!'@7RTUABKC"(*;E,Y_(9TV-\&@4_YT?(J.@%A%F,]I*7!@0*L@%?<:XJ3^+
M8V5+=:S/0=T#/2CIK;9\P#<O^S)I(MV<I;,BDO2'U([.B3/5SPZ'\#UU6-4R
M1T"O6"&[\K0:?U2I5(I:O=:H[[]0@B%P^@.+NAFVCB(@F@0+C"<#6*LP4#1F
MH&AD%YKK(^9:<Z$J],ME')R>!"<T%L1&Q^)N2"AA["UVN"ZNM'J==J3X\#G>
M0XD\A<?B@PE68QOVA'GY4K=@JS'8$Q;>Z@1B*=;8GXS'-@/+Q_ILZ,5,& 97
MIXT *3IS^^WL7H(=Y[MNBFXW06C/CO(O8O$1Q%>V59E4T ,4HES^S1F82=LQ
M1Y.@:2;$6R&AOD%%*S:Z4M +FE1K7)=R8<?C1DR/1@7[N?#&++M0FLL%A!;I
M9$RXO:V'U@BI-RH%5:TJ.59@6FW-Z>WXS'Q\,6*.77F$5D5DIF: I"P> (0!
MFE!@KL!+RB-A?)1;"Q!'663-8.Z#6OL]#'PM6%]J206$4%B\\1EAKYDEA2M%
MHZV/MB9:*-F[+JU,1,_8Y:K00)W'CF(D=!\#RY\P>T**I ):;AM40W\+=@:^
M&?F/\DJ,-3!FR_Q-9&^^/(-Z@0Y;"M02>/S4.5KAK%NF V@%?I)<V,M(MX Y
MS#(;S+% AS>'%#&JBQ$5@^+1)J$@5>F*Q[P:"2':YF,.']JA0&]<"Z#N^<FM
ME^R]9?D1P S@'$8&8+Q9)"=X26%!>L-2ZX?1!C]E_Q5P-"Z3F)03'A1+"-"1
M$YY05Z)C56D7GTV0,G^1L9F=($6$;>E]R^:DDGO$1.07F1 2!D_2-@F;8^8P
M,E.X\9L!X5CW0A0@U^"MDRPK$9[UXF[#8^A#B>8P12!P'_I3>7OT /3)C4P4
MJPP%0D)&8C * ;$MXB_XY4,&<ZX1$!P'Y"\5@S"+C#KTU@I2BV2GXQ+#\F )
M%^)QSD)#3:Q4B@7F8@O*P"5Z.O= Q-@_,9^M8RN%LI2)2III,\%>H<@$/P^
MH_B$X3@>I1#[E[:CE#"2E1D9C/F6Z4A5PDQ)2%T6[<#7[#*.R'8XB$R'P V@
M"3]Q"L_R3*4%M@!;-#=2*O5&H9X?=5O1B58RG>AET4/X5;O)\-LB=&8&R_1
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M60-!%UVII_1TFRNDSM>)!;L>T=ZS/KJ_&2ZT''Y1#O)>Y,Z"0+M'VB+1A0=
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MVJ>=UB4*#G+5:9^<G9^>O^UV>J1]?GEQ?MFZZIZ??6]2;Y%6$QM5*V\T*;D
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M/^[&T9FIS&0%CRYF636OHPS.K.2T,CC;8-K ([+:>\:A_N0_);K(FK.H;]?
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M+9FSJ8$L<U2U@6B?I/'/#AZKUW^@OWE"BS)_N%GUKC<;Y8(@Y=+B +.UVEW
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M&K 5-'WA7ZJ8: 5;'6.&%VR=&*+0,,V#JW\#KCXIV03C^<G4&I#M_J<U-JU
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M.#WR_X=.3H; $;_7IJ,RNLZ3<CSB596]N_T$#!RL6][M?H(;LLI;#3J.-9C
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M<[A^KM\?1RN35(\,\4["/1+N%#>3X@;6PV*8DCO<KHI4<BW6=2 JX74>UV[
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M/UR)C)]D$E8-P)S2D'9M5,$&KU";9MQY.0P&>FU(?8<A0-TDE(PGR6Z\NQ5
MZD=)_4AVN:YOY.6ZV\;MGL/6I%%#(58KH6 R2+_+L'A\&*,2CET&Y> I,$S!
MYA_!@SQLSOGQCSZ+I"[$<&$R2+?L.V@NPY'&!7Y>0^)=/^ELN>E@-E.CK=^E
M^>ET6B'B D=,IJE]EQQAS.9;,3T7FTFVEX,+F;$QM4CJ!G,4"&X5$]J2R_G#
M;E..3?!PGN4\95G1:]7URJF?8,'X%JU8@!92QBSBQNKQ^&.?\;=O[I.<41*$
M5C=@21!,P 4;XU;OV?;]8"7E&,44,K24T41D+9@BE0$[EX> /?69BQ'8#A7H
M@C=AOMQ'MZ2QP*PX:F#?Y!F)B%>6JVDT"LL*<*X4R?,Q ?"!Z[[/EJFN%$#?
M!5.6,] /B+5(!5V!([1]GK'?$6L3?SFM;:HOE*=CQ!LD-7% _&&$_,ZYU[E8
M!L$SKL-HX>XX)R3.#<%.R//2P*<O/T&]90]F3,O*/7X//\Y$"#[0C#7;EQC3
M0X%H2.TW6$FNB12/ <""XCHHE$$T;1?V&)8C.[UGZQ9CRL7 JOA)DG5Z,?"M
M"(:=U8VR%'B*T=>*=+V]>!U2A42UCVZUDS'S/0+;83OVF%CCR&_"[5R)O@[<
MGH4_<4Q[5"$[\?NF]2:%?<14&(T(,B*T&"$N*LI$5]$<TVZF?]JS1X.-R%N$
MBQT<NMB2'>8;,5=(Z2/"_ZFBW%7T)EGUG+H2$!D<R6,P/G(B;[ )#O^41[]I
M^\,]WAA#O QLDS<PS-!/+B;FZ:<V_K;G4%V%90>JL30RQ4=MW$-33)0D-N(5
M*'W!5X9*W^IG":\'9X#T?_<W1$<MWQF/\?F#Q[B=Q_C\P6.\[;[BYYMG7G2,
M=WO/I!CUL D9:$/^PK:S89(*:?D8(.S17(5W139N'L3EA%);N>5L.1SZ(ZSB
ML -+$J%QPY=%.^Q3<G33)(5$6=V'[#]_NG.VNW.P#7M?IP@RS$;NKN%P$'K=
M8"H<#7^7WLO_]@MU#C@1Q/_IF*\L12 =/I5CNDJ$=8+=G&#MHLM\IP]SZ$B$
MPSM(;!1F)/E,85_V8BP%FM'6#?C&]6,(Q\[)PT;GPJ%T.E(S<0PT7!L<=:;K
M]I]LUZ$Z\AM7'6]!?$[](O9_0]%X95AF7/,?RT)=8I%D4DVRIO)YO_O[ 'G)
M,7>E_3XN::(GB577EXZPM&6]&/ARV\81<$60M"/OW?<\Z%%?V9V#BCGQ4LDM
M#F67_&0:UA$0UYF=FWAX3EH,9JV"N?NY)><WOR63"2(T/II+-9O+'$XMDFK!
M'!^,VWJQI#X=6Q1Q9#53-S )D]SI1$1)E?67B\N'07M;$U!W8-N$VD:%T$&:
M([$1'$?VXYIE-?%SJ4JL8&O19;9Z @JQ@@;1OUH2+K"J_1KM4EM@C$?7^JDZ
MU' SJFYR^Q?[AW&5S5<WNE'B5_E-K)YSHR&RVJ*<BU(9K"CL 9-R+I8@%_')
M]4+JQF'=.<(0M:\1+8!&LEK#ZRY!#[ODO50\Q8TKGD]9DQ.70W1()U.WM$)1
MGF$4[H+.$>K&[1A._2[<W*C"&83XF#:XRS5=[K;IEH@49M6YSS=5--P$SC+X
M?$8'=+Z?(KW4QYJ_"YFYN>,2SJ>6AUIJ.-=M^L*A9^9Q-$,<!<%<82:Y'R+<
M]C8S1:V)-@9\U%PAN.7G1Y?#F2KL >9[H,<AAV8[30XW0!V^D1)FS7=LI%6F
M:+N_ #C9DV66<\7[F<D54L:B3)\^X?]N!7A[Y0 7!1]"M?*XIO(TPA\2*KE6
MI W""SW<(+U#</I2&(*3P\!GV3Q8@>"V3"P%-9(9A+]C 8WTT<&1+FNCSC>R
M!,$GTPQ[/6(40#0P'5M\\5<;)9I;T7H;URA(:6+R))M'B8B*1#R]MNTSMXIT
M'G:V5-5ZD@?(Y- MAH%A*K# 79OO= 3#M9#G+8IU0E\A'+VGFI=)V-3?_=:?
M=EO&=%\\Q'2WB^F^>(CIWG9CK+Q)_FJ07*IZ7&(:^(,HI7YC3%N@]AEEC Q@
M76<$ 4TFNFI"2L&R\2:7H3ME4LS'(\5;F>?EA4"-QZ/7<-SB/X8 \3%'93#%
MZQUMCI-C*=8ATJ01=(G_0ZY ]"2FH#DK2Q@5M*3\_]:$*E^#"7(\QHJ$!*$V
MU3D>)'+3M%RL],'VO\,':)M-O+F<->AVQ>0)/SHK+[R"X!:[B!ZG,,L-$6PY
MYSFP5,6>A>-CQR]BC;U*57^A(W^=;<VJ,YDUV>^9R>W4-]@=-O=]^P^1;]JE
MG_P*)1:8DDR#\6B*[1<, N4PS.;*U*JH6.:4U'4A,$G]BM5$U9^:K&56).X_
M07#K\K.A)JW;%7&HN][MWT.!0!9]VG L_+Y$.FM#)+.#*]@!NU"*K%4>DO,R
M2Q7]D9;+"<$YL)R-O[>N"5VM]#G\UM[W*TC%@RWH1=)8$;L^;QES9-.,H!VP
MIQN_&;5P@1*,I)'8ZQSVF27 Y'@+1D^23LA@E^-:,TPT42Q3X-@<#)IG-=&^
MP.9,FBRD'.G=;# Q&^9\J^_UK&#=GV@%,U,/_I=TLY!@,%[ Q$6LM(B&;=9'
M[2]?BC(MO7?K5E-KC#J'G^UJS'L_F7[$O%;%G721T?JNZ0C_B!R/^AUV6T*O
M>"[0I>F2YV<*]Y$7DZISBGZF95<GR"SYI368<8WR-GVR!]5["HG9$)NR+U'5
M$*89[#[DZSJJ(L\'ULZG/E+Z@0F[/;A_007.OB:=P!&^<W$(B](=ZB!2;2"0
M5#'[&NNNB0[2K7%9DV-''-A$%]W*I_ZH@%_*CC?[A8A<;(*5?5XQN:TTP23Q
M-,,.Z8;#8"X H^N$Q8Y<IDB!UK"^KF&TU38:;%CB^$-QH*H@-;SA!ZZ9-Z,5
MUF#Z.D4G(C*U,!=86HW!89!_6V&GQ5XK)6U UK+*,#\'S1XQ":;+<*MP![:O
M6YYESZFJ5>+] <@AJ\ZN*PR#244(XK5^-UY#V&M346WCFTR>VH_^*#-4011<
MV7!B],SF7=OZ_JEQAB%6W&8D+3 )6-2]K*:N$*_FHESX=U$8*0$X%99DL?6\
MJ9;8H^4K!"=K63!L@T-*:Z:]L]N<(14M:VOC](V1AR6@569Y\:"M6+KZ!2PN
MJ8]SG(R]GRL-Z<4C$G<II/%!/F9L5%=1;(]PTSZN74_:X9=@9-)"EMSN"!]"
M>'ZY<UJFQ$8T]]%,UHZS#!'2Y:O$TEQ"O- 8$TIV793D+G+EN3X"JYKUA8BF
M1=;4,Y PPS9FD<W1,><_[=[BC;!EG.Z'ASC==G&Z'Q[B=+>D6@_)-#R'<;8U
M2N?BK&32AE.8&GOR3M%MEY8)05$#55ZXL!0J)00<*7A\C@$"5U?#8;*6E27^
M7H2X^!GLA))RZLX$C)!(O,%Z>DL- GH9#(X:C3LR1@6/U)-CL+RN'@,S-:N$
M&>%$DLR1'8[T..#4)-,;8&E3W2A(9.![X_8'>TF2BFQ2]FF80HP? D8MJ$D*
MB:2QSJL0ATD*B N0EE-.3=FB,;\UL:GF]G#J?(Z'+6!CFFM<9+90NVMYO1RE
MG/+BZ(2>$)LGE8.G:_PRB7(RF<XM/A*N(S:^N'&@PG$!%C"Z#U[CG;5.V#2I
M*M8+E>&(5.ZD9 *V]2QC(%ZF3Q9F"%L4!)NQ)O(<%K/%DE/\=#W1%&,1##O(
M<X33"F,5[1YM^59E]6?R)S*/(H6](29CFG!E6U((%3)L2WA+5I\9>:=I:R[L
M6!=Y!"V6$H>=>XO&L-\E;!J]7#?K*MDD2=J' LJ:M4$&BPH"\X[FS%6BENP3
MPN3-$,Z04?R5T4B2*7?CIJE,.,INVV?R;@:MBCXRLRS2=-B"4\QP3'!V01'A
M=U4T OLL)I66N<LDIJ9I=V%5<3'X4EBE*<Y&\2#U&=L.(WC6GJO(A(K$@Y?@
M.&JI(O8HCE .,/A*ZA[KJ!%ZPJ7;_RLIEO!V@<7'T<'>P4'<(3RU]%.P<S/)
MK?=,GBX8N3@UT<5("-8Q1ITI'^1]A7S^>?/(*Z]=T'CT+]0\MC*6Q?U(48R"
M!BW]%D-A\66'>+L7&QBOA012/)3"THP%].IEV12846\L4Z']WBE')CVLXZ<_
MN(_Q^4][JW'7/%N\T*S-S1MBH;QZC!NAE+N?FZ2Z>2[H!(&]IG[T_DMN5CU'
M/^Z")OEL.$%->;Q*SFZ+TT7V4V'O00(@#NR[PI6PN\4&1M7<)V2RS3?"85)A
M#OQRL+=W8(W(-:R(?@%0XZBNV/AF>;-TI(X,JE'^YZ9-AMP93)!?MJ'6AIJ[
M.L;60J(UO4R#_N9C[MDN 3<2(HU'O*N5#4G_%9)%$VD9Z03?WB9J9"0?88ZY
M6+O1I$P+@#_:G\B) #M"&0A\^F:YQA( $VDFI<!<K]X2MP\W$]/^\!TX]/9I
M%1I/^#2.4D1S,Y\@=YRO$&W9E:?_+O'RVZ^+M@Q*_?@0E-HN*/7C0U#JMA^5
M];_!00;Y+3!*?>@(L5]C$4N9>[#^25EB])M3D)8*B-W7 7[GT&!$DY/!8AZE
MM+#XQ,/<Q&QO!3TRD?)?\NV*W<$Q\)6V4,[U >]GB=8;UJ*6_[V-<6U+^]!+
MUB@ \F6M:G@K1R-X&7U:\ZFL(CQDQOEA[D&*QD!J D.G%O=/,D&N'-R?>(J(
M2#2RMZ\[[)B$N\#9J)L$+RCPH+2I08^E.J@O;[].4][D*;LJ84(-S;-&.-^E
MP(D(XWO9R3HC)?(G855U\XFRHQ-HR6V\; ]RQ]?,4L1B!A8.#Z0A5GABUA^/
MKF):I-S<9U)R<Q&,D$T'.QZ.75A8&27[+6TG7T6I/KOV)#GGF%2C3>U%+<1C
MS-14[L.II=E,@7$;RO$<ZW"Q<G;R!9PJ% JAR)2-:#A$@TVZI\2S1"ESW<6!
MX%MI9T.4:=:D/L""'X+HOUT-"X,H99)C1<1A+<8<M#[H3 WG,6F-BEF:-(D:
M69V/(GJT[@@5O\'U_3>@5D*R&3(SJV29VK@\V9D^6$2*$*0JM/8DV)5+NV))
MS)1(I0)\GFULW)[ESCQ\+^V[KN.@;V[\H']M*HYN_FI#0P%&ELI@"&N]DJR-
MXG'J..PGC"C%L 7HS$,HZO(72;.4\E3<+W"]2D*LH$W&FZ(CDYTJC<3,=%%N
M^+@,90:CI#T=)2S<SFNV*_MA?>]@ZS7;%JHLV_[GQD%#O?##W6PQ>YG,USIZ
M,MY9&##VX%C^R&66. JMS'4Q5S$RWX9#V' SP%OOR%W'!EK>:)D%*$$BV+-)
MVVZ-A>5U ;W*K#A""2Z!$A&#]\)]$V\AGJV&FBKZ@DZG&*<T1.DI<5W7_ME/
MM/@A&NWRR9D31U"CGR\YIY6VJO7I7CUN'@91VYMTAB2^M?_CTSW&&,TI;G,_
MY??\!N7W+=M_G.C[W8-4?O1:.@42[5JX4Q#/]GX=[E!WL#,)^P&T&H>)* ?,
M>VQ68@<95NNI4FDB/,SFF:2VTQ7/P)#R[#,:=8T8'F3E\C8COTYIB23\&;2!
M]=I2N2[O_;WY>F.5W:)4VX_"9R]2$J3,Y]2D 7F#(^].WX@>>!.,]48PH&WW
MTZHX&YS5-^X?2%_!:+"M8.QF1\IU+2NJLDK^3E7OB'L-(L:!Q!&<%SN)8W(J
M1^$C_ ?H' ^RH7JU31F5*0ERI_LT7I4[0A ?7-QN?4<K(T,>CWC,_Y;E\#XK
M5AC^.J*-K'':W06R36VXR&ZV)*O,K^N;$ JGMU4WS4+NE:)[4]9J"->:LTBG
MK$^A2$4/XMN5R@LM2(.QH*HLX!"D0,",MB0'_?$[WAB*]Y05"A.HWH#Q5;GE
M?" $T2-P)(2QI^I8M\1%*XRH W5 /S(SKM/TT.MM*TT8QU9#V.7I+@I6H'XQ
M?W<&;O_IN%V8_F#O(4R_59C^8.\A3'_;C;>+&S3>W*$!/N'^WN31,V>I#?"X
M["@\0SO<NVY\&QK:[6J_OYKTO^UM1Z%H[8I,<:OU;?VXB9UJSH%AZBA!K3:/
MC*4/);= &BAH6S/*?,8!&7:&?3?-%%%M]MYX<[M;]]7=1H0= [#M@5&9^F!&
M'IMOJAG9\_ T2ST/T;H_S ^B9S[!VF9!DUT]SFT779JTWAZZ7@+%[Z%[)0UT
MU_?-[>U[^P'[G,VI'02Q$XB)$_OFSMI^M3&S%B2VTT"KWW&\74/;<$'8SK[\
M<H<R[GUKM/6GAO57ZV3"$QYGWUEYL#:*,+1KF]1-8J*=EL%R62LF7]]&&2_\
MM@[*7$_E1.FE)JS2:)!ZGF:%@G8-]::0^<%E7-FOT@:X3);O-]:5!,YR(8]B
M\PSQ'QD6?C.\1;#W7GL%5*\%FWFM&%]?_,^3J2!0.5 &^-'[PG/C@/[<SQ:K
MQ#<X'J$0]@DGOG=@VRDRSZKB0""M8O:23$%@U#EEK<\XHQ))64Y*F+7D1S[*
MSA!YR2:(^GYKHQ]<V7[F,D5(+R=G+'.UAK[>V&Z+.'62(:\U_(5/E L_5.CL
MGG!2CE-X,**3,\P6?;!9:AH"N$\YB.FK+ T>1",P" 5V'13AB^7Y1\XSH @B
MV#J)E&6\:?6#<9KNL2621K27Q7J]^L43P.C8"?3/?WOE %^HP+O]W-UF';0A
M8MT\W5.XVW-X4\OYKU/)84=Z+HU6T\?[ !#;S5^PJ5]]1XEN;E??.4Q99GM.
MTYT^#>*M1EA/.9'.NT:0B%N>1\'V]X^BW6]7WU%;>0^;HG4I*\ JUWT/5=]<
M^H,"?>9* -S[D_4B@*<L)F%ZFV='UR['M6\#<N"G>^Y_G6Q^A6 .'>L$^[@*
MP6@E'WO:A6_P5&@D[2!*$V*%PFY&^+Z)Y-\L&"%LR"WRZ(UB X\^FDXVL>YG
M5=RX17SIB7 .B/?"S>C;*5CA#E[?1[V_!3H:V)?8(&78Z]SO:XY'O[I^FYJ<
M"^-Q.*O='N?^%+.K0-8-U=,1OV4*BVPH3-XE8? K_BY,CIPD0U%I05K[C1D4
M]HTE[A=G"%<0:LPKWU3>@J&GNM:YNG:SVA9",=5GW-Z.WPD48\M8X_Y#K'&[
M6./^0ZSQML<:O]PX4N@=Z"N$!9^R=:F(A<'F G&;R-<5I+F?/G A-1[,F'TK
ME%B_(3HM\7W!/=06:E0)@H>\*P5Q/=!P1'PP$6^:%HKQV4S^=$V5GHU)_1OP
MA%NN@FL%T=/2HQX%[S0A?F0Z1'0FAA$;?(9F;O*XSREUM].N1QW"9'3HA7K$
M?HO?$1![;7)9&]B!B,\\[_1W7Y=@]9CM_(YV+=!V9;Q$*R?BJ9.'G_/4<]R6
MR%Q[TE-S[K"<J4*LM#L?M2"E$S[(+WKF09U]>42V@9A;?7EK&[YS!I,K.:+W
MD(CU]S+:?_KTD 4HIB3D1Z\\ZPV.]\3BS$/#,?;[[4HS5?FVH*FI\E9(X3GW
M*HVC/Y>@6&88YN86IJ4P@-//KK.ON]_'DJWK@LJ2:-]?+AL;TI%WQ!X[D83<
M^MF],8X7: 6OLG,'^T"C-T:4#9GK<L6;,9A@7:%VIR[2%<-](U59"&'BD+)@
MI@_:)I5IV]@6_Z3;6>,U&[T"WAW.OT,UP,X^CX;R*6NQ7^U7]&^UVY\=OHXC
M<76#Z;<31$ 74RTB?940T93E@2-+, D;HP?,68&2=6I7&)*YP=X:N"#!:6 &
MPR/#5I J%)!A-LU&1*$%O(:=S:D>AVZE$^<<;>?6X!U8GHL($,*N&$0ALI!C
M$[W@26<O$>5=IU/IP#MLQ4)J)I)]U!Y=7C-SIZ<1&T:\#=IRU;]P5_K$$$!_
M674:&@Y\H',+A3\5E)/7PZ>>4^6PM%C%\E8F#BF8170]Q0-'P?T^"^YW]U5^
M#]>"5EGZ\"%_FFW&1V) ?1272$VA-_@!*2LN?B=V>5TH6'$HT\)@_0>W*NI[
M-'.7R _)>9+E+4[)..HV3H25$L0-]2Z?Y3!!;<J!ICQESB ;V+&R'F1:I+<2
M@<YB]G?9*<\S&"4="4QSQ&<0K:WL.-O7,)A/O!KT+K6EI*Q0[:PE'&[LNCRW
MZJH29E125I<^8<<Q^#+,'GE(!M,]AW#O##"N$!R+KJ/^Q+)A)F952CV;5]N"
M Q2Z4-I5P:Z(=G@RT+9K25>#427&?]EOD[;S.KX5Z8VA+\;W[?:!*<-V8ES_
MS.&OL)NXGM$8K9#E[06]87")S&F0O.HT*;28BDB;61SPGRY-/TF*S]5RT4Q7
M4?<N[+]M^;#_ !5:IYD+-F+(IC#1"COP6.WKZ_5U$(W+T4A$I*#@.YNS=NY7
M4[\H\I[Q1M:.;.AEH?\Z+G!E3,H%6+V%XWZA/9>ICT?=2O_.Q;2^2*N0$01\
M0_\7[SXF5@!S,,&6:'T59_Z@8QV,:Y<21W['(9%'.J.TX5"\IM?0K3>GM@R
M'3P$P+8+@!T\!,!NN[7_WS<> #OZ>'QRV,,:,UOF<,)@_H*"5V!<GVJ^3A%J
M[F@A]M?E'&X2%8RZ.,'B><[1N]J))WL'JGW_\?CDL25P@K.C$3L+ W+$;'VB
M,2Y;3//BJ=_-V0[=YO%=&;R+39!=MU2,,A5F+BK3R*^-(Y-I*>#QB/!8\CH,
M&5@$0]"I.OR\G2>N,H3&YRK;MQ]45EC:,3@+7?$I%:4KBIR,G$IMM\BVO6'R
MMSPIOI:XIY'4%*/5_7X7(9O/MWX6T7/)=')JGYY^=$[%XCRU.^'<[A_PVW9#
M*B^.,+3.2@6G",G-!V_!6D^51SIV-_^<GGK-R."?:L *ET^K"[J)/(JR\>B-
MR[<3RV%!!=7^Y3:J:HU:S^=*HJ;*3D_Y H/3(EN,@*.XHD'AID?RJ<G4;I5S
M3_,A[4Z[(U9*DA.&I&),&,5M>*(+UX$N2=G+ES)^L&'H]&AXF+MLD5*9R<IO
M\8K>NU89["!*Q2#A'CX7[7.-REUDM=F-T0PWN=$VU&#B5]1&#IZ#U7541D@6
MCON[I:@4$>AV3[$[A$!3?B\5QRST;R<1^@[.I22YW,&TF>HO^8+U:>">;=M?
ME;:H9-A]I38S*3H:,:>4XR@OI^BN%ZEV,X^:Y L(*3B"15\\E/HG6'" 7Y,3
MQ%SY1GT,D85A&ITW?H6RM:8E&-=\N?HQ:95@*;HL=9E7!D5!)7P>#!\^OSZC
M'F6%*F$9AU"I)=2W3,$4\I96*D9+R[XTIO!*RX@[-:D< WU$[6):+2=:: [7
M@Q/F-EFFVDF:"F/5<M!.S2_9&:H$O1OR2=A8D:=RZ*'NBV!.I(%ECY]5=MM,
MWGY/YSJV[&1RS5OV5]Y.6$-985P!''CFJ=ZF-3O](H33L+3E-',I1&'.#;*G
MDC2U 4,F(@:W/T(<4*,@5)\S+E:>.&0UD&/!(T??)#5Q)T,;</7!_A?61!YD
M@&AV=:4]#_[)A:.IDP9;'0(()!.:22:619Y<@!G.I[N 7F%$I]D,=0@YGHCB
M":E*[%W8=1W[^*&AI.6X);$"PQH1>5*3G8-A\](+$=NLLWV*GMYPJZI//#Q!
M"X!D3J-39-"5$5!\$+EU2I\PA5-6,Y45_V8W%CJF^>)I A,'ETJ8OS4Q+_WH
MJO3^DL(:-5)U:7]]_>&0R6 LLY"7)POG2K[R?BJ*Z?2:%85 R1,MO ='DX\>
MKT<D-EG&*&>[-5"8(C_$DX665%8T(^X&_%X\6U ,@P)^2@EY+&&SK)K[>#S;
M1J8#7W5[@DLLI":!G>$%N+MEER.*DDM]I%R*E$#=Y:JH6[F8\>BP*) ^_Z/P
M+DE8=);5N$4H]LKG9_0&3G3DS!2?D]FOGX8VDTZ5+6SWL *,$*B9_]H9!G;L
MXU%0I1 .VT</N&J5L":$57WQB"P!RY9#2-\@%;ZL>WSH_;W#G5/K17/2+6 J
MN)>[-$VO>9?^OPB#*MCBHO;UC/#__Q[CGKV74V[,PY3?\)3/9C<(=WC_Z^%K
M.9#6VJI]9,:%U_HV2.P%9]<Z<S0.6KM:P)#-7Z^Q($->B7HY^<.+@U%8M09%
M+B&Y%(.S<B**HI=&G/ BL>&C0\8!"!>J;1U$S_J$\99EM4)2"+#3.)CCHK Z
MBQJ$=15>KD)0:@7Z;6DJ\ N2WJU@&>/-<E-PCQQM0>:'CQA(+CEYQ!%2$-0F
MT<N>3N"\N-SN#X-8F)'$[RL80!5X**4V[(VY))%&ZQJHR<$IIZL8UIG#7\E3
MOG7)<(9O_Z&W9;;NR4.V;KMLW9.';-WW$1L]/;UF,P'5PWCTT?BMM?Y>YBFS
M5UNJG74T?>P&8/2=RY02UCF5D8@;/?-,GNDS"'E574)Z1P=48+#_\.,+QX0G
MO*<?,3&PQ*&DAG-W/SSWJ_X[+&E2REZ7L$DK7 N7C@CKJIV_A%Z<J>^I/W!V
M=LU2]RHI/H]'3LXLK^$6T;V>%H/PD]>[)ZO],Q"?@:^+>M[&PO/L>4Q,+,H9
M$=1XPUC__KHG$5QZN4DU?5Z5297B,W^CR%5966OC5\X;@+2AOVJB$^8;;[U)
MKL+M2)?Y;[WLI)07C$IWW,E#P4>_%=!XM//LK[N4?"LK:X(&@"C&W(LQ,LT3
M1D"=EXV%2V4:?FLNX)&K1T&OH9V#GA<T):(@,8["S>&3\0@!9FI7L;D4:6.B
M]F+#>@VO46LEOGI:R5STYM5\P88W"&U,=&YSAD+.<CY44198QP7DS[:%&I5$
M?OWG42II\_?=2_V593<.=?F]+) /X6U"675;Y84G9M LH17*ZNOP4!DY5;6+
MO8=Y9EAM0_/;QS5H@17@2]AH(7.Q?S9FH?!3IE_'?_75V[_F!#V/3[TXOU^:
MA!'Q?@>?V0N/8))XGI3<3@H%+I?:DPR^Q$>#2H^*-9V:/$"-TB%H^]'2-62D
M!\3!C?#KZ3)+38ZH;2R^IQ*A./2&R!$C) -Y1OATEX+ I,8I3<K.M*1NI*#%
M<@DA.Q5.8A Y*8#_O*@[IX=E:HT1L\PI*7$H\1YFLF$#6S(XRXHNZAE/K/T.
MN%YO4J869Y!4DPP1LYPL+?-S]2+7R9]0T;1"S[W?Q6T;BE3A$QM#%LT9=:8M
M[BM7\1]_W"3?W7\F\\7+]^/1_T%#%H2M2&"C2_[T$/:>S\#D>%K$(/\SN(D5
MC9$Z!^/1=;6+/FS[0F9JD_Z%?&"U(_H^>PZHC@M#X +&DV?E:94LSN2 E(:J
MBD>V]$8#A'C8:6,#8,)CT&D["ZZW)P$2J/.&&CC^G+6+6^DA_@4=;MNA2;6I
MHF#"W%Q2CH<& SI=&@ YMA?[>3[40;[N?NZSSY^O8I]M!BE@UX#Q2*U!YR9O
MTH-%Z>7I>SMR;H$@<%E$L.T)E3>+GOVU;4JW]R?67MDD9FB>>]EO>J+%YW%1
MVM<]$+OW2.V-Y^;O_[#W*$U6KHRX776ZE@20V^3:L+?ON-@8MU2I*.R#H)-L
M&L%]M&#2$S",9E 8.4G/,]G&@6J24Q(SO;7)$:*<J7:H13UP5T>ND.<XO-]=
MT&NHNFT(G@P >4/1ZNSJ("T:0D87PO\X#[W+SD@0\[[]2F'+>._3AWCO=O'>
MIP_QWN\CWIOG-YFC9%WE@IZO*3J*71B,F(GH?+@_1M)60KRC=(E8?NFV9JR]
MTN?EHNO%>!!;AA_P68):^ZW,33$!10D^$85KB9S+(/MALI:GM!]Z&G"#)I9P
M"PPD^HO"4QIF,[O]*O$ZI&T^_WIIVQS;Q2@H'7-OU)IUL1 ;(K6_::^]*B-"
M@)F"B&KTV[&/()=GRA'F43?R X7!8QH&6-S]U3DW;*E!R^.K^7QT1C^*@;2N
MUB:8^I">L0I+LB-#[C:>MF5"+HSA-9B65D,2PW!E,!V,4^<AKB8D: MQB&48
M2=U0#:T<_L/C5[X3IAY/-'#A0D4([*P:KQAI#;O(-TU *X;#4(#-GWE<6,RV
M=OV[VNXA/) !)IU$)QFIZ?Z06$NOI"FCQ>#<$WF%Y4.QT$(WX^-1=Y8WSL_=
MU%X]76*NGS&I9^70[3B' :=81N%ZDB BG.L1I$*[P99[9XC;\+4)D@75,W+9
MJ&I\41;J^?<5;Y$GPO=(=+$=HFW5/#XYM#[%NZ1.DS\C:5/E\^;HINSY.OCI
M;S(M[8\95B3DB:7E@H+2T?0,W WB@4 WR'[P=J./U@S^\1V3Z/XCD)MX]4@8
MY90\PJD;$[-N'G[32GV-F U\TZ"T\?QTQ"UZD+9OE38L0'73F2<7T01]7LI)
MKJ3\;&Y,TS^I,G=4]B:%;%+:)24V=6"GW;%9W6!3%\4U8R=>K]" E?)U@9C>
M=#\U*@BW[^08.!8",,_D.M(0CV%DF#Z$2+4LM319C'3B4#:T*!U!)88F,!>A
MD$IR),IY5C/4E:AH7'V21^#825NT"52\;LM>Q-],SXHR+T]7DEJ8+Y:HB+A]
M/")W37-15I^IOJM*,3*(&;YRUM!_<I-KCVY+PIZ) @V\KBQ3$,%R#G/BH+S4
M1!M=!OKK.1B.FB@@M_<L@XV.<;\5/U/;L;._3KU)_$JR#-GI<6,O%)'@?5TK
MQ^GRF\>?!+O"+WX#+^ID-RV/=Y]'$Z8:0WYK[@%)7F#L@&4]Y$9<O\YH%F&(
M\Y(Q'KG8A!I^,.L6P26D>CP.N$O'HV$Y4GQOSX>_[.<_Z_U4RNH[ H3^-H'$
M2JH>(9(F:7\5RIAK^>T?R_14&C%0W!)3W<,I<P7F: ;9RPFW\\FT6^C.$OL,
MV;1R[#J.6]"*<! 0,0#6%7D<'L&6(Q>IRLX301,X:ME9WY0J;H=O*QLCY >:
M NR[A4KYEH47AUK6ABO^L>\\+")QO<(H;'9@7J8V9A#W*K(!\B.L#K;L1^MU
MV,L65]MZ\:!G97/;J"BR32)Y!Z.5A$ C&HX5<!A/G<Q@S8@.A2C/,R5?3W4"
M27QM7A#[,&1XGN$_?-VFPV*23EIV:6Y9(N']PI(G5"8%SS0I6BO*!%\@G[T[
MA<O>SK]Y.M \62XDJ5PGU%L982TPXRM?<2'C!2:C$+K&QDB1@B:%BQQM#,^-
ME!/??M=YRUS(LX=<R':YD&</N9#O(Q=2EM=L21\5YUE5RO&'V#V&:CV^XICX
MMQGGX]$W6N<_A8RTOIY5X$Y?PGDMFY.'EK$]C05F1W9*:'5T+  ZD!O$?O'G
M@6E;:2<QF)-%62?$+-J47[(I,0 )6Z5WC'$0 TQ&D^3-F<Z <4L8L'?Y*XM8
MM<!(=;PL803>YYOUC;MB"U+NUO'E,:,DTMW<[^$=XOA\_)YOQI/M1N0D%='&
MYDDVEZAPC^BN-3@&5SX<*BSK MNJHW$)$T,<#\XJ5LY\KX<./3)JIS/ (6TO
M )DG F0-)IKA%5_')D886!BGM4/3++!VN4*//@3\+_D0LG[E"U[ZQLAFM(ZP
MJ7KMMI%7.7(TS3(?RAFS!MM!L&TJ*)0.XLXR$_)?XM: #UI61B;-Y9RZTRJF
ME7X,C-66W C-FW:!9Q\+D3UI3.D,C&#CVDZGRT4FR#X>_Q80%?M U^(@\E-*
MH(],A;0:$?9J&N)[QS=4Y@R)B<X[4O,1UAP6%53':S]@"(-[J\1I#G[\0P _
MCG:>'E 5TNO'80CPQ^=[^V#Q-X_!;OWS\:ZO,UX??7S]-JCTB%T' *H#;7\J
M@2:UN1*UI.KD];BC$5:8$E,4*,OABH/!.09ED\Q;\[LH&S;BR1^@B2+F/M(<
M.MT\'/ZPVV_H7H<-L5A<LPUQ7"6P/B=:7[MU_9)#>A+<3X">6Q=^MZJ\XZ#&
MNU5@/, C%.!=37$*CTP51NJ5&6OI,(FS2TD&.S?"68CL),3:X%-VJ1"-O<F0
ML(N.:MFV!WO[>QR)#!_@MO6/SV,)UPM=UQLS(V5^*.X^ZP2\'FNG?V4^D_]"
M/A-X^('W\$^$/<?:*CR"U.,]68'NC?Z^!-F,/G(_#C>V PT+'C$S(WSH>VHN
M-A!41*?@M,2_M^)G0E5/AS"R&$XPD"":BBFOL94=+CS\;[ND()R:+:OA47I@
M(/CR]87QA,KNKXR/+ET8WR:^7E\0#T-I5\1'/07Q)*J":MQ.5L,9O)^*\,\_
MKUD1HO>"R;0IVJ,HE](^Z:,4Z&BHF&$[M;M:0EUTL5;S4 "[30XT /;?E,K@
MT0RZ2^0'3+0;"8*P847.=6/6Y;*RC:S\G2:T^<J_A'AEDCK:Z@+1#R#&&.QF
M))L&[_"M&=&QQ3('*1F^IV698B.1YDS:MBM*IZPNDBI]E)?E9ZVEHD^P5+3=
M@NI.#O3@A8,+2(N=\/?](U4$/B_2KE<APD2IZ[OF;I%U&H^^TK&]_1MWRU#=
M\X=0W7:ANN</H;KO(U1753?92<IO#D_F[N^@ZQ82?/HV!@&T@:FA+3=:)#LJ
MXQZWPY7R:GV4Z@4+P6^IW-]SZC [G(_DLC'*N]G$I+V9.W\H@7?Z%4^U-\6V
M+[J;,&;2=O-E@8R5T#;)E+E&@ &MJI_ \R>WH2 )FOOH\#(@)-=O2W)C^[_
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MM#(*D\P:2Z$L35%3)X ,&=;(X6:+5#B%A&;9ZV</S@F2N%>P!Y$/1P:]"*U
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M]$F -E78$-<"ZRJ;?J ./XJ?! Y3!=:$TP<L+PTM,5*]4IY49IYM4";I3L2
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M4S+!Z M,N(Y8?'HUQ3KL//H '41S-IT[%(&DH#-DS6&\T54_%."$1!#2;)Q
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M IE.<W?7MIF/0&9C5NG[:TDM;D(5]B-Y(,Y!"&8S3LF!G;-T_5<-6,:H+TV
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M=HT*7R#>3@JEWW":( J,^.=1655D.G3\D"*$>'<@,L$'@FM+A]8_D:)99@W
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M%Z?,AO7->*W_!A74_&5G-[:CP0_11-Z%V$W7F;%9>O ;GYW5%0(:$]X@+2^
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M^\%PVBRIBAS*MY;C-SXC#=KJY9CL7,O0FK/W3;!3K1F!-NVD^&6>K*YD/UQ
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M;FW>2PK<+OB1T(:X-/PB30#\B/V0"*7@4$2$2,+# :P<O-)%NAC;'05WC%8
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MVZJ@0G)SASAVNY:334E"YXUHF#$M-]I<J!*:Z6?(Q(,&&892A4Z&3<2*8M+
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MA;_81[DWKZLKN#]&.':*'TRJZQQVF_]-%CJH>?@;]DWAJ9454%"BLTJ.D&Z
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MIG"*>;5H$&$54PK<+34!(*?RR@.F2 XQ^1K^<08;4A/-@%2<,;O\\/!O=UX
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M3>>VV=-0 ):S4_,C+]VBYIM?&0EW7:X3O+IJ3&]RX/!F7DLVNOHUZ-_I4B+
MK-;/Z37AEJ2%T)-YZ#6"D:E'X2KCS8>%W5E8TW;9U?8OQ,+O,)*2-*67FEQY
MXRTW;#Z;^I[LKBF&\[S9W]PX%G1/IKT#.GCLE"< I.KOD@38QB9G@+XI-01;
M^(  /9.*S8_BB +NO!WM8,2NO%^D2R?5PJ+7T!(5O!_'&T[RT0+D[1Z.J"P1
MO!17X[ZP X,GE=,22I.9RV(<E"%LI2XK53LZZ-5SXU)X%>-*T+_,>.:U)M+H
MMJM"7RX<,M %W'(U\8OXYV@X03BP[E\_T)?!:Q!RNW7Y@W\S6V#_V*DX9;G7
M(?EEN.8<KI-*AWLO4D>S;BBK;(MT'&>K#RPDDQQU KOO;/Z^]4893>MUKGF1
M'4)).F=WU[G2S^?[X_^]D&YL#L49#"U#=.)/#&A*4:_S&(ZOP\(WJ#!V5'9%
M.L,2>=)G16-0O1JG^=QVI%,F^]"5,P)>=D62TD0WE05.,Y;+\HOVG:8LP,::
M=VQR,5@X&(&,,B\=*4S/OD7[L!H_G,,(((1TPWS'N\8V*N)Z2C5Q"5G:*,A6
M"[!F!TS3%OT[R?SD=[^J<"12/7DI]X0;!E^'&^0TR#W>Z90FM$"HFY2OXY*=
MGE:Y8,02:0@P0-(G_P]\A9D=E*=HT"C\?%%3!\##N"D[2/\>*!'>(0V&D4H$
MMZL%F^@M;-/O^#"F#WRH!T #^D031*((;.( W5>7.0&<48XZMELQT_BP<[Z#
M"?,@QQ4E[1TJXFGR"A3\;&$^H#'!""F&=S\JZQ>._/'_?IAC3<5JD'45&"P7
M4Z4T<3$UF)SKJ0DV-<=ILHGH,_6HDR.M&)#"_IL;WN =)Y(5]_9>)C39LLE,
MN,^'7!1WOY%2)N.1&QZ:7TENTU+==]0Z@:;<P;?,#%!? (-!G5O)2BU(E1>9
M1Z/ =X^(%G%Y7D8$EW+4>6)Z-5AD&.=D(ND<X65R1N^RW4MBVNDM9H$UXQN/
MO\4W[EU\X^U)\NO;BY/C\_/DUS?'9\>GK\4#J0!"8@E1A)!:EG;*/:1LS<O3
ML_#RB(&$[+G,LUH NN!N@,'$9? 5V<)"$+B0 R$D@5_;CT@$^\GZ,Q"R'H*J
ME<T;($#]VP.BFYO!!XBV+H[,W.&OYL/D\!2G?O+7!X_-/-VCG>;CEB?[L"G^
ME?.,@:[=BA+Z=IS-BNGR^4V+Z8[TZN7AN^.#L_.W/YTD%\>';TY.WYW^]/;X
M'&9V]O[T[.#B[>G)BT>O7DI9A44S^(\MWAGJTR<2$,.SW3\_B,]MW?GL)S+4
MDS]_R7-YM7SN[GAG7JN%K2\?5L_[Z?=F"];Y[Q<E@,\Z],_Y^9<[F)-LEC__
M&LQP!_?B O7'K[(9_P')<&OE\R_G%Z>'?TLNS@Y.SE\?GZ4)(:S<&XE\>\CY
MJ\O<__!.W9J-_B9#UY.AMQHO:DV3\LDWD_(.FI1#BNO0]7-0EOGOR<%S!R;"
M:4?G)JN<L5M<<;?YCKJM'I'X>G\].(-K]@),R+.+MZ_?'AY<'"=GQ__WP_'Y
M17)R>O'V\/CVKN@&;#(0-=7S),1K0V4B=7K::*LT]+7=#.'J><G$5Z?>L+N\
M41/!X)>&?+:P]1_\/_V3 @BVAOP]8_@[Q;E;LC?Z@6Z.>O.I@4%WW"YR!I?R
M!'!!4KQ!6?5<1ZY5\/$.9DXK!:^$6%W%3A$O9F58+.A\6EU_0Y+\(TB2>SOZ
M &D_MM*\>_H>7HH22$ 0S_4WL?_]NQ G_P<<V^/>8X.SB38)Q%8&Q1A$*TE1
MC+^6G?->XX"W5Y[PMV/^LL?\Q#EF4XOEGE+9.?Q/8<QO)_7%3NKIRI-"K86+
M(/N3J0=:&!L[JF\G]<5.ZME.^$!4U_J#_*:-8Z7751(W3;A]":A,WIG?,61F
M1O8.-<65A&X11K%BF!7.H$W(5U3KOI")%J1HW'0I?EO-M]7\SU[-)]NW"K?@
M9+Y)J;@%8$CCZ9=.MVM%3#*Y^*Y07ED,I5*^<4K7*1W!X/+E@@181F^+OKM!
MC&R]3)Q7Y?_$/#M),HH,*I9R%X_(F?LM3O>Q%!"XJHD<.'D,]NQYLIACKF&&
MR0S_A2D !Q<?SHZ3T]?)F]-W1\=G_VW\TG=AI6JAO2VQ$33><5@:TRYO-J7N
M*G_#Z;Y]>6[ %S#_T_8WY,\KSKL+]^3%H[<OGV]NW(<MT&./+?W3C_YNK)FB
M1E]NT7=DU4<@=3^/F>_.>M<,JSW]%E:[W6&UE79W;[#M^'<"'^!)[#U<(^IV
MNZ-L:U+SLV_4?.^H^;]N@#U?YNB)(*I_?7KV,\_T]/7FQN'ISS^?GB0:BKTX
M35X=)V]/SH_/+HZ/G,2G_[[S9/_=-[*_W60?S16@,D"BVTY5\2T5QI]W%SGE
MT%]W79^4Q;_^2[U\_YNS^'MSQ']X]N<'+W^&UTZF%C[Z8#0K2L1LY#P(V*AD
M"TQI\_U;##%L)^NFF1%-V2D_,RG9R9]07=W9W77'<++ENL-^4JI;)RD\0N@]
M.8MKO)F)Z/C_';XY./F)W HBU,]!GH-<%TE__N;@[/C<TMD7F.@=VZCW0#D_
M9U3[>:S-#5QWU-8"C/9I A9\)K6:6&=Z='%(&YJ<$US*]N?/?"61W>K8R/K^
M+9'7[X\/WQZ\2T";^.7MH4MUM]S1U>/*/7=A)KCZWO9^B93C;VZX]?AM#>/D
M#FS$"'N1*-1$BLBOY-)]U.:"OS:V7>RX7+JAS*=100Y3OWK?/+A-@'12-4\^
M5?;F:AZ3P*(JS@I"2SA%J!/8AEN-^ORI-'CJP0.X, 5WF1*Q\MQ"C\0A$!A3
M"P&6X4_TZ1>=!C&)Z0]#D! $F@#24*A 29PA#AFXR&VJD1*TM'1*&5'; Q@Z
MKY=I,@:64$QG;;O3F-KD='-C7C54<H\/ -6/[B+ &L=V_"TD^$8"EC&,6V$#
MNJPN$(-7 RP8Z1#O&.,@U!Y'>A7BVK0D&60-WT5CPN&M\ZL")H_P8(+L<<OY
M=ATK[?O]Y)1ATIXG[[*FO3U&V[_/@GKTZO3H[Y@,\NC-Q<_O7OY_4$L#!!0
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M_"7QQ>><KR<HB'%L-'SDGR!$\8$,RXW!"J*S)S,64N=&\#Y2/O^ITF"X66%
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MR\";C/[V#\5+_C)B_D2<R;SX<B:!=S:6NYE/]N@ON=V?=M-?@/\74$L#!!0
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M%0Z&/A0RL)#YS<CJ7C1VF:_++)I(.,X>_/+PNX/O_MRR:]TZ<$9#ZOX,&]Y
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M,F.8/<8[-BM^7Q4\ZSZBA)<P<1)FO$FE5; _TKF.LF5 ^LMFZ3PM:O6CI"[
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M6IIR4JZ*F42GO++U.M&4O Y9&:Q0P]N*QV*+H#<4#.S+P_86M()]5M'["LX
M1-T>Z'7=15*P*ZZ?2'W1L_@=:[U8-)V[6]2YV1R-,##/<<_HAENB.8<RU.G
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MM(:[)^]%C2V)RTP,SP42\5!FP43(7).%UA97O\24B0^RN'']-7SED7V.^'/
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MRVRF<9E9N9H0F1IX++GZ.(Q=F)L!]#]?B(DMY$0ODBIW4 W[&U0CXMIPP,T
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MR+6@J9!($/>#\2B$L.\30<0"C,OD?6J7Q?\]6Y')F&/LK8WF=\Z[FU 9M*>
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M!H8B?A8"S91VC?@I'?J7JE+E)FHJ\.V0BA9RG; ]$,_HDR0G#H/]N(1"</M
M/$0[R&7ER@;:QR)9#EF$3@G+*!T@Z#\^9J-9G"PO@3,GYJZG\2@%&ZK@)_Q>
M:"!TPVE9Z^F,:HIQ&F7,)V_8$]89X8:^R5;LULQ5&I@X+@R8PD?SV,"B3#&S
M8#]*T2JQF[&,7GEHA[>W8.X>I,%93 -_R"Y::LGJ*R5,E0_EBGN84:G'DX>5
M#21L44B4WI8>_?O$^V*F,WF$$@:)U@;T3^6L%7JGM%JU<)!DEJ+"%#2?G/!(
M<,F6C M<B1N G]N+2H'Q09 '_(@"A,"V\1.K@R\0/M&0HT%K._59"ZR+!$)M
M.PCDTHG;!)CPJ*S= \*-%J;8M# ]V=^[<2]C!^^)0N&TI_"LNH4%'[4NB/"G
MD)6'_1BQJS"1(3W[1$<R.5[5.%?!B9IVC%M$Q0%C[@AZM\D$)GO A(MWS$53
M^HQ+'S[CU?,9[RXJ3Z"B^8 UDZ"*7@,]DV1TLLC@B7 /E\@.[?%LT(@LVX'J
M@\1#I&C4\!J-!ET( QZV8PI)AD=((WM";D.9JD!2$/!.09BF>_>0+:0AE&>\
MV5G$Q-3&$]Y?Q;=# 7-$H7L2*0L<+])[BB;,'M=$-"MZYE@2KL]K*7C,Y"$7
MH7M:7;J!S".R4M@M 5* RB=:G1"(+<);D[39GKCU^U)7SI-'A*\B/]-(R3BZ
MU'(-K*C0[J"P0Z\OO*2=W@/XV+'X,I\1J+X,CF+L2%8W57_@^O650-/0O0%2
MCM>=X3JZM*(<%PTQX/*2^S)&$*K_+0!!='LT(%&]XQ-]MB-@,;'-92AJ?6%8
MYZ:WON;6V)]-[Y(%GF78(LDPHY,B:10<R;?@$5<:N)X"8O?&B6E4ZJQA>,$E
M,RK?'/?"-JNGIL\,I\J,4\_D'X.Z$?#?+UF%-^FYO$O_DEW4+?[BF7%)W1F>
MY9OK:TVG:GK\!<NGE\],3@3_Q;:^F38GT&66<^[:YR9OZZQA6Q4C,*O85]6J
MU:Q*TX;'_:;I;POY4#1?J;A>U7).[4LA\E@.DF14 LMU^#HUK:# 7(\U/+=B
MFO#H^IIXAL^-Y5<M?)*5/;=Y6@]8^1*_$R,_-2S'IT&Z09T/ ?_.N:!NXD>+
M3P/.%,P0DH%$6T[ !\B;-6P;GG;Q!3YP/BS>G/D=OEY?:YC>F17 2*'7!HZ[
M;)O,-BZX*&=Z)ORY[+MV,S"AG:;#9[IJJ8;%B#W//'?A3>K<_-[P3-_GOR$?
M^*SF\@=@^H$-H"M@BFTJ=+X\>$X*J,HZV?25';N1YG'6,,EU"XJWO]\Q32GU
M[7U(?:LF]?%#Y\(*'+XS^1G)][9;*^@F6YE]3+)6*\3:M'@O:KB(4A_/AM]#
MY,,P>4SMN^3QSXIR F48\KC)"]1! (10W=9X%R.^-L088, 3R%!7G9^ONW/'
M]W"6:8HY3#/"'-AU@$<C8-'Y#:/"S]H_-HH;^'O#J%;E[S.3]Q!?#^[@T>(G
MM7.@M&K8[7,>EY\VD#5_#SS)HD&5WU1 B?/'QI[J]B>8.5IA(L?+!YC+(?,T
M#5=LT_!\Z]0AR@*S4G=<VSV%JXE?C@W7,^#"$-?F[SM!51O#$W33.CQ!NER7
M:1IZBPF ]&@*7R)R0,XE?) CNN/2@?/_>3DKJ4M#4XU6+7UI8_:7%_7"Y,']
MBI4I/QX1?9+*/!;,F<N1"^PJ>X$=LYRQS)/LG?X.D5?AW;79GR&\7HV2).I-
M&L@J[*5*$H4]D*[$81*U[MJ=I',+5T6ET^L* _/T>RIW$.+,/?@TKUEYKL'Y
M39##F>%HIO77"=S[NG@*:?*0=8DVG7]?Q+F"^-*\EVO_#6;CL%C:(Z),,'M_
MV?.JE$O&7QG& XF?7MQ])4LOQ>X.XD'R$NY]&XZ]BZ,;L504'L6E5I?R%U;W
MP V&23\L$"GNCR2\XV^QW_9W]_;>+T.^?2M+M:3&0 3E' DI AA[,D]_K.\2
MK:\)X:-'XY+@$XLXG9JHFTCF:8O(JM%(TY+W _%)3*;)="!G+J8(!N'/2;--
MB X*S=@Z(BO3RG'C63QHW46 ;@3$^'%R%?7X?[="\0KO.0G?VL-NE]EV8V[L
M^O^VY_?W?B,ZSL+K&' NC)_1=H&5#C@OUI).9YK3_&-F<Q6JZ('HH$Q,!8&Y
M6RR62A^S.B<9I)Q X?-RV)M*=_^8TY?=^SMHHSYY_XX*Z4O[MV>>&1;Z9MT:
M:QBG9M9UR6RS%K"R;3C?J!H,V)F-H.F9]' -'*M-KU(W?-Y$S;5M]\+_S])[
MW_8_O&]+Z'U33)UR9)9=?7#$*W=)QE.ROJ:Y2IAO5IJ>A<Y]V58:MO".V7L.
MWDC*QL.<OO6U7^^*9,H3N;[V>E?DY-E_=P[&:4RH!Y_F;=W.P+=.-A8JP_#D
MR_H%[IS4I+\WUP$:[>N>%#C]UMU#V!O\-]66GA>-<L?Y[!]G-N_,U3UJG:3A
M,GQM#;7[I,I(6_ QL_ 418/3<33%:%^ZU/3@%&[,)9QXN9G2"4_G.G]?S7L7
MK>:\HA?C8V+G/[&HX# 12S'QJ'BK69[?V$(\^/\YX-)+I]WM;[<Z]RM\YAM:
MP0Q'Y?X]<ZLOY2:9.*'IVXN9VJH&(:%AHN@EY30<7J %:ELCG 6";_0SE4U2
M0_5\%^>)=5@:8X4RY?@=2.^72L@C<X8 70<)&$'X5S=\Y)^M:E9\S80?-4\6
M$7*_D#!^C%M;O**C*S:CBL_,G3ZIVRAA_A!"2(2%(HENH%W21I_9S-),>,7Y
M&DI,M*^AET[OB/5NKS9+Q?U":>^P4#HXV-H8WQPS:VJ'NR-A*4#J,>M"*D_[
M-C6M8+P4I;@TV_$@DY1#5% QDJ/\33LS73!YN43,<#241\]MJ9U^HJ-N]I!>
MF)R-D[_3X3)[OP<O[ABS0C=.#@K%8A%^1BF874//G]^\X<YX&3W-OQ=W\2!Z
M%=-.8DNZDU[-?W-GNM=PVJR,]DKFVB_BS\N9ZZTY:JXGXFRGH)1[/ACNQ0QW
M6-@MXL_R,-RD(RPGS.]IWGCIP\^-;LH7Q0J\X,T5V,&-7O3Y9H@U!L9DF>?%
MF,S,+&3S/C/W,XL?TW#":)NY&^LM&>/UPL+LW##%F?[+5S]_R\Z#!?);_N6,
M\+[O^ ]^> T_*+/,XNPH\P^JF%_&F*S>DZRON0]0H> N[O*UZK1^1#TF+6-/
M=G?!EP%K.TRB27OH'W_;_7*8FH U8('][:]?/X%IZ2TZ^PJ=+5E8P52#SDOV
MT&>!"!W!%L1"":-0[_%8R;01X$&LX=6ZBUH_J)X'?_:J\Q?;C+52V3D%(S&H
MX+, ,08$?QG6@-4)^FF\PUBMHK' A[2@+:'Q::!M H)=[RP%-LVA2KZ'6/40
MVRM0]14U8O#9!A7^R["MJHV&"2'T$PP__0U?EY@J*7A^W*>B*]#49JS/FWA6
MHN80BHN WZ+:6YM[6'V\-[GZ^ 3,%Z22]RJ[Q5H2JL"K1J^.L(JU:$;:V;Q"
M3$)1[I<@IK6A(9<D$-*2L@;.XA8AU"AX0 4//5++6!8%T69>%3!5:-H%K61R
M(0-^)UY/XA_X6;$; ?YM@DM P1=NJ:AVEG3:MU 71M2L%=.B@^KV!U%XC25N
MP_8( XRC4$\8S!@-?!;%7 BDMF<'257^IA^E1!O4\,$E=RT)\L^4<84'Q\Q%
ME:I_! V+(F?'[#Q,AO#]VX0=OAB08?S S\29:".78SYFP6.7/V$ 3G;KF&'V
M+,Z+TX'!EC+!AO(M^$9=DQ_QD*^-A_R]?&)^KUME*Q"824N)^E,^L9QSTP]<
MC_VKR?^U7,<Q+,]<TL%D5J2\I(.HN=Z93YVY-6:[E6^?FXTT4G9)1Y59FLJ2
M#@*61JU,Q3T[<QUV87B>L1K+4EW20626I>&9GVN C%==I:59UA/9-VW;<DYY
M\_P<J[LV),4LT4TSI0CZ11-!;4#$>/M,EU\H8.V4W>HEA#SMU(,S^^1_4$L#
M!!0    ( *=%DU@9?1O=0SX  $ ^ 0 5    =&TR-#$R,C$R9#%?97@T+3$N
M:'1M[7U[;]Q&MN?_ O0=N-YD("TH6;+C/&R/ ;V<"*/87DE.;G"Q&+";U6K&
M;+*'9$OI^^GWO*KJ%!\M*98SLL8#3"RUV&3QU*GS^)W7RY_.?SYYM;[V\J>C
MO4/X-\+_O3P_/C\Y>O7R,?\+?WTL?WZY__;PM^CL_+>3H[\_FI1%\SS:W9DW
MT7DV,W7TQEQ%I^4L*6+^(([.3)5-'L$7X:OO;ON]%]$LJ2ZRXGF$E^Z\B!KS
M1[.5Y-D%?)2;2?/HU=^*43U_\?+QNT_QB"J[F,(S7NZ_.OICFHVR)OIF>_?E
MX_U7G^AY?\$KC4W1F(K>Z?3H\.CHY[W]DZ/HX.W//[]] P]Z>_"/Z-W[TX.?
M]LZ.HE_W3D_WWIS?Z0O_5:_W^NV;<WMGNJ"IDJ*>E-7L>;28STTU3FI#9!CG
M)JEJ^/;Z6F/&TZ+,RXL,'G]05O.R2IJL+)@">,M/2(ASWHFCDY.S=WL'QV]^
M_/NCG4?T^[N]PT/[^ZT?>I6ES10OW?GZ130JJ]146^,RSY-Y;8!>\M,C.ODO
MST_M RY-U63C)+>$;<KY(Y$.+\\/[55R\V^^@7OCDK;J['\,KZNU!_3723++
M\N7SZY;<N=.O206[UT1GTZ0R]?/HG_P_MR7GAX-+>_8M+&V>I&E67&SA^8)[
M?O?=]G?/YDWG03V'7S[*BM0@P;?L=^_R[8Z+K,F2/#KZ [@RJTUTF#3&OF0<
M/=EY\HU^4_C/*>_68V*95Y_L$'W2D_K[HFZRR;)%X-VL>/3J_*?CLVA .JVO
MM<53M-%,3?2W//W7HGSQ\KUEEI>/W[_Z6T4?;L(; 3=/\%0WTZ2)80^JZ#+)
M%R:JS-ADER:-+5/Q_R*X(&OJ**E1,M3M9_Q4YG".]"/6U[(Z@E?(FAQOMIB7
M183? 4+.X#9%&M6+T>]FW,!)HC_DV2QK2+K4$5QK[.;CI?CW<5FD&?]Y:BJ3
M%<D$[A75IL'5-],X2AJX>!DU0'&\ ZR8+@$Q!E]/@8?HB^6DO?A>?@O(A6O@
M.\ZK#/X+2W[V?&<GFF_/MIDI-G#+?RNK#]%!UO :-O$KCH#Q^AHP[@_M9Y\#
M.>!5\+VZCQTMFJ@H&WS]RM"[Q/AH(%P]KK*1H6W#M<T7U7@*\CN:5.4L.D !
M?@;;%)T/R&]83!(=FCRY OD!E'5_:"_OH)S-@:9Z5;B7N KABYI$4+21U'I#
MDQ39>0;[3S1? #?CVOOX<GV-I5CPYK!)\.@9+.BL*<<?MJ-S^*I[2]B$L<%K
MRL+P MI?B.B)\$!@0BLLX<(\CX!JYE\+V&UA.[OI<([PKL!%=92:25:8-,K@
M;O!"0!?>Y"<;HTU<2N>F&7-0OL3;9W6]@"_COLR2K&@2>R]\'"I<7&P"C#M>
M5,@K4Y/3GT=E^6$+*%8MU]?H,LOYAV9>UEE35LOHO *R1K(K]DP6);"0,=&&
MI^WA^4% SYYEXIWK,L<3?Y'5P%NPR"D=8UP?4FY]3=XR#K8VXL/^MZK&>]>L
M%_ O)I=+1(; I99,\'HB<L; Y"F3 ?:S7N!?92M8--##C?OFWH4IQD"1O8O*
M&&2H&&]V-<W&TPA-%M[C&B5T,3;RHGAHDOD\7VY_+G9:O_3?V7Z&\O_N5"NP
M1L#1N\@EHDQ%DB'W(/^SK,6_;Z^O'1<1F@PD(H+=LD?%Y+6YPJ/.C.Y/2"QL
MG^?E%9@<_+58-G"6+&FO@!WKN1D3>R![CI,YZ((<%@ZJ8YI<,K?.3%+ +8 O
M@3["2/9IX5L]O[_;SO_%?;T% _B#O3>99'D6*HKU-:1,3<KOG:EJTK2HU=,,
M3F*3LZ HW&_-M"H7%U.2GO"764F[AAMCTBRI,EPZ:-NF*O.:OEK;7T&51Z.E
M?,8B=LQ25RY87[O*FBD<?%X'2=-Z 3LM:A^>M*AYVU"ZP;?JID)IR3<[7>2&
MZ?W-SC,GPPWN+LI*U&)[X^;^'^K >O.;MU\F58H"[I"VHJRTTHMX$^%UU]=&
M]L+47FC%HHC^>TR"CV3P_44- J6&0WZ8++OD01Y/06J8/\9FSO;>6=(L*O@L
MYM^ :^S/>"$+&F#7))H8X"?0_+FY@/^"KLOP E',[T'@ 1^>@0EJB.OE!NMK
MI54WHZ3X@"(L Z;-F@7;HO)U^AYNDK,#D=>313,M*Q1C>,<*#(^LXB,$IA=^
M5*)I%UV4X%T6J-Q@7<G82MEQ7M;FX>XTVFM@*Q&<T)%EW2U1,@!%Q]$?8 L6
M%W0BY#8/FU1E 98RVK:],L/*X9JLWU!8Q.#O6_?NJYWMG9V=W6B.KA-:SC%1
MDZQ)XL5Q#BX>WJ#V] ;E4,H90&&^OJ;^ABK<N2>HR$%@X2W0NR2NYVU*_T,V
M)SJ",PZDADM[A#N26=$NW"8D%HD2<.\R4<1"]:MR 3Z">--TD5CJC7BT:)>/
M2;J 9Z?<8.T3H>$\SA<(_(#]!6JZ!/?2>]TB,LT(#(=Y92:F0E%5\S?)QH^C
M<LY77HEQ[B181GJ<_#TT/2)T'O0Z0-$3@#;*#7,3?%,\_ 0_HU^94^AW\ ]B
M=_<K],GEY>N!MQ>7(P[=Q@?+<VQ>]=J 9.E=9BGZN'C\E->/<J IX*O3; YV
M.?J2Q!1R"9_711%\ D>Y'&?R_=]+V+SH$M:T0,E!S /7@$$Z JL4?-FQ2)SU
M-;Z4Q9']5"FZ:(-4;)20>X?/!1<3UUUG#!3AQFYZ!J/M7Y+G##P%:O@!"Y13
M<LAYSU"LP#X@R?KEO@@/[XVK+P/YY;L(1;T&GYM?]&SK:;3Q.H-S]J84K^_I
MTZ=;3[Y]]L.WWVT^7,)Z$V)]#?R(?H*&O@9RW.X/3Y^2)Y, *5-T22TR4X&_
M4O,[XD= ^T4N$.:\*F>+_(+.4.,PL =,6ZNUE@.>:>TN:.L] H,1MT%8 "$$
MA&[ OP=% *3.ZU(4EV$-12Z1=FE7W!IQ)I."#5]9_9@R*!RU,.&'NS'G58(J
M?\B?(B?)N3A".X^C@N,$PB0UA'\GD=PL^CFI/IC[[(@_\H')_[6U%;W.3)X^
MC]Z!NGD!U_]K@6 AW#;:VK*1LL/C7^PS^4Y;33F'2YY@'$P^&95-4\Z>1]_B
M9Q([M)_MYPG0:Q<>7J-G"0MX%]Z/5J9?].5C>&;/XT=@37_8&AE@7ECCG-:L
ME_1MSXIPF;=]I"+,8Z0,$^,^[N9='0%FVWZ[7"2'1RIG='&M;=-Z]4G)$4<G
M(PKN+3 W'1^\G<2_4.8@@ F7F!I5Q7/Z^,UO9T?1W@S>?8RTH(^2.DW^%1TP
M%BI'+OC3CWDY6OF7,X;D@PLL/D&K7E^S?G0<O3T_^+_[N'C\X;_$0$.Y/1X;
M, *KFKP,32G0=V#E73Q@B^&<DB0PAHAQB![.^84WWUX71R<G!TQHL"(J\H?D
M3V3J-AW77/#260(&-'!)DJ:580=\]_OH))DD2]. EGH'TL6 6?UK6:; );!=
M;WZ+=G>?_?"]\]_=1JU^Y,/=K/=H85VA[89GW06,^LV\A;H8Z.2"2ZEX/4BU
MO7F5Y1)2^($3#Z*1::Z,*3H&S+O%"&R6Z!?VC6IB!+@-!Y_=PY!#M"$Y*U,'
ME-0+,'MH%2@Y,)!+KC.&6_!?A,S'X)BE"<:YB&TP^$? ^L/=4Q<DYCA@M')7
MDX:BC D&" 6A$/^RL\&2'S!"# 1WJ#<'(.[;[?4U:_WK$.5]MH7N<@L&3I.5
M?TR+'I&D]^,_1R()Z>I>@%ME$5!^">$<@4GA$AZ$>K7-+1@M _G3#J1K0>A/
MS#TF\[V(A3_IC85;@4"!\/M+P3_%J,EFYS7!59Y$*F-LVTM$R0IQ3(O(_\C
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M$^268H(YVGP@$EQ-)4(PN63\^LQ*>+BR[OQB!5DIDID)=[2]D[%#9X:= Y=
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MQ-/W+I#3Q'PE?+<3AO4R7!H$^ $[-7M0(ZQY&K'CJYMQ!X#\^EK'WZ6H#T\
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M/Z)SV,FSUT>G<71R<M#6C+VBX*/5Y9]4@S?5OG]"^MTCS7B-'+Y_M@"IGT_
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M-#$R,C$R9#%?97@T+3(N:'1M[7UK4QO9U>YW5>D_[..3I$25C,'8,^-+7"5
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M%D0)>I!*SJ4R!]O=V7X.5(Q7DC_0YXD4@ -'8C\H=$(586)($ \67R0*,8C
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M4N(ZT1IOYP=J)I 8AY[UX\[HQSF>E3X$\@BO(!![NC!X(?J*'*['\.#X?EW
M?L,VOZ9/CS^?]U4/#!P@ZH2OTG&03X)?U4$PCPH@5[U8^U6[]2%.1[5?*?GF
MG 2%_P-M&?&L^[*TKCH9'OQE'^>.__BKZB"-(BW:^*78A&:G@#.GL++OWZ'Y
M_(TZF9,9^1K'%=WR#?-"^/K;^#O77V(5B.*[.G=J)D,N37<3]/+?J.%R#JOL
M9<$H&K\!"IJ%O$7'*2[\N>?QU$_A-X_>V$V!;X#=QC'&_LA5I(PN&+K>5$_I
MXEC1;8817NHI^5:T8Z<0;Q5^*HZ6\LN @X5!P491#H*&.%<XH<@BS&0<Q*@%
M:-'C&2+6KQODPEKSU_>76]1#O/ZJ_JP^JT[OZ?[6L]Y#P*S=X)EO\!B&!%8^
MZ!\=G2+*^?C#GY_L/*&_ST][!_IO>>E--"FN\*T[?WRC[CJ#V]C=\$R_!O12
MT%:#6.\%/(CI'V^'A^6)$"CHV?#P7?6[G>T7^"T0A/[!NY6V(IM- BL3BT9,
MM4Z6XI4U'R<A/E&(WY9<LBA7\2W/AF?X?[BI#_W <"ZW'1FF =4>FE[4\+#A
M5W)\G^7XY$>KC[!L]VCESV&]!C]H @+.P2%8TA[=X^']NX?7JSF\&N="U0)[
M/).-G<E^S9GX[IIONOG?TD4YV8B+$NQL!/):0]N"?W9?O."@Q6+T-!<G(,RB
ML[?E6< 2!R3F%('41U'3924Q+])TPD8SF"))>L,@+@8]U=G>^8)\ *N=?NAX
MJ54=+7Z+/!CY.(M&[,"X35D-1NFU:)#M%LC1"<*.26!>!=?HKP@QT/+K(D)T
MELR]@&/U)W8#KV4)O*T^@3$"8V:_=6= -K.?9@YDDTZ,L[CD!_A=-ZS=,CIW
M:<,H@@JFV\1S131MUO>BI:\$4CS?$)#BEZLP:;<,C^MK "(C6_HKXTY-QT/T
MS%!&/&[/]>D@!"AHC8/J\#KYI,CAYX2N76]:Y=WV=13P->%4JXT:#R'<!<)D
MDU6'EZM;BC> OHKAYV"&095D2;D2T30:DUL_<__D0%=)O3*;T7!KW.!?[0V@
M.*J&7*S@%00IUG<8-;U,_D7\-0LQ7FN,85$?_NUP]8.X0WN; H:',:(IE^3+
M\#CH@4LTR(V/;9B=;U@/*"=E#IF%09XF0#IX3Y!Q<E2 <3<K(\!EG RP]2 3
M=W+$CG@& Z -0*&U+ P52%H^"_>ZY4PZ]-)NZ08Q$B3\.@\3F$,G2L;QPL0Q
M=+1YM$21Q!AIN$@VND'<6!7!US#?ZL),"-&P,"$YL2TE\(?7D >9P V@[:T8
MGIK$89Y.)H2]6+EZ15<*Q@ ZNWBWN^/<L"ZAAQPKENC?683SG0"^G;68@#@O
MAT*G$PI.?#<^H=\#@18 1TO3+T_A51EP:\QQH^WN, AE#@P2) 0R7/0@@+I-
M4/@XO 2FGM.)V3/8J@EPDQ"P&*FN2;=CXNI2G'I)46OD\1.5I,G3( ?5E&&:
M5:>'C9 (+5AX9U)$15QFG&^0VAX&"6P&"X/,:8Q0<\/+2'O5J ',(&L (\'Y
MQM$7C(@E>.4Y4]$H?_I6:Z+(0H2J(7-JDGUK&P3,@"\CP@*P6J,Y41E957FV
MQ"2%E2TU2RDGK*"2X$/1:D =I,'<]N;O/Y2U]QBUHJC5WF/4ZELKBB\VI"CN
MATG(>(YVZ^0F 97]*IJKHV@6%11UTND$9>0GXBV$\9 NUZ@&ZIPX3UCATV0[
M>(FW-@"W"AV]$N7+%@MP) .OZFK&")N*3(S\#0W\D]@8L6 D9_H1PE>LN62S
M5<4L=!2P8T8)._!_SYSK5"&^_(U!=O>FTRB.2"_OX+O(*D2L182NBBE"4PB(
M;?U5+W9>H@4W6\27@<UIPZ'/+<BE-RZVQ.^2:'0X)^<!<Q]3LCMJ,>HR2RF_
MN7Z62A +&K&Y8NXL#/@-70,4N7C7*T!_&C&,YA1E!:8^7Q@0.&K@E'\X,B2)
MM0IN$I3%F,&7&XS-;41+^R=;QGG%6W7X&@=F 2>+[JJQG)D5T/4%-BISK )'
M=;*ZLS/X4<TFR)U@L1RN]_Y&/:'=HNTW/J?:" O]1 .>>,=,G&463& 3,)]!
M)^[=85H\/!TC>0K\:1H,D\\M',VH2^JOS?UP>("WK.KVE^TC3:UP8_Q#@&_J
MSL"'.=D)9I@"@GF)#OAKD=@9P@]PRORCPI^RO6\N'*Z<O&_4L2Z=5KI ()NF
MY&[M(.4" ,ZV:R/ =<=HSPM"C-BE"X8S,UERZ=8?9E>M,;-).$*.G(6<OZQK
M%A!+[ZITSK^\D6/3?)F22[(%U]20?& J3J!G)-L9D9&>P+P))^:DK%O8&&.]
M4?UVN;[>AKQA'P1MV[5KIV(4EI([]?445!_V#TPXK%W@9K!LN?9^X&P3"@J7
M@C+'_98$<7J9+G(MH>Q38)"D.JE%D)?KDWR9[=13O)M ;\6:^#H,'A38B6&,
MTSJ 8M5I^ *9>M>9+\V66;0Q536NA=TKY8P./W%G#P-!DL3/"%M'NFF('8HY
MG-3NJ[T7;);/*/I031VVOR\5QQ!%Q2D:@!]E7!Z G#>.K*6)9"%)7(IX,/?T
M0AO^^;@A(+JU@EK-0MAMW&4I.U-^A!B?BP-BZQ3S*N" ;>):\Z:)U>9L5$DI
MBW("UA.B-P=.G4=RJ1BDB(E.N"D$3XK$ZS5"<'%</C_9%IP0:(U5Q<LG<V6I
M7->':* G5K10CV:;U15=L,";*U9:_$2D*/>8!G!:J>^#REM:PU5K;I6O#^%V
MW"[0MS@!<<I\N=UJT&15:7[67;]6KH,^0V \,Y"S6N;4Z*&UKGNI(%'2X];:
MV?+$[[2Q6G7\#^QLDXE0FA^YHLE935X>8=1 J6E)F51UNJ3=:-\ (O,E@<6.
MP'HS2[]&*V\I:@.5CR(K80Q;$8R71H_QMGF[W1K '9IPHBDZF_Q3" PXF%5T
M=%(NR#&#UR<$-D!\U(GH<@#,Q;/?E</6<HOU.*.RC+$!U-XH,V"B>MHD>WR=
M$_0/6'I"GJLFE<6YN>@ SY"GB:EVEX$X]C&-*5Q(1E>GYR#@RSFYLS0O2*4
MVN/H-18)HYH6F&[#:1+"+HU=Y0@QW$VSXS@/N<\UA9WX&T]R418?12^1O''9
M(Z#YSKY,.(#I9:&9'A?6@IFE"Z &-[2@Z1LFWCFH?5AGQDI"K/\<)5OAWT,=
MB>A=XD.@7)!H8P5C+3/".2#)2L7']-M1S\MH6PDL6^*+3#7^7=4QIIO4EM#U
M<F'T9<5QXZ4.4NEJ=&6AO,8*"HIA>^L8<-0+#ZEL9*Y!D'7W>H47V%,Y'1_&
MJF)TCL+O65O=JJ*YGDV51\AOC#\\8./',4'OM ,W="<YX8@]4DYB^6H>7JDG
M1;+PQ?:K5W^LAJ/MZROH$W>67M)I\T$8;U(CK:SK].<U:^E//Y5[6,85( N
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M;-69 A4=F&/V!*?_"..I2=XB_U,<*T][ZVL7DU0G\W:,>*4OG1NY324CL2&
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M+'?U^V"$B8,&,?.91/D(A+UXKAWIK86TFX9@TF:M5<]"TS7NO7KO=0ECE!2
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M>'80>!T;99E@2>IHQ*X#H,A$,AI]+*Z\QM8BD9&VV/Z?IG&<WN"]=G9#F$1
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M7])K^2$DXQD0!UX,W[+]U,&\B8JR06)4*;U9C$\&,M;#*ANDM(6XM-F\&DY
M1T7CJIQ&NWF:5+AIT5DZG!1E7I[#KH/^+JM96=&S@'317IHGER Q@<[V\W!Y
MN^5T!A36J\*=Q54@B]0D<:.-I-9[FXR0KZ? "K1O<V!K7'@7@ZZOL=#V7KL<
M1_#<*:SFM"F'G[>B,_BJ?478@&&*UY1%R@L(OQ#1$^&!P(]&-\"%>1X!R=)_
MSF&GA0/-AL.!PKL"5>IHE(ZS(AU%62%'_]/;4W@Q( [__FQCL/GFNT]O'XS5
MURUD1(C?GKP.Z;2#1!+YO&5)N8?4Y4--1 0?L8A0XQ#WR;:PQ# ;D>9U>HF,
M!%OB;2KSU!BLDO(2-!9_+8XN)]EP @2YHK,#6U[/TB$(/E!^^54T3&8@=')8
M.,BH27*1TDVF:5+ +>"0 'W@RH88@)[6S07T=J_N+POPOTIYK\(,[GCVQN,L
MSWQYM+Z&5*I)XAZG54WB'17)* ,%T@!M46,4]K=F4I7S\PF=4_C+M*0=Q$U*
M1UE29;AT$/%-5>8U?;4VOX+^B 97\AD?YB&?;[E@?>TR:R8@PW@==&[K.>RZ
MZ!IXTKSF+43Q"-^JFVH.'_#-3N9YRO1^L?W22HL4"#F<5\")0.7>L+G'!_P/
M[NZ[,JE&H)O&T1YM5EEI 1SQ-B-!!G@ABM>1N0Y_P;^(8GC$-)K7('UJD A[
MR56;.G@(1B!BTM^&Z8RMD-.DF5?P6<R_ 5N9G_%"EDK STDT3H'A0 GEZ3G\
M.RGS#"_(V%KZ!-(1&/44#*.4CH7<@$P)OLD@*3ZCO,N J[-FSA:2?)V^AYMD
MK1$\#,F\F905RCR\8P4Z$/:3SAB8 /A1B29&=%Z"EU"@XH9U)4,CDH=Y6:>/
M=Z?1=,C R"V+#F'7WA(E)%"V]'\#LZ0XIQ,AMWG<I"H+,-K0S.H6&2*H:S+$
M?&$11[/$N!Q_VM[:WM[>B69HT*,1%Q,UD=F9%X<Y.!YX@]K1&[1'*6< I?WZ
MFOH;ZGMK)J/6!X&%MT"/A[B>MVGT;[(Y41_..) :+NV0[4AF13M_FY!8)$K
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M&C6.DO#]M_*O6N!WW@KO'ZUO/8A_RWRP@]EXQ02'9WMPIQ*5W_?@;A7-I.:
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MC^QU0G5][;J;&H%B# SA%;.1_!9@&= 1Q Q_68&@K2=.@5S_!+PKBWNC;.@
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M3 >@:5,T-0S;>MSJF-3<N O[1P(SSRE[ID,UXS15.AT?@ U.GF*K"=AO; Y
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M)(2MT H"CW:B2AVS]'*11VYR6E-JD1%^271>E11[Z+ZK:83877/C'B40=GF
MQOWUFJ;*!G-.UU&AN#^$:3.64,\@+5)T5ZATO[RD" LFEVQCENB=O2(ZNI2N
MJXK9O$X=@S0O+S?-R*SW7'?+4/92LM"V,YG5X6$=[X+\5[C23A\.K55%'_Q(
MD2(22AC$*L=VT]6>3YR%O-(18=5>;!?P7O+ ::,:\V2$W.)F=M@:"*>!\;*
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M9_M&B@X""(B]M#^ITA4];4V0_9FZ,SN0]K8;I)XXLIM<E-G(&#6C<HZS?%V
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M<;1 %-_4<*%;J#$4V+J"BH6K(9><..V^OI:.D0L(0%@.*&7CWEN4A\DF,D[
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M:^-"M<:(5)>F1Y2C$@ L)25,\P"YI<US,\S!#& *)YCEN0X*^[/"8@D\W_]
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M%L&;Z@,8"C!F\5MW!H0S6\=S()M\;%QT@?7UIV[86L\HW<&&410R&UD[FPS
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MDVW!"8'6V%2\?#)7ELIU(G4'/;&BA7HT6P^NZ((%7DU9:?$S?)+28QK ::7
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M\7-2MZU*0#-QJG5X0B? !N(B.F&Z6O7GIH94M2KG_QVBX4!EHV.^5<)U=!N
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M-S"+Q N$;3&U.*-4PB"#7_QW+ON (?RK@\>, D_\C"P3X83>^]Y;@^02T&S
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M7%#?TN)2N#'LTZCQ&Q)M/$T35W-V!C7,Z+.I%11154M@/&Z^'$R(%/)P3K_
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M3%>SQ)C,"069\:28W'PG_1L)R(2>62&GX',\OA^,ZN6*&-41EN+<BX!YG(&
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M-$K>F?@U.,FMRGLQD@(.-B-;VC)Q$@16@2*R<3-TN/NK[J)435LJ>"XHCNU
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M<^I+'HQ=5_P'51)UXO.[:U]C\=<YW)&[._N[_H&QY;I/.(_9+0U/#@Y(6_;
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M,#(T,#0Q.2YX<V102P$"% ,4    " "G19-8H42:'_T*  " A@  %0
M        @ %: P  8VQI<BTR,#(T,#0Q.5]L86(N>&UL4$L! A0#%     @
MIT636%YYNU]8!P  UU<  !4              ( !B@X  &-L:7(M,C R-# T
M,3E?<')E+GAM;%!+ 0(4 Q0    ( *=%DUC'?_2N(2$  "''   2
M      "  146  !T;3(T,3(R,3)D,5\X:RYH=&U02P$"% ,4    " "G19-8
M+/]0%HNF   >R0, %0              @ %F-P  =&TR-#$R,C$R9#%?97@Q
M+3$N:'1M4$L! A0#%     @ IT636/5BE=4X3@  =I0! !8
M ( !)-X  '1M,C0Q,C(Q,F0Q7V5X,3 M,2YH=&U02P$"% ,4    " "G19-8
MV(3#9?@,  #4/   %@              @ &0+ $ =&TR-#$R,C$R9#%?97@Q
M,"TR+FAT;5!+ 0(4 Q0    ( *=%DU@\;5?;*PT   @^   6
M  "  ;PY 0!T;3(T,3(R,3)D,5]E>#$P+3,N:'1M4$L! A0#%     @ IT63
M6'OL"?DZA0  +>@" !8              ( !&T<! '1M,C0Q,C(Q,F0Q7V5X
M,3 M-"YH=&U02P$"% ,4    " "G19-8&7T;W4,^  ! /@$ %0
M    @ &)S $ =&TR-#$R,C$R9#%?97@T+3$N:'1M4$L! A0#%     @ IT63
M6%08>2KA10  :W,! !4              ( !_PH" '1M,C0Q,C(Q,F0Q7V5X
M-"TR+FAT;5!+ 0(4 Q0    ( *=%DUB&@KD[SD,  %9B 0 5
M  "  1-1 @!T;3(T,3(R,3)D,5]E>#0M,RYH=&U02P$"% ,4    " "G19-8
MQ)IB2G)#   M:0$ %0              @ $4E0( =&TR-#$R,C$R9#%?97@T
M+30N:'1M4$L! A0#%     @ IT636--B$\KF#0  ZBT  !8
M ( !N=@" '1M,C0Q,C(Q,F0Q7V5X.3DM,2YH=&U02P4&      X #@"H P
&T^8"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>tm2412212d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clir-20240419.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434524</identifier>
        </entity>
        <period>
            <startDate>2024-04-19</startDate>
            <endDate>2024-04-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-19" id="Fact000004">0001434524</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-04-19" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-04-19" id="Fact000010">2024-04-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-19" id="Fact000011">CLEARSIGN TECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-04-19" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-04-19" id="Fact000013">001-35521</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-04-19" id="Fact000014">26-2056298</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-19" id="Fact000015">8023 E. 63rd Place, Suite 101</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-19" id="Fact000016">Tulsa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-19" id="Fact000017">OK</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-19" id="Fact000018">74133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-19" id="Fact000019">918</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-19" id="Fact000020">236-6461</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-04-19" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-04-19" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-04-19" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-04-19" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-04-19" id="Fact000025">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-04-19" id="Fact000026">CLIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-04-19" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-19" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
